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i
Abstract
The  prohormone  proglucagon  encodes  for  multiple  peptide  hormones,  including 
glucagon, glucagon-like peptide-1 (GLP-1), and GLP-2, produced through tissue-specific 
processing  by  prohormone  convertase  (PC)  1/3  and PC2.  In  alpha  cells,  PC2 yields 
glucagon,  the  major  counter-regulatory  hormone  to  insulin,  which  together,  control 
glucose homeostasis. In contrast, GLP-1 and GLP2 are mainly produced in intestinal L-
cells by PC1/3. GLP-1 stimulates insulin secretion following a meal, and therefore has 
opposing  function  to  glucagon  regulating  glucose  homeostasis;  in  contrast,  GLP-2 
enhances gut nutrient absorption. Efficient sorting of proglucagon to secretory granules is 
required  for  nutrient-regulated  secretion.  The  aim  of  this  thesis  is  to  discover  the 
molecular mechanisms by which proglucagon is targeted to secretory granules, which 
ensures that proglucagon is correctly processed to mature hormones, and is necessary for 
prompt  physiologic  response  to  nutrient  status.  This  thesis  identifies  several  sorting 
signals contained within the mature hormone domains of proglucagon that encodes its 
targeting  information.  Using  quantitative  immunofluorescence  microscopy  and  co-
localization  analyses,  the  molecular  mechanism that  sorts  proglucagon  to  granules  is 
directed by the domains of glucagon and GLP-1. Despite these two hormones sharing a 
large degree of structural homology, it is their particular alpha-helix structures that enable 
the sorting of proglucagon. Further, the evidence suggests that proglucagon is first sorted 
to granules prior to being processed to active hormones. In alpha cells, carboxypeptidase 
E is  required for the sorting of glucagon to granules.  Together, each neuropeptide or 
peptide  hormone  carries  with  it  a  unique  sorting  “signature”  to  efficiently  reach  its 
destination, and allows alpha and L-cells to tightly regulate nutrient homeostasis.
Keywords
proglucagon,  glucagon,  GLP-1,  peptide  hormone,  carboxypeptidase  E,  prohormone 
processing,  protein  trafficking,  protein  sorting,  confocal  microscopy,  quantitative  co-
localization
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1Chapter 1
1.1 Introduction
Proper  regulation  of  energy  metabolism and  glucose  homeostasis  are  crucial  for  the 
survival of any organism. Collectively, glucose homeostasis is exquisitely regulated by 
the counter-regulatory actions of insulin and glucagon, the major hormones secreted from 
pancreatic islet beta and  α cells, respectively. Blood glucose is the primary trigger for 
secretion  of  glucagon and insulin  in  the  maintenance of  euglycemia and the defence 
against deleterious excursions of glycemia. Insulin and glucagon target the liver, skeletal 
muscle and peripheral tissues to regulate glucose homeostasis. In order for these islet 
cells to be responsive to blood glucose, islet cells must first package these hormones in 
specialized organelles, called secretory granules. Granule storage is a prerequisite for the 
conversion  from  inactive,  precursor  prohormones  to  active  hormones,  and  for 
maintaining  concentrated  stores  of  hormone  such  that  physiologic  triggers  promptly 
counteract changes in nutrient status. The mechanism of packaging insulin in granules is 
understood. However, the underlying mechanism of glucagon sorting is not, and it is the 
aim of this thesis is to investigate this mechanism.
1.2 Structure, Function and Distribution of Proglucagon 
and the Proglucagon-Derived Peptides
Proglucagon is encoded by the glucagon gene (GCG), and expressed in both pancreatic α 
cells, enteroendocrine intestinal L-cells, and select neurons in in the hypothalamus and 
brainstem.  Post-translational  tissue-specific  processing  of  proglucagon  is  achieved  by 
cleavage at  dibasic  amino  acid  sequences  separating  hormone  domains,  and a  single 
mono-basic  site  to  produce active GLP-1 (7-37)  (in  L-cells  only),  by the  differential 
expression and action of prohormone convertases (PCs) (Figure 1). In pancreatic α cells, 
where PC2 is expressed, proglucagon is processed to the major product glucagon (Figure 
1). In contrast,  PC1/3 expression in enteroendocrine L-cells and neurons produces the 
major  products  GLP-1 and GLP-2,  and minor  products  oxyntomodulin  and  glicentin 
(Figure 1). Further details of the processing will be discussed in the section “Processing 
of  Proglucagon.”  Once  secreted  into  circulation,  the  proglucagon-derived  peptides 
2(PGDPs) transduce their actions through a family of related receptors.
Figure  1. Post-translational  processing  of  proglucagon  to  its  derived  peptides. A 
schematic representation of proglucagon in which each domain has been colour-coded, 
and the amino acid positions of key processing events have been identified. The amino 
acid numbering is relative to the first N-terminal amino acid of proglucagon (lacking the 
signal peptide). The major hormone products produced from tissue-specific processing by 
their respective prohormone convertase (PC) are shown at bottom. In pancreatic islet  α 
cells,  the  major  products  are  glucagon and major  proglucagon  fragment  (MPGF).  In 
enteroendocrine L cells and in the brain, the major products are GLP-1 (1-37), GLP-1 (7-
37), GLP-2, oxyntomodulin and glicentin.
Glucagon, GLP-1 and GLP-2 all mediate their effects through cognate G-protein-coupled 
receptors  (1),  known  as  the  vasoactive  intestinal  peptide/glucagon/secretin  receptor 
family. Mammalians have well-conserved proglucagon and cognate GPCR sequences, 
suggesting their physiological importance in early evolutionary nutrient metabolism and 
regulation  (2,  3).  This  receptor  family  activates  adenylate  cyclase/cyclic  adenosine 
monophosphate/protein kinase A, and may also couple to phospholipase C and store-
operated Ca2+ signalling (4–7). The proglucagon-derived peptides have a degree of cross-
reactivity for other PGDP receptors. Most importantly, glucagon and oxyntomodulin are 
very weak agonists of GLP-1R by about 100-fold, while GLP-1 is a weak agonist of 
GCG-R, approximately 10-fold weaker than glucagon  (8–12). Though their sequences 
share homology, the PGDPs exert distinct biological effects in the regulation and counter-
3regulation glucose homeostasis.
1.2.1 Glucagon
Glucagon  is  the  primary  hormone  product  of  α cells,  the  major  counter-regulatory 
hormone to insulin,  maintaining euglycemia  and glucose homeostasis.  The prevailing 
belief is that glucose is secreted in response to a hypoglycemia (i.e., a fasted state or in 
exercise), by primarily acting upon liver hepatocytes to increase glucose output through 
increased glycogenolysis and gluconeogensis  (13). Normally, fine control over glucose 
control is achieved by the coordinated and pulsatile secretion of glucagon or insulin (14). 
The  importance  of  glucagon  in  this  balance  is  seen  when  exogenous  glucagon 
administration  potently  stimulates  large  and  transient  increases  in  blood  glucose  in 
animals and humans  (15–17). Mouse models in which proglucagon is globally deleted 
(GCGgfp/gfp)  (18), or glucagon signalling is abrogated either globally (GCG-R null)  (19, 
20) or  only  within  liver  hepatocytes  (21) causes  the  development  of  a  slight  fasting 
hypoglycemia,  improved  glucose  tolerance  and  normal  insulin  tolerance.  Post-natal 
GCGgfp/gfp mice  are  severely  hypoglycemic,  and  the  normalization  of  glucose 
homoeostasis developed in adulthood is an adaptation due to dampened insulin secretion 
and  down-regulated  hepatocyte  signalling  mechanisms  to  compensate  for  the  loss  of 
glucagon  (22).  Taken together, glucagon is  an important  regulator  of  hepatic  glucose 
output in conditions of hypoglycemia.
In the relative or absolute absence of insulin, glucagon secretion becomes dysregulated. 
While a healthy individual resists hyperglycemic episodes, increased glucagon output can 
be considered a general defence to prolonged and severe hypoglycemic episodes. In both 
T1DM  (23) and  severe  T2DM  (e.g.,  approaching  insulin-deficiency)  (24),  glucagon 
response to hypoglycemia is lost, resulting in more severe and recurrent hypoglycemia. 
T2DM  is  further  characterized  by  hyperglucagonemia  and  increased  basal  hepatic 
glucose  output.  Fasting  hyperglycemia  in  T2DM  is  further  exacerbated  by  the 
inappropriate and paradoxical hypersecretion of glucagon in a hyperglycemic state  (25, 
26), leading to prolonged hyperglycemia. Dysregulation of glucagon secretion is central 
to  the  pathogenesis  of  T2DM  hyperglycemia  (27) although  the  exact  mechanism 
underlying  this  dysregulation  is  debated,  involving  a  mixture  of  abnormal  intrinsic 
4signalling of the  α cell  and abnormal autonomic or paracrine control. Since regulated 
exocytosis  of  glucagon  involves  membrane  depolarization  and  elevated  cytosolic 
calcium, it is not difficult to imagine that a change in electrical excitability of the α cell 
may contribute to this pathogenesis  (24). As T2DM progresses, impairment of K-ATP 
channel regulation results in the relative decrease in glucagon response. This mechanism 
will  be  discussed  in  further  detail  in  the  section  regarding  mechanisms  of  glucagon 
secretion.
1.2.2 GLP-1
Glucose homeostasis is also regulated by GLP-1, which exerts insulinotropic effects in a 
glucose-dependent manner, and opposing those of glucagon. GLP-1 and GLP-2 are co-
secreted  from the  enteroendocrine  L-cells,  located  mainly  along the  distal  ileum and 
colon  (28, 29), in a bi-phasic pattern of secretion and in response to nutrient ingestion 
(30–32). GLP-1 makes an essential contribution to the control of glucose homeostasis by 
direct  stimulation  of  insulin  secretion,  as  shown  using  both  GLP-1R  antagonists  in 
humans  (33),  and  using  GLP-1R  deficient  mice  (34).  In  contrast,  GLP-1  indirectly 
inhibits glucagon secretion (35), in healthy humans at sub-insulinotropic doses (36) and 
is maintained in T2DM (37). However, In T2DM, both the early and late phase of GLP-1 
secretion  is  reduced  (31).  Evidence  from  mice  (38) and  humans  (39) suggests  that 
glucagon suppression acts through paracrine modulation of α cells via local secretion of 
insulin. GLP-1 also decreases gastric motility in healthy lean and obese humans with 
T2DM  (40–42),  and  decreases  gastric  emptying  and  appetite  (43,  44).  As  T2DM is 
accompanied  by  hyperglucagonemia,  this  may  be  explained  by  the  loss  of  GLP-1 
secretion.  It  would also suggest that a healthy individual maintains tight coordination 
between the glucoregulatory GLP-1 and counter-regulatory glucagon.
1.2.3 GLP-2
GLP-2 is recognized as an intestinotrophic factor influencing multiple functions of the GI 
tract.  Unlike GLP-1, GLP-2 does not stimulate insulin secretion  (45,  46), but it  does 
stimulate  glucagon  secretion  (47).  GLP-2 increases  nutrient  absorption  from the  gut, 
maintains the integrity of the intestinal epithelium (29, 48), and increase mesenteric blood 
flow in humans  (49). This is especially important in intestinal malabsorptive disorders, 
5such as short bowel syndrome or distal bowel resections, whereby GLP-2 administration 
promotes  intestinal  growth  and  adaptation  in  humans  (50,  51).  Therefore  GLP-2 
indirectly contributes to post-prandial nutrient absorption and nutrient homeostasis. In 
T2DM,  the  stimulation  of  glucagon  secretion  (45) further  contributes  to  prolonged 
hyperglycemia. With respect to the islet, GLP-2 protects against metabolic stress (e.g., 
from high-fat  diet),  and  is  essential  to  the  adaptation  of  α  and  beta  cells  to  obesity 
induced in mouse models of obesity and GLP-2R knockout (52). In this study, the obese 
and  GLP-2R  deficient  mice  had  a  disproportionate  loss  of  beta  cells  and  increased 
number  of  α  cells,  leading  to  ambient  hyperglycemia  and  elevated  glucagon  levels. 
Pathological  expansion  of  α  cells  is  known  to  involve  the  up-regulation  of  pro-
inflammatory cytokine IL-6  (53). IL-6 is known to mobilize serum FFA levels in mice 
(54) which causes oxidative stress and is toxic to beta cells (55). Such a mechanism may 
be operating in the GLP-2R knockout mice. Additionally, elevated IL-6 shifts the α cell 
phenotype toward expression of PC1/3, therefore producing intra-islet GLP-1 (56), and 
later co-secretion of glucagon and GLP-1. In mice,  this  links the action of GLP-2 to 
controlling systemic inflammation and cross-talk between islet cell types with the gut, in 
order to preserve normal glucoregulatory responses.
The  diverse  actions  of  glucagon,  GLP-1  and  GLP-2  operate  in  balance  to  maintain 
nutrient  homeostasis.  In  a  fasted  state  (Figure  2),  glucagon  is  the  safe-guard  to 
hypoglycemia  by  stimulating  increased  glucose  output  from  the  liver  to  maintain 
euglycemia.  Simultaneously,  fasted  blood  glucose  levels  are  below  the  stimulatory 
threshold  needed  for  insulin  secretion,  and  the  lack  of  ingested  nutrients  will  not 
stimulate secretion of GLP-1 and GLP-2. Beginning shortly after meal ingestion (~15 
min), GLP-1 and GLP-2 are secreted in the first phase (Figure 2),  initiating the ileal 
brake, modulating gut motility and increasing intestinal nutrient absorption. Therefore, 
GLP-1  and  GLP-2  are  together  control  the  “optimal”  rate  of  nutrient  absorption. 
Absorbed  glucose  directly  stimulates  insulin  secretion,  further  increasing  insulin 
secretion by the action of GLP-1. Together, insulin, GLP-1 and GLP-2 act to suppress 
glucagon secretion and therefore prevent its anorectic effects in the absorptive, fed state. 
Perturbations of intestinal absorption or secretion, or insult to islets (e.g., by oxidative-
6stress) disrupt their balance.
Figure 2. Overview of key metabolic actions of insulin, glucagon and GLP-1 on glucose 
homeostasis.  Hypoglycemia  triggers  α  cells  to  secrete  glucagon,  which  potentiates 
hepatic gluconeogenesis and glycogenolysis. After a meal, ingested nutrients potentiate 
GLP-1  and  GLP-2  secretion  from  L-cells.  GLP-1  regulates  glucose  homeostasis  by 
increasing insulin secretion in a glucose-dependent manner.
1.2.4 Oxyntomodulin and Glicentin
Oxyntomodulin (OXM) contains the glucagon sequence that is C-terminally extended by 
IP-1.  Oxyntomodulin  modulates  appetite  and  body  weight,  as  well  as  gastric  acid 
secretion.  Oxyntomodulin was discovered in 1981  (57,  58) for its  hyperglycemic and 
glycogenolytic  hepatic effects,  mediated  through  the  glucagon  receptor  (59,  60).  In 
randomized clinical trials in humans, it increased energy expenditure and satiety, while 
decreasing food intake  (61, 62), consistent with effects seen from co-administration of 
sub-physiologic doses  of both glucagon and GLP-1 in humans  (36).  OXM has weak 
affinity to both Gcg-R and GLP-1R, when compared to glucagon and GLP-1 (9, 11). For 
instance, it is (~20-fold) more potent than glucagon to stimulate gastric acid secretion 
(61). Despite signalling through both the glucagon and GLP-1 receptors, it is believed 
that OXM is a GLP-1R-biased ligand, showing a preference toward phosphorylation of 
7extracellular-signal-related  kinases  (ERK)1/2  and  less  stimulation  of  in  vitro cAMP 
assays through differential recruitment of G-α subunits when compared to GLP-1  (63). 
This bias is consistent with the recent findings that OXM elevates the intrinsic heart rate 
in mice through the GCG-R and not GLP-1R (10, 64). These properties make it attractive 
as a new class of dual-agonist for anti-obesity and anti-diabetic therapy as the potential 
hypoglycemic  effects  are  tempered  by  the  GLP-1R activation.  Similarly, glicentin  is 
OXM  that  is  N-terminally  extended  by  GRPP.  It  has  even  less  well  understood 
pharmacological effects despite also being co-secreted from intestinal L-cells. In humans, 
glicentin opposes those effects  of  OXM on gastric  acid secretion  (65);  it  has  similar 
inhibitory effects on gut motility (66), and delays post-prandial gastric emptying (67). At 
present, it is believed that the molecular mechanisms of OXM and glicentin signalling are 
likely to be similar. The remaining PGDPs (IP-1, IP-2 and GRPP) do not appear to exert 
any interesting effects.
The prohormone proglucagon  encodes  several  structurally  related  peptides,  that  have 
wide-ranging  and  contrasting  physiologic  effects.  The  α  and  L-cells  that  express 
proglucagon  are  able  to  liberate  only  the  relevant  constituent  hormone(s)  needed  to 
respond  to  nutrient  status.  Tissue-specific  processing  is  known  to  be  caused  by  the 
specific cleavage by expression of either PC1/3 or PC2. In order to prepare adequate 
concentrations of active hormones within these cells, proglucagon is sorted into secretory 
granules, where conversion to glucagon or the glucagon-like peptides occurs along the 
late secretory pathway. Nutrient status potently stimulates secretion of the proglucagon-
derived peptides so they may exert tight control over glucose metabolism and nutrient 
homeostasis. However, the molecular mechanism by which proglucagon is sorted from 
the  trans-Golgi  network  (TGN)  into  granules  is  not  understood.  This  thesis  aims  to 
uncover this sorting mechanism for proglucagon within α- and L-cells.
1.3 Mechanisms of Regulated Exocytosis
1.3.1 Secretory Pathway
Cells use multiple pathways to ensure exocytosis of various proteins. Beginning with the 
early secretory proteins, the nascent peptide chain is synthesized into the ER  (68), and 
8packaged  for  delivery  to  the  Golgi  from  so-called  “exit  sites,”  loaded  into  vesicles 
defined by coat-protein (COP)-II (69). These COP-II vesicles undergo homotypic fusion 
in mammals, forming the ER-Golgi Intermediate Complex (ERGIC) that subsequently 
becomes/transits en bloc to the cis-Golgi (70). The Golgi is typically regarded as having a 
tripartite compartmental organization – consisting of  cis,  medial and  trans cisternae – 
along with the Golgi-associated TGN. As cargo transits the stack, it may acquire post-
translational  modifications (e.g.,  sulfation,  maturation of N-glycosides,  addition of O-
glycosides). The mammalian Golgi are morphologically similar, in which several Golgi 
stacks  are  joined  laterally  into  an  elongated  Golgi  ribbon  (71),  and   sometimes  the 
neighbouring cisternae within stacks can be joined by a tubular-mesh connections rather 
than existing as disconnected structures (72, 73). Neuroendocrine cells have been a recent 
focus to detail the 3D Golgi morphology  (74). The beta cell in particular exhibits this 
more  complex  mesh-like  topology  (75).  The  exact  details  of  how secretory  proteins 
transit the Golgi stack are still a matter of debate.
There are two dominant models for Golgi traffic: vesicular trafficking between stable 
compartments, and cisternal progression/maturation. The stable compartments hypothesis 
describes the Golgi cisternae as biochemically distinct compartments, in which proteins 
progress  sequentially  through  each  cisternae,  exposed  to  the  unique  enzymes  and 
conditions  of  each cisterna,  by  means  of  anterograde  carrier  vesicles  (76–78).  These 
carrier vesicles are thought to be defined by coat protein (COP)-I  (79, 80). The finding 
that purified COP-I vesicles contained Golgi glycosylation enzymes (81, 82), weaken this 
model because it implicates COP-I vesicles in both retrograde and anterograde cargo flow 
(83, 84). The limitations of this model compelled people to favour cisternal maturation as 
an alternate framework. The cisternal progression/maturation model offers a more fluid 
description  of  Golgi  dynamics.  The  cis-cisternae  is  formed directly  from the ERGIC 
complex, progressively maturing through the Golgi stack to the trans-most cisterna, and 
is ultimately “shed” at the TGN as secretory cargoes are carried along post-Golgi routes. 
As a cisterna matures, the resident enzymes are recycled to earlier positions to maintain 
their polarized distribution (83–86), though some groups have found a lack of some Golgi 
resident recycling in COP-I vesicles (86, 87). A fundamental question is whether COP-I 
9vesicles  carry  (anterograde)  secretory  cargo.  A recent  super-resolution  fluorescence 
microscopy  study  showed  that  fused  cells  can  exchange  both  resident  proteins  and 
secretory  cargo  over  long  distances  in  COP-I  vesicles,  suggesting  bidirectional 
transportation (72, 85, 88). The cisternal maturation model is extended by considering the 
Ras-related protein subfamily of G-proteins, Rab proteins. The Rab network is a set of 
~70  proteins  spread  over  the  various  membrane-bound  compartments  of  the  cell, 
including the  Golgi  cisternae,  which  may provide  a  mechanism for  both  maintaining 
cisternal identity and signals maturation (81, 82). By analogy, Rab proteins mark distinct 
membranes to help define organelles and vesicles. At present, the cisternal maturation 
model is most consistent with the literature and is considered the most appropriate model. 
Once cargo arrives at the TGN for sorting, neurons and (neuro)endocrine cells possess a 
regulated secretory pathway for transport of specialized neuropeptide and hormone cargo.
Exit from the Golgi along the regulated secretory pathway requires formation of secretory 
granules that undergo several steps in order to form, mature and become competent for 
exocytosis. Hormones must first be sequestered into an area of the TGN that begins to 
protrude (extrude) from the membrane, called the granule precursor or nascent granule. 
Scission  of  the  two  membranes  forms  a  nascent  secretory  granule,  and  often  occurs 
simultaneously with cargo loading  (89, 90). The granule undergoes several maturation 
steps, including 1) the removal of extraneous cargo proteins and membrane lipids, 2) 
trafficking toward the plasma membrane, 3) acidification of the lumen, 4) docking at the 
plasma membrane, before finally being rendered mature granules. These steps are partly 
dependent  on each other  and partly  concurrent  with each other;  the maturation steps 
happen with some overlap between consecutive steps as will be discussed later with final 
maturation steps. Consider that a beta cell can only immediately release ~20-30 granules 
(i.e., readily releasable pool) (91), and that secretory granules are reduced in number (92) 
and secretion competency (93) following the development of T2DM. Each of these (more 
proximal) maturation steps are therefore very sensitive to interference, to the point that 
even  slight  perturbations  could  severely  negatively  impact  the  ability  of  the 
(neuro)endocrine tissue to adequately concentrate hormones into and maintain a pool of 
granules.
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Newly forming granules are limited not only by the cargo to be packaged, but also by the 
specific  lipid  membrane  components.  The  membrane  of  the  TGN  is  enriched  in 
phosphatidylinositol-4-phosphate  (PI4P),  derived  from phosphatidylinositol.  PI4P is  a 
signalling lipid on the cytosolic leaflet  of the TGN membrane that controls Golgi-to-
plasma membrane traffic (94, 95). In part, PI4P is implicated in the regulation of granule 
biogenesis and exocytosis in chromaffin cells  (96, 97), and insulin secretion from beta 
cells  (98, 99). The precise membrane composition dictates the biophysical properties of 
the  budding  and  mature  granule,  and  also  provide  for  spatial  coordination  of  cargo 
sorting. Lipids rafts play a central role in the formation of secretory granules, of which 
cholesterol is a key component. Mature granule membranes contain cholesterol in the 
range of  33-65 mol  %  (100,  101).  Cholesterol  depletion  by methyl-beta-cyclodextrin 
(MBCD)  causes  multiple  defects  on  insulin  and  glucagon  secretion,  while  insulin 
granules appeared morphologically smaller with less-dense cores (102), without apparent 
effect on cholesterol desorption from the plasma membrane (103). Cholesterol depletion 
caused the mis-sorting of POMC to the constitutive secretion pathway by preventing the 
granule targeting of carboxypeptidase E (CPE) in AtT-20 cells (101), similar to findings 
of diminished glucose-stimulated insulin secretion from MIN6 cells (104). Several of the 
key  processing  enzymes  associate  with  cholesterol-sphingomyelin-rich  lipid  rafts, 
including PC1/3  (105, 106), PC2  (107, 108), CPE  (101, 109) and secretogranins  (100, 
110).  The  other  main  component  of  lipid  rafts  are  sphingolipids,  including 
phosphatidylethanolamine (PE). Reduction of sphingosine kinase  Sphk1 in INS-1 cells, 
which prevents the biosynthesis of downstream sphingolipids (including PE), abolished 
glucose-stimulated insulin secretion by 50-90% (111). Not only is cholesterol a necessary 
component  of  both  constitutive  and  regulated  secretory  pathways  (101,  112), 
sphingolipids  are  also  critical  to  their  formation.  Additionally,  they  both  provide 
membrane flexibility due to liquid-ordered phase separation in membranes (113–115).
The flexibility of the membrane is essential for granule biogenesis, a process of budding 
or extrusion from the TGN, ending with scission of the two compartments. Cholesterol 
(115) and other lipids like diacylglycerol (DAG) and phosphatidylethanolamine (PE) lend 
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spontaneous negative curvature to the budding granule,  enabling the formation of the 
characteristic neck (rather than a tubular protrusion) for membrane scission  (116). The 
next  most  abundant  lipid in granule membranes is  PE, at  ~18-20 mol %  (101, 110), 
suggesting that the granule membrane is specifically optimized for its formation. DAG 
has a cone-shape in an acidic environment (e.g., in the TGN) that lends itself well to the 
extreme negative curvature (117) and are implicated in the formation of vesicular carriers 
(115). Together, it is believed that these lipids promote the negative curvature of the neck 
to aid in granule biogenesis, and a scission complex has been implicated to be recruited to 
the granule neck in DAG-dependent and protein kinase D-mediated manner  (118–120). 
Positive membrane curvature in the secretory pathway can be sensed or even induced by 
Bin/amphiphysin/Rvs  (BAR)  domain-containing  proteins;  the  banana-shaped  BAR 
domain, formed by a coiled-coil structure, has a convex side that associates with and can 
induce positive membrane curvature  (121, 122),  and are specifically recruited for the 
deformation  of  the  TGN  membrane  (123).  Three  BAR  domain-containing  proteins, 
arfaptin-1, arfaptin-2 and PICK1, are implicated in the formation of secretory granules. 
PICK-1  regulates  granule  formation  in  chromaffin  (124) and  beta  cells,  such  that 
impaired  PICK-1 function  results  in  reduced insulin  secretion,  glucose  intolerance  in 
mice, and is implicated as one cause for T2DM in humans  (125, 126). Arfaptin-1 and 
arfaptin-2 are recruited to domains of the TGN marked by Arf-like 1 (Arl-1)  (123) in 
endocrine cells, or Arf1 in non-endocrine cells (127). Arfaptins interact with DAG lipids 
in  the  budding  granule  (89) (presumably  at  the  neck),  to  promote  the  formation  of 
vesicular  and  tubular  structures  (123).  Arfaptin-1  in  particular  mediates  the  fission 
process of granules in beta cells  (89), either by recruiting a fission complex, or itself 
effecting the fission  (128). While it is likely these same principles from beta cells that 
apply to α cells, granule biogenesis has yet to be studied in α cells.
Since  several  neuroendocrine  and  endocrine  tissues  produce  secretory  granules,  it  is 
expected  that  they  would  have  different  characteristics  (e.g.,  size,  contents,  secretory 
response). For instance, secretory  granules are quite variable in total number and size. 
Estimates of granule numbers range from a few hundred in lactotrophs (129), ~20,000 in 
bovine chromaffin cells (130), to ~7,000 in mouse α cells (131), and ~6,000 in beta cells 
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(132). Similarly, the mean granule diameter varies considerably, and thus its neuropeptide 
cargoes from ~250 nm in diameter in PC12 (133), 275 nm in mouse α cells (131), to ~350 
nm in chromaffin cells (130), with ~600-800 nm being the largest granules belonging to 
pancreatic  acinar  zymogen  (134).  The  reason  for  this  variation  in  size  is  not  well 
understood, but at least in lactotrophs, granule size correlates with increased probability 
of complete fusion events and full exocytosis of all cargoes (135).
Concomitant with the maturation of immature granules, the granule lumen is acidified. 
Vacuolar-type H+-ATPase (V-ATPase) pumps in the Golgi and granules (136) gradually 
acidify from pH ~6.3-6.0 in ISGs to pH 5.0-5.5 in mature granules (137–139). Critically, 
the production of mature endocrine hormones requires the acidification of the granule 
lumen (139–141), which can then activate PC1/3 and PC2 which are optimally active in 
the range of pH 5.5-6  (142, 143), coinciding with the conditions of the mature granule 
lumen. Inhibition of acidification prevents exocytic fusion, and in particular glucagon and 
insulin secretion  (144, 145). The V-ATPase also directly interacts with the small  Ca2+-
binding protein, calmodulin, to mediate the calcium-dependent exocytosis of insulin from 
beta  cells  (146,  147),  GLP-1  from  GLUTag  cells  (148),  and  presumably  glucagon 
secretion (149, 150).
The process of transporting a maturing secretory granule toward the plasma membrane 
involves four discrete mechanistic steps: membrane approach/delivery, docking, priming 
and fusion. The extrusion process of granule formation is still debated, though there is 
good  evidence  to  implicate  the  BAR domain-containing  proteins  in  chromaffin  cells 
(124), possibly by acting as a “proof-reading switch” to sense when the granule is “full.” 
The kinetic energy of extrusion is controversial and may result either from membrane 
scission alone, or from the combination of scission and extrusion due to the action of 
myosin Va motor (151). On the other hand, granule size is more likely to be determined 
during the membrane-remodelling phase of maturation, for which myosin Va interacts 
with a key regulator of granule maturation, Rab3D  (152–154). Once ISGs are formed, 
they are immediately transported over long distances (i.e., several µm) toward the plasma 
membrane,  directed  along  microtubules  (155,  156) by  the  conventional  microtubule-
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based  motor,  kinesin  (157,  158),  until  reaching  the  actin-rich  cortex.  In  the  cortical 
region, the granules are carried the last few hundred nm by myosin Va in neuroendocrine 
cells  (e.g,  chromaffin cells  (159),  PC12  (160)) and also in  beta  cell  lines  (161–163). 
Interference with cortical trafficking either by siRNA-mediated knockdown of myosin Va 
or a dominant-negative of myosin Va-tail protein impairs insulin secretion  (162). Since 
delivery  to  the  cortex  takes  ~3-5  sec,  it  is  thought  it  precedes  maturation  due  to 
membrane remodelling and cargo maturation which take take 2-4 hours. However, newly 
formed ISGs become competent for secretion in as little as 30 minutes (164), consistent 
with the timing of VAMP4 removal from immature granules in AtT20 cells (165), and the 
recycling of furin from PC12 granules (166).
The last step in this process before exocytosis is membrane fusion. The basic mechanism 
of  fusion  is  mediated  by  a  variety  of  soluble  N-ethylmaleimide-sensitive  factor 
attachment  protein  (SNAP)  receptor  (SNARE)  protein  complexes.  Generally,  fusion 
occurs when a “donor” or “vesicular” membrane, contains a single SNARE (denoted v-
SNARE), forms four helix bundle with two additional SNARE proteins on the “target” or 
“recipient” membrane (denoted as t-SNARE). Each protein contains one or two SNARE 
motifs of ~60-70 amino acids in size, comprised of a repeating heptad of hydrophobic 
residues, with a central amino acid being either arginine (v/R-SNARE) or glutamine (t/Q-
SNARE)  (167).  The  specificity  of  these  interactions  is  encoded  by  and  within  the 
SNARE motif itself (167, 168). SNARE fusion generally requires the assembly of one R-
SNARE (usually  from the  vesicle)  and  three  Q-SNAREs  (usually  from  the  “target” 
membrane) (156, 160, 169–171). The minimal fusion process is thought to occur in two 
steps:  the  initial  formation  of  a  heterodimeric  Qa/Qbc complex of  plasma membrane 
syntaxin-1 (as Qa) and SNAP-25 (as Qbc),  followed by the insertion of vesicular R-
SNARE (synaptobrevin-2/VAMP-2) joining the two membranes in “trans” orientation, 
and then “zippering” up to form a “cis” oriented complex and achieving fusion. Though 
this complex is sufficient for spontaneous fusion in reconstituted liposomes, it proceeds 
with considerably slower kinetics (t1/2 ~ 10 min) compared to the rapid exocytosis seen in 
neuronal synapses (t1/2 ~ few hundreds of μsec) (160, 161, 172). In vivo, several accessory 
proteins are important for the regulation of modulation fusion kinetics, responsible for the 
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divergence between synaptic vesicles and secretory granule exocytosis kinetics, reviewed 
in (155). Synaptotagmins are a critical accessory protein family because of their calcium-
sensitivity  (173).  Therefore,  layered  into  the  SNARE  mechanism  is  tissue-specific 
modulation for a broader complexity of regulating exocytosis.
1.4 Mechanisms of regulated secretion
1.4.1 Mechanisms of glucagon secretion from α cells
Glucagon secretion can be caused by cellular, hormonal and autonomic triggers (Figure 
3).  These are  commonly referred to  as secretagogues.  The hypoglycemic status  (e.g., 
during fasting or exercise) of the individual is arguably the most important physiologic 
secretion  stimulus.  Glucose-regulated  glucagon  secretion  follows  a  U-shaped  dose-
response, with maximal inhibition occurring at 6-7 mM glucose, in α cell lines, isolated 
mouse islets (26, 174), as well as in humans (175, 176), below the glycemic threshold (7 
mM) for insulin secretion (26). Chronic insult of hyperglycemia to αTC1-6 cells results in 
up-regulation of exocytotic machinery and enhanced basal glucagon secretion (177). By 
autocrine feedback, glucagon can upregulate its own biosynthesis  (178),  perhaps as a 
rapid  mechanisms to  replace  the  newly depleted  granule  pool.  α  cells  directly  sense 
glycemia  via  the  glucose  sensor, glucokinase  (177).  Glucose metabolism is  linked to 
glucagon secretion, such that increases in the cellular ATP/ADP ratio, inhibiting the K-
ATP channel, subsequently inhibiting glucagon secretion  (179), otherwise the α cell is 
rendered  functionally  “blind”  to  external  glycemic  levels.  However,  the  precise 
mechanism underlying glucose-regulated glucagon secretion remains controversial (180). 
Amino acids and lipids can also stimulate glucagon secretion. It is well established that 
L-arginine is a potent glucagon secretagogue both  in vitro and  in vivo (181–183), even 
overcoming the inhibition present at >5 mM glucose. Leucine in particular can be both 
stimulatory at normal physiologic levels,  or inhibitor at elevated serum leucine levels 
(184). Mixed meals (especially high-fat meals), will also stimulate, rather than suppress, 
glucagon secretion in healthy adults  (174, 175). Nutrient ingestion and composition are 
important physiological triggers for maintenance of glucose homeostasis.
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Figure 3. Mechanisms of glucagon secretion from α cells. A simplified schematic of key 
mechanisms involved in regulated secretion of glucagon. Stimulation by amino acids or 
decreased glucose triggers membrane depolarization, elevates intracellular calcium, and 
initiates glucagon exocytosis. Several paracrine modulators (e.g., insulin, somatostatin, 
GABA)  can  dampen  or  increase  secretion  rates,  generally  by  coupling  of  GPCR to 
elevation of intracellular calcium.
Similar to other electrically excitable cells (e.g., chromaffin cells, beta cells), glucagon 
exocytosis  is  triggered  by  fired  action  potentials,  triggering  Ca2+ ion  influx  through 
voltage-gated calcium channels,  and the resulting increase in intracellular Ca2+ causes 
membrane fusion and secretion of glucagon. A principle component to regulating action 
potential firing is the K-ATP channel  (131, 185). The past 15 years have seen several 
investigations into the mechanisms of action potential general and electrical excitability 
of  α  cells.  Most  clearly  underlying  glucagon secretion  are  the  voltage-gated  calcium 
channels  (176), and ATP-dependent K-ATP channels (for a thorough review of α cell 
electrophysiology, see  (180,  186)).  Closure of  K-ATP channels  (e.g.,  by tolbutamide) 
results in α cell depolarization and glucagon secretion both in vitro and from intact islets 
in  rodents  and humans  (187),  while  membrane hyperpolarization  (e.g.,  by diazoxide) 
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inhibits glucagon secretion in rodents and humans. The exact mechanism underlying K-
ATP channel activity is still debated, however, since α cells are spontaneously active at 
low glucose, and become “silent” as glucose is elevated, a recent hypothesis suggested 
that  the  membrane  voltage  is  maintained  near  the  threshold  of  depolarization  (180). 
Under normal conditions, excursions to high glucose should inhibit glucagon secretion, 
and hypoglycemic excursions should stimulate  secretion.  Ashcroft  and Rorsman posit 
that under pathologic conditions of T2DM and some forms of T1DM, this sensitivity is 
reversed leading to  paradoxical  α cell  behaviour. Whatever the importance of K-ATP 
channels on α cell behaviour, there are also K-ATP channel-independent mechanisms of 
stimulating glucagon secretion.
Several  paracrine  factors  have  been  proposed  to  play  a  role  in  glucagon  secretion, 
including insulin, somatostatin, GIP, GLP-1 and GABA. Of these, α cells respond most 
robustly to insulin and somatostatin. Insulin is a paracrine inhibitor of glucagon secretion, 
as can be expected from counter-regulatory hormones, and was found to be an accurate 
reciprocal  relationship  in  T1DM humans  with  intravenous  infusions  of  insulin  (188). 
Under  extreme  hypoglycemia  (1  mM  glucose),  insulin  completely  inhibits  glucagon 
secretion from human islets  (176); perfused rat pancreata and isolated islets  (189); and 
mouse islets (190). Transgenic mice with a specific α-cell deletion of the insulin receptor 
displayed glucose intolerance, enhanced glucagon secretion under hypoglycemic clamp, 
and gradual increase in beta cell mass (191), confirming the importance of direct insulin 
action on α cell glucagon response.
Somatostatin  is  also  a  critical  paracrine  modulator  of  glucagon  secretion.  The  main 
isoform of the somatostatin receptor, SST-R2, is functional in human and mouse α cells 
(192), that when activated,  hyperpolarizes the α cell  downstream of intracellular Ca2+ 
influx,  though  prevents  exocytosis  though  an  incompletely-defined  mechanism.  Mice 
lacking SST-R2 (193) displayed normal basal glucagon and insulin secretion. However, 
glucagon  secretion  was  two-fold  greater  upon  depolarizing  stimuli,  and  exogenous 
somatostatin failed to suppress glucagon secretion. Somatostatin is a potent inhibitor of 
glucagon secretion in  fed states.  Easing this  “brake” contributes significantly to  non-
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fasting  hyperglucagonemia  and  hyperglycemia  (194–196),  consistent  with 
pathophysiology of T2DM.
The incretins  are  interesting for their  divergent  effects  on glucagon secretion.  GLP-1 
indirectly exerts an inhibitory effect (197–199) on glucagon by stimulating somatostatin 
secretion  (194,  200,  201).  On  the  other  hand,  GIP  stimulates  glucagon  secretion  in 
normoglycemic humans (202). The GLP-1R is virtually absent when detected by PCR or 
immunocytochemical techniques in normal rodent and human islets (203). In contrast to 
GLP-1,  a  direct  effect  of  GIP on  α  cells  from perfused  rat  pancreas  was  shown  to 
stimulate glucagon secretion in conditions of hypoglycemia (201). From this, it is likely 
that GIP is a direct enhancer, and GLP-1 an indirect inhibitor, of glucagon secretion.
The metabolic glutamate/GABA-glutamine pathway is functionally linked to glucagon 
secretion.  α  cells  pump  glutamate  into  secretory  granules  via  vesicular  glutamate 
transporters (VGLUT) 1/2, co-secreted with glucagon (204, 205). In contrast, GABA and 
glycine  are  pumped  into  α  cell  synaptic-like  microvesicles  (SLMVs)  by  vesicular 
inhibitory amino acid transporter (VIAAT) (206, 207). The activity of VGLUT is down-
regulated while VIAAT is up-regulated in response to high glucose, and vice versa (208), 
allowing the ambient glucose level to determine a fine balance between stimulatory and 
inhibitory  neurotransmitters  loading  into  granules  and  SLMVs.  Uptake  of  glutamine 
serves as  a substrate  for  production of  glutamate and GABA, and the mechanism of 
uptake may mirror the case of neurons. Specifically, glutamine may be co-transported 
with  sodium  ions  by  diamineacyltransferase  2  (SAT2),  producing  a  depolarizing 
electrogenic  ion  current,  believed to  stimulate  glucagon secretion  (209,  210).  This  is 
consistent  with  the  generation  of  intracellular  Ca2+ oscillations  (211),  which  does 
stimulate glucagon secretion. In contrast, beta cells load both glutamate and GABA into 
SLMVs (212, 213), which can be secreted independently of glucose  (214). At the same 
time, glutamate uptake depolarizes α cells and stimulates glucagon secretion, providing 
an autocrine and paracrine feedback mechanism (214). α cell VGLUT activity may also 
work in  association with the vacuolar  H+-ATPase,  which coordinates  an increasingly 
acidified granule lumen, similar to their operation in beta cells (204, 206, 207). Ambient 
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blood glucose levels can direct islet cells to load both granules and SLMVs with either 
excitatory  and  inhibitory  neurotransmitters,  potentially  coupled  with  granule 
acidification, to amplify or dampen glucagon and insulin secretion.
1.4.2 Mechanisms of GLP-1 and GLP-2 secretion from L-cells
The  “incretin  effect”  is  so-called  for  amplifying  insulin  secretion  following  ingested 
nutrients  when  compared  to  intravenous  administration  (32).  The  incretin  hormones, 
glucose-dependent  insulinotropic  factor  (GIP;  previously  called  gastric  inhibitory 
peptide) and GLP-1, are mainly derived from the gut. GIP is mainly secreted by K cells 
in the upper small intestine. In contrast, GLP-1 is secreted from L-cells in the lower small 
intestine and colon, also able to directly sense nutrients in the lumenal environment (215, 
216). Both cell types are expressed in similar (diffuse) quantity throughout the entire gut 
(217),  making  it  challenging  to  study  directly.  Because  of  their  ability  to  increase 
glucose-  and nutrient-stimulated insulin  secretion,  this  anti-diabetic  property – and in 
particular due to GLP-1 – remains actively pursued for T2DM therapy. Two biologically 
active GLP-1 (7-37) and GLP-1 (7-36 amide) peptides equally stimulate insulin secretion 
in humans  (218, 219), though the physiological significance of two forms is not clear. 
The biological relevance to stimulating insulin secretion remains a key gut hormone in 
the maintenance of nutrient homeostasis.
The mechanisms of GLP-1 secretion from L-cells are less understood by comparison to 
insulin  and  glucagon.  As  a  note,  wherever  GLP-1  secretion  is  discussed,  the  same 
mechanism is  also  assumed  for  GLP-2,  as  both  hormones  are  secreted  in  equimolar 
concentrations,  which  has  not  been  examined  separately.  The  most  reliable  in  vitro 
models  remain  GLUTag  cells,  derived  from  a  mouse  intestinal  tumour  expressing 
proglucagon-SV40  large  T-  antigen  (220).  More  recently,  a  transgenic  mouse  line 
expressing Venus (a YFP) under the promoter of proglucagon  (221) has enabled more 
efficient  and  specific  primary  L-cell  studies,  a  necessary  advantage  for  such  diffuse 
enteroendocrine cells (28, 217). The post-prandial profile of GLP-1 secretion is biphasic, 
with the first peak at 15-30 minutes and the second at 1-2 h  (222). Intestinal nutrients 
appear to be the major physiologic stimuli of L-cells, especially by sugars, fatty acids and 
amino acids and these mechanisms will be discussed below.
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As with (neuro)endocrine cells in general, secretagogue-mediated exocytosis is coupled 
to electrical depolarization of the cell membrane (Figure 4), in which calcium uptake is 
coupled  to  exocytosis.  Chemosensation  of  sweet  molecules  in  the  gut  (e.g.,  glucose, 
fructose, sucrose, artificial sweeteners), activate through the coupled G protein-coupled 
receptor,  TAS1R2-TASR3,  and  can  be  imported  into  the  cell  by  facultative  GLUT 
glucose  transporters  (223),  and  the  Na+-glucose  co-transporter,  SGLT1,  typical  of 
intestinal brush-border transporters. The taste receptors are stimulated by simple sugars 
and common sweeteners, and couple to the G-protein α-gustducin, that upon activation, 
elevates intra-cellular calcium and triggers secretion. Mice with deletion of α-gustducin 
(-/-),  TAS1R2 (-/-)  or  TAS1R3 (-/-)  have  nearly  abolished  glucose-stimulated  GLP-1 
secretion  (224, 225). The electrogenic current of Na+ by SGLT1 is the most important 
glucose transport system, directly depolarizing the L-cell, thus triggering secretion (221, 
226, 227). This is the key difference to the Ca2+-dependent action potentials in α and beta 
cells (228, 229). GLP-1 secretion can also be stimulated by sensation of free fatty acids 
and amino acids. In GLUTag cells, GPRC6A is the main amino acid sensing mechanism 
(230),  primarily  by  basic  amino  acids.  Although  L-cell  function  was  not  assessed, 
deletion  of  the  receptor  pre-disposed  mice  to  obesity,  insulin  resistance  and  glucose 
homeostasis dysregulation (231). On the other hand, fatty acids are sensed by FFAR1 (or 
GPR40)  (232) and GPR120  (233).  In humans,  GLP-1 secretion is  stimulated by oral 
administration  of  lipid  (234).  Though it  is  unclear  which  fatty  acid  receptor  is  more 
important, mice lacking FFAR1 had reduced response to FFA-stimulated GLP-1 secretion 
and serum insulin (235). Together, the fatty acid receptors also couple to α-gustducin to 
stimulate GLP-1 secretion (236).
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Figure 4. Mechanisms of GLP-1 secretion from L-cells. A simplified schematic of key 
mechanisms involved in regulated secretion of GLP-1 (adapted from  (237)). Intestinal 
lumen  nutrient  sensation  by  GPCRs,  facultative  glucose  transport  (GLUT)  and 
electrogenic Na+-glucose co-transporters (SGLT) are shown. GPCR activation or inward 
sodium current can trigger membrane depolarization, elevation of intracellular calcium, 
and GLP-1 secretion. Thus, several mechanisms couple nutrient stimulation to incretin 
hormone exocytosis.
Only one report to date has characterized major SNARE machinery involved in GLP-1 
exocytosis.  GLP-1 secretion  requires  the  interaction  among VAMP2, syntaxin-1a and 
SNAP25 in GLUTag cells  (238),  consistent with their  expression in L-cells  and with 
exocytosis  of  both  insulin  and  glucagon.  There  are  several  similarities  between  the 
stimulus-secretion coupling and exocytosis mechanisms among endocrine cells, and it 
suggests that the hormone secretion mechanisms are broadly similar among endocrine 
cells.  Tissue-specific  differences  between L-  and α-cells  are  manifest  in  proglucagon 
processing and possibly sorting mechanisms.
21
1.5 Processing of Proglucagon
Mammalian proglucagon is synthesized as a 180 amino acid precursor (239–241), whose 
domains are organized as in  Figure 1. Proglucagon encodes for a plurality of peptides 
that are processed in a tissue-specific manner through the action of PC1/3 and PC2. The 
end result of differential expression of these PCs in α-cells, L-cells or neurons produces 
the  characteristic  pattern  of  proglucagon-derived  peptides.  Proglucagon  is  not  post-
translationally modified (such as glycosylated) with the exception of processing to its 
constituent  hormones  (242,  243),  and  C-terminal  amidation  that  occurs  to  GLP-1 
(discussed below).
1.5.1 Glucagon production in pancreatic α cells
The processing of proglucagon in α cells begins with cleavage at the inter-domain dibasic 
site,  Lys70Arg71,  liberating  glicentin  and  the  major  proglucagon-derived  fragment 
(MPGF) (Figure 1). Glicentin is further processed to glucagon, (along with the flanking 
GRPP and IP-1)  (244). Proglucagon processing is accomplished by PC2, shown to be 
necessary and sufficient for processing to the α cell profile in αTC1-6 cells (245), and is 
sufficient for α-cell-like processing in AtT-20 cells (246). PC2 activity depends on a co-
factor, neuroendocrine peptide 7B2, both stabilizing PC2 in its active conformation and 
inhibiting enzymatic activity until delivery to granules (247, 248). 7B2 also prevents PC2 
from  aggregating  into  inactive  oligomers  (249).  PC2  is  enzymatically  active  within 
mature  secretory  granules  (137,  142).  By  using  a  pulse-chase  paradigm,  the  time 
dynamics of proglucagon processing in αTC1-6 cells confirmed the sequential cleavage 
beginning at the inter-domain site, Lys70Arg71, producing glicentin and MPGF after 30-
45 minutes  chase  (245,  250).  These  chase  times are  consistent  with  a  conversion  of 
proglucagon beginning in the TGN or immature granules. This leaves open the possibility 
that some amount of proglucagon is initially processed to glicentin and MPGF in the 
TGN or immature granules. One possible endoprotease that could substitute would be 
furin,  found in all  cell  types,  and active in  the TGN and is  removed from immature 
granules. This is suggested by the findings of proglucagon processing in several non-
endocrine cell lines which only express furin (245, 246, 251–253), and is consistent with 
the expectation that PC2 would be inhibited by 7B2 in these early compartments of the 
secretory pathway. Notably, the remaining processing of glicentin is carried out in mature 
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granules at dibasic sites recognized by PC2 to remove GRPP, and in particular, the PC2-
specific site to remove IP-1 (Figure 1).
Mouse models confirmed the role of 7B2-activated PC2 on α cell production of glucagon. 
PC2  knockout  mice  abolished  glucagon  production  and  severely  impaired  α  cell 
proglucagon processing (254, 255), consistent with an α cell line derived from these PC2 
null islets (256). These mice lacked detectable serum glucagon, had improved glucose 
tolerance, consistent with a lack of active glucagon. Interestingly, these α cell granules 
became irregular in shape and electron-translucent, suggesting PC2 expression was not 
necessary for granule targeting of proglucagon. Proglucagon processing was significantly 
decreased either upon depletion of 7B2 in an α cell line, or in 7B2-knockout mice (257), 
similar to the PC2-knockout phenotype. Altogether, PC2 is essential to produce glucagon.
There  is  recent  controversy  surrounding  the  production  of  bioactive  GLP-1  within 
pancreatic α cells. Whether GLP-1 is produced at all in a healthy pancreas or terminally 
differentiated α cells (as described above), the relative expression is far lower than than 
of the the gut, its principle site of production. PC2 cannot cleave the Arg77 to yield active 
GLP-1, and therefore if it is to be produced, it must encounter PC1/3 (discussed below). 
Notably, this is not the case in one recent report (258). α cell differentiation is controlled 
by a sequence of multiple transcription factors (reviewed in  (259)) such that mature α 
cells repress expression of PC1/3 and thus incapable of producing bioactive GLP-1. In 
the face of insult or injury to the islet, α cells are known to adapt their phenotype and can  
even revert to a precursor α cell, allowing them some functional plasticity in response to 
metabolic insults. Severe beta cell chemical ablation in mice is so severe as to cause beta 
cells  to  trans-differentiate  into α cells  through an insulin+/glucagon+ intermediate  cell 
(260), implying a transient ability to produce bioactive GLP-1 by PC1/3 expression. The 
α cells isolated from PC2-knockout islets expressed PC1/3 and produced GLP-1 (256), 
whose α cells were hyperplastic in the originating mice  (254). Mature GLP-1 could be 
detected in such hyperplastic α cells resulting from the loss of glucagon signalling (by 
global GCG-R knock-out) (19), implying the expression of PC1/3. A time-course analysis 
of PC1/3 and GLP-1 production within α cells using diabetic (db/db) mice as a model of 
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T2DM, and NOD mice as a model of T1DM show that PC1/3 (and GLP-1 production) is 
promininently upregulated in T2DM  (261).  Obesity  and T2DM systematically  elevate 
pro-inflammatory  interleukin-6,  promoting  α  cell  hyperplasia  (53) and  production  of 
mature  GLP-1  and  PC1/3  in  α  cells  (56).  Therefore  multiple  models  of  metabolic 
disorders (e.g., diabetes, obesity) or chemical insults to the islet can profoundly alter the 
α cell phenotype and begin producing detectable quantities of mature GLP-1. However, 
the gut remains the major site of GLP-1 production in healthy individuals and animals.
1.5.2 GLP-1 and GLP-2 production in intestinal L-cells
The most important products of intestinal L-cells are the mature GLP-1, GLP-2, and also 
glicentin  and oxyntomodulin  (262,  263),  which are increasingly  being appreciated as 
important  hormones  for  nutrient  homeostasis.  The  processing  profile  of  proglucagon 
within  the  GLUTag cell  line  and  native  L-cells  (253,  264) is  coordinated  by  PC1/3 
(Figure 1).  Just  like pancreatic α cells, L-cells  also process proglucagon at  the inter-
domain  site,  Lys70Arg71,  after  ~20-30  min  chase  (250).  Glicentin  is  processed  to 
oxyntomodulin  after  30  minutes  (250),  in  a  molar  ratio  of  about  3:1  of 
glicentin:oxyntomodulin (264). PC1/3 further processes MPGF to predominantly produce 
GLP-1 (7-37) by cleavage either at Arg109Arg110 or the internal Arg77 within GLP-1, as 
well as GLP-2 (250–252). Viral over-expression of PC1/3 into PC2-null αTC1-6 cells is 
sufficient  to  produce  bioactive  GLP-1  (265),  suggesting  that  the  simple  change  of 
convertase could shift the equilibrium toward GLP-1 production. Knockout of PC1/3 in 
mice blocks production of GLP-1 and GLP-2 (266, 267). Therefore, PC1/3 is necessary 
and sufficient for proglucagon processing in intestinal L-cells. Considering the cellular 
location of this processing, such rapid chase times suggest that initial cleavage occurs in 
the TGN by furin or PC1/3, or within immature granules (142). Recently, a hypermorphic 
PC1/3  mutant  (S357G-PC1/3)  showed  increased  specificity  to  the  two  dibasic  sites 
flanking glucagon, liberating ~20% more glucagon than wild-type PC1/3,  but did not 
alter  its  basal  secretion  based  on  conditioned  media  samples  (268).  Since  this 
hypermorph is active at neutral pH, proglucagon is more likely to be rapidly processed 
prior to arriving at the ISG, and it would suggest this initial processing occurs prior to the 
sorting of glucagon to granules in GH4C1 cells.
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GLP-1 and GLP-2 differ in the extent of their processing in vivo. GLP-1 and GLP-2 are 
co-secreted in equimolar amounts from the same granules (263, 269). The natural form of 
GLP-1 extracted  from human  intestine  showed  a  further  processing  of  the  (inactive) 
GLP-1 (1-37) by cleavage at the monobasic Arg77 to yield bioactive GLP-1 (7-37) (262, 
263). As in cell models, there is natural variation in the ratio of glycine-extended GLP-1 
(7-37)  and amidated  GLP-1 (7-36)-amide  both along the length of  the  intestines  and 
between  mammals  (263,  269–271).  Mono-  and  dibasic  C-terminal  amino  acids  are 
removed by carboxypeptidase E (CPE)  (272).  After  carboxypeptidase activity, GLP-1 
amidation is accomplished by peptidylglycine α-amidating mono-oxygenase (PAM) (273, 
274). In contrast to GLP-1, removal of the C-terminal basic residues from GLP-2 is its 
final modification. The focus of recent GLP-1 research has shifted towards identifying 
enteroendocrine L-cells along the entire gut and its multiple physiologic roles.
1.5.3 Proglucagon processing in the central nervous system
The pattern of GLP-1 and GLP-2 production in the CNS is similar to that of the intestines 
(275), and so it is presumed that PC1/3 is the responsible convertase. Indeed, the role of 
PC1/3 has been extrapolated from the numerous studies of proglucagon processing using 
neural-derived and endocrine cell lines. However, this assumption has not been tested in  
vivo, partly owing to a much smaller abundance in the brain, compared to the pancreas 
and gut.  The predominant areas of proglucagon expression in the brain are a subset of 
neurons in the solitary tract nucleus  (276). Several sensitive peptidomics studies of the 
crude lysates of the brainstem (and other brain regions) in normal and transgenic mouse 
models such as knockouts of PC2  or PC1/3 (277, 278) or CPE mutant obese mice (279, 
280) failed to  detect  proglucagon-derived peptides,  presumably due to  extremely low 
expression in these regions (personal communication with Dr. L. D. Fricker). Thus the 
actions of PC1/3 (or PC2) in the brain have only be inferred from correlation of their 
expression  with  proglucagon-expressing  neurons,  and  this  avenue  of  investigation 
remains inconclusive.
Two alternative views are parsimonious with proglucagon expression and processing in 
the brain. Proglucagon is certainly expressed by subsets of neurons in the brainstem and 
hypothalamus.  By  comparison  with  POMC-  and  NPY-expressing  cortical  neurons, 
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proteolytic  processing  to  NPY, ACTH,  beta-endorphine  and  α-MSH are  significantly 
dependent on the action of cathepsin L (281, 282). An emerging idea is the expression of 
proglucagon, and secretion of GLP-1, by activated glia in the brain. A previous report 
identified proglucagon+ cells in the cerebral cortex and hippocampus that are thought to 
be glial cells in mice, and also detected GLP-1 secretion from the mouse glial cell line, 
BV-2 (283). An alternative endopeptidase, yapsin-1 (284) behaves similarly to PC2, with 
specificity  to  dibasic  sites,  and  in  vitro,  can  liberate  glucagon.  The  mechanism  of 
processing  in  glial  cells  remains  unknown.  PC1/3  is  the  traditional  prohormone 
convertase  for  processing,  though  yapsin-1  and  cathepsin  L  are  recently  proposed 
candidates. The idea that proglucagon could be expressed in two distinct regions in the 
brain  also  invites  further  investigation  into  potentially  novel  mechanisms  of  its 
processing in the brain.
1.5.4 The ultra-structural localization of the proglucagon-derived 
peptides within granules
There  has  been  much  interest  in  the  ultra-structural  characterization  of  α  cells  and 
localizing glucagon within the late  secretory pathway. Previous  findings by Orci  and 
colleagues (285) distinctly co-localized glucagon and glicentin within the same granule in 
which glucagon was diffusely located within the electron dense core while glicentin is 
segregated  to  the  electron-lucent  halo.  In  those  granules  studied,  there  were  equal 
proportions  of  glucagon+ granules  and  glicentin+ granules  (which  was  likely  GRPP), 
suggesting that glicentin enters mature granules where it then undergoes processing by 
PC2. Using anti-sera directed against mid-sequence GLP-1 or GLP-2 in α cells revealed 
that the staining pattern is restricted to the electron-dense core (286), consistent with the 
identification  of  MPGF  in  α  cell  granules.  Similarly,  glicentin,  GLP-1  and  GLP-2 
appeared to co-localize in serial thin-section immunoelectron images of human L-cells 
(286).  Here,  GLP-1  is  diffusely  localized  within  the  dense  core,  while  GLP-2  was 
localized to the halo, suggesting that MPGF has undergone processing in an immature 
granule to allow for their topological segregation. Interestingly, there have not yet been 
molecular  dynamic  studies  to  determine  diffusion  rates  within  granules.  None of  the 
ultra-structural studies have shown glucagon, or any of the other PGDPs, to adopt higher-
order or crystalline structures, suggesting that proglucagon is less prone to aggregation in 
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the  secretory  pathway. Previous  data  from our  lab  has  also  ruled  out  an  ability  for 
proglucagon to bind to reconstituted liposomes. This makes the existence of a receptor an 
attractive  hypothesis  for  proglucagon  sorting.  Immunoelectron  analysis  of  granule 
contents does not reveal the degree of co-storage of the various PGDPs within granules. 
To address  the  outstanding  question  of  whether  proglucagon  processing  precedes  its 
initial sorting, and therefore MPGF and glicentin may enter the same or different granule 
populations,  live cell  fluorescence  imaging or  proteomic  approaches  are  necessary to 
determine the proportion of the various PGDPs within immature granules.  It  remains 
unanswered  from  immunoelectron  surveys  whether  glicentin  and  MPGF  are  always 
found  in  immature  granules,  or  if  they  may  be  diverted  to  different  granule  sub-
populations.
Processing is only one critical component to the production and secretion of hormones as 
they  must  end  up  in  secretory  granules  for  proper  physiologic  response  to  stimuli. 
Critically,  sorting  form  the  TGN  toward  mature  granules  necessarily  parallels  the 
processing events to yield the PGDPs. As proglucagon and its derived peptides transit the 
regulated secretory pathway, they will encounter the necessary low-pH and high calcium 
environments necessary for PC1/3 or PC2 activity, they will be concentrated, and this 
compartmentalization is required for nutrient stimulated secretion of glucagon, GLP-1 
and GLP-2. To date, the molecular mechanism that determines how proglucagon is sorted 
to  granules  remains  unknown.  However,  several  clues  from  the  study  of  other 
neuropeptides and hormones suggest  that  structures  within proglucagon may act  as a 
sorting signal, guiding its route toward granules.
1.6 Mechanisms of Sorting
In characterizing the route prohormones take along the regulated secretory pathway, an 
essential bottleneck that must be overcome, is the efficient sorting and condensation into 
secretory granules. Two models were proposed to explain this step  (285). Sorting can 
occur either through a cargo-receptor interaction that is mediated by a sorting signal, or, 
cargo proteins reversibly self-aggregate prior to entry in nascent granules. Subsequent 
research  of  intracellular  trafficking  research  has  focused  on  identification  of  sorting 
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signals and their receptors, and characterizing cargo aggregates in the secretory pathway 
(reviewed in (287)). This section focuses on what is known about the specific structural 
motifs, or sorting signals, of peptide hormones and neuropeptides.
1.6.1 Aggregation of hormones
Condensation of granule cargo by aggregation was first described by Palade (288). The 
hypothesis  is  that  cargo  proteins  have  a  weak  affinity  to  aggregate  under  the  ionic 
conditions of the secretory pathway, and that in doing so, provides an thermodynamically 
efficient  mechanism  condensation,  which  then  enter  granules  as  electron-dense 
aggregates.  Two  “classic”  examples  of  aggregation  are  put  forth  as  evidence  for 
aggregation of cargo hormones. First, pro-atrial natriuretic peptide (pro-ANP) is secreted 
from secretory granules of atrial cardiomyocytes in response to increased blood volume. 
Sorting to granules in either AtT-20 or PC12 cells seems to require calcium-mediated 
aggregation via diacidic residues in its pro-domain (77). Mutation of Glu23,Glu24 in the 
sorting domain (pro-ANP 11-30) increases solubility of aggregates in vitro, and results in 
constitutive secretion from AtT-20 cells. Second, the somatotropin family which includes 
growth  hormone  (GH),  prolactin  and  placental  lactogen.  These  structurally  related 
hormones are characterized by a four α-helix bundle, they do not undergo processing by 
prohormone convertases, and are stabilized by intra-molecular disulphide bonds  (289). 
Prolactin  and  GH  form  aggregates  in  the  Golgi  that  traffic  as  electron-dense  cores 
through  the  regulated  pathway  (288).  However,  aggregation  is  not  a  one-size-fits-all 
mechanism  for  the  regulated  secretory  pathway.  The  ability  for  cargo  proteins  to 
aggregate (either  in  a high calcium or low pH environment)  varies  substantially, and 
aggregation  is  better  observed  as  a  function  of  the  protein  rather  than  the  secretory 
pathway. Human prolactin could not aggregate in 10 mM Ca2+ in vitro at any acidic pH, 
conditions that match the granule environment, negating the idea that sorting relies on 
this mechanism (290). Sorting-signal tagged human serum albumin traffics efficiently to 
granules in AtT-20 while undergoing no (or negligible) aggregation in AtT20 cells (291). 
While short charged segments of amino acids mediate aggregation of pro-tachykinin to 
sort into granules (292). Alternatively, inducing aggregation in the secretory pathway can 
actually reduce sorting efficiency and secretion (293, 294). Regardless of the influence of 
aggregation  at  the  TGN,  ample  empirical  evidence  shows  that  prohormones  and 
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neuropeptides mostly rely upon specific domains or structures that facilitate their correct 
targeting and secretion.
1.6.2 Dibasic sorting signals
Dibasic  sites  are  well-known  because  of  their  endoproteolysis  by  prohormone 
convertases to yield mature hormones from their  precursors. That these sites undergo 
cleavage along the regulated secretory pathway makes them attractive sorting signals. 
The representative example of dibasic sites influencing sorting is pro-renin (295), which 
contains two dibasic sites in its pro-domain that are essential for both its processing and 
regulated  secretion.  Similarly,  pro-neurotensin/neuronedin  N  and  pro-thyrotropin-
releasing hormone (pro-TRH) both require processing at multiple dibasic sites to gain 
entry to granules (296–299). Dibasic signals are identified for pro-NPY (300), pro-gastrin 
(301), and pro-VGF (non-acronymic) (302).
1.6.3 Diacidic sorting signals
The  first  identified  sorting  signal  was  a  di-acidic  motif  from  pro-opiomelanocortin 
(POMC)  (303,  304),  and  is  also  found  in  pro-insulin  (305),  pro-brain-derived 
neurotrophic factor  (pro-BDNF)  (306) and pro-enkephalin  (307).  For POMC, the key 
acidic residues for receptor interaction are Asp9,Glu14, stabilized by Leu11,Leu18, that 
must be constrained in an amphipathic disulphide loop conformation (303, 304). For pro-
insulin  the  disulphide  bonds  constrain  Glu-A17,Glu-B13  and  Leu-A16,Leu-B17 
necessary for receptor binding  (304, 305). Therefore,  this  constrained di-acidic amino 
acid motif is a well-conserved sorting signal.
1.6.4 Amphipathic α-helices
The  somatostain  family  includes  somatostatin  (SST)  and  cortistatin  (CORT).  Pro-
somatostatin  is  sorted  to  granules  via  an  N-terminal  amphipathic  α-helix  in  the  pro-
domain (308, 309). Cortistatin also contains a homologous pro-domain α-helix (309), of 
unknown  functional  significance.  A  final  example  is  found  in  pro-cocaine  and 
amphetamine regulated transcript (pro-CART)  (310).  The amphipathic nature of these 
helices, in which a large hydrophobic patch surrounded by charged residues can direct 
granule sorting (311), possibly by hydrophobic association with membrane lipids or inter-
molecular aggregation. Although not a hormone, PC1/3 is also targeted to granules via an 
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amphipathic  helix  (PC1/3  738-753)  that  can  be  partly  attributed  to  both  calcium-
dependent aggregation of these helix domains, and membrane association (106).
1.6.5 Disulphide loops
Pro-vasopressin and pro-oxytocin are  highly conserved peptides that sort  to  secretory 
granules using both oligomerization as well as multiple intra-molecular disfulide loops 
(312). Entry into the regulated pathway first requires cleavage of the pro-domain from the 
hormone (313). Once processed, these pro-domain/hormone heterodimers can aggregate 
via  intra-  or  inter-molecular  disulphide  loops  and  the  conformation  of  the  hormone 
domain is crucial for sorting using both AtT20 and Neuro-2a cells (312, 314). In contrast, 
pro-somatostatin contains a mostly disordered pro-domain and two dibasic cleavage sites 
to  generate  the mature hormones,  SST-14 and SST-28, characterized by a  C-terminal 
disulphide loop. It was recently suggested that the nature of this loop can dynamically 
form fibrils and directly affect exocytosis, and possibly even sorting efficiency  (315). 
Therefore, further nuances to the sorting mechanism remain to be identified.
1.6.6 Glycoproteins with sorting signals
The  gonadotropins  including  follicle  stimulating  hormones  (FSH)  and  luteinizing 
hormone (LH) are distinguished in that they are heterodimeric glycopeptides, consisting 
of an common α, and unique beta chain. Thus, the beta chain determines the identity of 
the  hormone,  its  biological  specificity, and the  mechanism of  intracellular  trafficking 
(316). Despite being secreted from gonadotropes, FSH and LH are secreted differently: 
constitutive  secretion  of  FSH and  regulated  secretion  of  LH  (317).  The  information 
encoded for regulated secretion is encoded by the C-terminal heptapeptide of the LH-beta 
subunit, not found in the FSH-beta subunit (318, 319). The exact mechanism is not clear, 
and the data do not rule out a role for either increasing folding efficiency in the ER by the 
presence of  the heptapeptide this  leading to  regulated secretion  (320) or  whether  the 
hydrophobic nature is required aggregation, or interaction with a yet unidentified sorting 
receptor (321).
1.6.7 Compounding sorting signals may increase returns
Sending hormones to granules is often not accomplished via one signal alone. Instead, 
multiple sorting signals may synergistically combine to increase storage efficiency (302, 
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322).  The  advantages  of  this  process  are  clear.  Prohormones  that  are  differentially 
processed in multiple tissue types (e.g., POMC and proglucagon) may use tissue-specific 
receptors,  thus allowing independent routes for prohormone processing and secretion. 
Increasing sorting efficiency is paramount to efficient production of bioactive peptides.
What is clear is that there is not a single universal sorting signal. So far, the molecular 
range of identified signals can be as small as two dibasic amino acids or large loop-based 
structures. Aggregation may play a role in these processes, though its extent appears to be 
highly  variable,  and in  many examples,  is  unnecessary  for  sorting.  Still,  all  of  these 
modalities may combine in any particular prohormone in order to modulate the efficiency 
of their sorting. Generally, sorting signals tend to be contained in the pro-domain, and not 
in the hormone domains. In order to complete the mechanism, protein binding partners, 
so-called sorting receptors, recognize these motifs to facilitate granule entry.
1.6.8 Sorting Receptors
Just as there is a variety of sorting signals, these signals are recognized by a smaller 
subset of receptors. The search for a universal sorting receptor is elusive, and in reality, 
multiple (neuro)endocrine mechanisms exist to serve the diversity of (neuro)endocrine 
peptides. The operational definition of a sorting receptor must meet several criteria: 1) 
receptors and their cargoes should co-target to the same granules; 2) receptors should 
bind to their ligands in a pH- or cation-dependent manner to show specificity for binding 
in the TGN or immature granules;  and 3) a loss of the interaction or receptor should 
severely affect regulated secretion and cause mis-sorting the constitutive pathway. Due to 
the need for a receptor to selectively bind cargoes at mildly acidic conditions of granules, 
and then release them upon exocytosis when exposed to a neutral pH, these interactions 
are likely to be very dynamic, binding with both low affinity and high specificity. Sorting 
efficiency can be increased by the partial co-aggregation between receptor and cognate 
hormone(s), in a one-to-many relationship along the ionic gradient(s) of the secretory 
pathway. In  this  way, cargo  is  efficiently  concentrated,  while  not  creating  additional 
demand for activation energy. Two sorting receptors used by endocrine tissues involve 
processing enzymes and granins. Together, these few members serve a broad range of 
hormones thus identified.
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The first bona fide sorting receptor is carboxypeptidase E (CPE), which is responsible for 
trafficking the “POMC” proteins: POMC, pro-insulin, pro-BDNF and pro-enkephalin, as 
previously discussed. Inactive pro-CPE is directed to the TGN (57 kDa form) by a C-
terminal trans-membrane α-helix in cholesterol-sphingolipid enriched membrane domains 
(323), and maturing in granules  (324).  The ability to bind prohormone cargo relies on 
Arg255  and  Lys260  (304) that  can  bind  two  acidic  amino  acids  ~12-15  Å  on  the 
hormone, stabilized by two hydrophobic residues spaced ~5-7 Å apart. Evidence for CPE 
as a sorting receptor is most convincing from depletion studies of transgenic mice.  A 
strain  of  mice  called  CPEfat/fat,  harbors  a  mutant  S202P-CPE,  that  is  enzymatically 
inactive  (325).  CPEfat/fat mice  constitutively  secrete  POMC  (326) and  proinsulin, 
becoming obese, diabetic, and the granules of beta cells lack the characteristic electron-
dense cores (325). Similar results for pro-insulin were observed in CPE knock-out mice 
(327).
 
PC1/3 and peptidylglycine α-amidating monooxygenase (PAM) are the other processing 
enzymes  that  act  as  sorting  receptors  and  are  co-targeted  to  granules.  PC1/3  has  an 
membrane-associated amphipathic α-helix (105, 106), while PAM is a type 1 membrane 
protein (274). The loss of the membrane-associated α-helix in PC1/3 mis-routes pro-renin 
for constitutive secretion (105, 328). Within granules, PAM acts on hormone substrates to 
produce  C-terminal  amidation  of  glycine  residues  (such  as  in  GLP-1).  In  secretory 
granules of atrial myocytes, PAM is the sorting receptor of pro-ANP (329), despite not 
being a substrate of PAM. No reports on whether PAM acts as a sorting receptor within α- 
or L-cells exist, though it seems unlikely, since heterozygous knock-out PAM+/- mice 
have normal basal blood glucose and glucose tolerance at  2 months of age, and only 
develop mild obesity by 10 months, likely a non-specific complication of the model (329, 
330). Therefore the possibility remains that PC1/3 may sort proglucagon in L-cells.
The granins are a complex family of proteins, co-operatively sorting cargo hormones and 
are major components of the granule matrix. Chromogranin A and B (CgA and CgB), 
coupled to secretorgranins II and III (SgII and SgIII) are most important for sorting. CgA 
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is the most abundant constituent in chromaffin and all pancreatic islet cells  (331, 332), 
while beta and α cells also contain SgII and SgIII (333). At the TGN, it is believed that 
the  granins  nucleate  partial  aggregation  at  the  mildly  acidic  pH  and  the  calcium 
environment of the TGN (334–337). Importantly, the granins  selectively aggregate with 
neuropeptides and hormones, excluding constitutively secreted cargoes  (338). CgA and 
CgB  are  soluble  proteins  that  require  the  aide  of  an  adaptor  protein,  one  of  the 
secretogranins for granule targeting. The most profound demonstration of CgA (and also 
CgB)  actions  on  hormone  storage,  is  that  CgA-/-  mice  have  severely  impaired 
catecholamine storage in adrenal chromaffin cells (339, 340), and is moderately impaired 
in CgB-/- mice (330, 341). The effects on other (neuro)endocrine tissues are rather mild 
(even unaffected)  likely due to  compensation by upregulation of  other  granins  (342). 
Over-expression of CgA can enhance sorting of GH and NPY to granules (343), and CgB 
can  direct  POMC  to  granules  and  for  increased  secretion  of  ACTH  (344).  The 
secretogranins, SgII and SgIII, are adaptors of chromogranins (110, 345, 346), by directly 
associating with lipid rafts of granule membranes. The granin mechanism can explain the 
increased stoichiometry ratio of cargo to receptor, a common (yet unproven) criticism of 
the  sorting  receptor  hypothesis.  Co-aggregation  of  soluble  cargo  in  the  TGN  by 
chromogranins produces a large mass of peptides that can then be targeted to granules by 
the  membrane-bound  secretogranins,  efficiently  packing  large  quantities  of 
chromogranins and hormones. SgIII  does bind the condensed aggregates of granin and 
neuropeptides  (e.g.,  adrenomedullin),  providing  a  high-capacity  sorting  mechanism 
(347), and SgII appears to operate in a similar fashion  (110). Together, segregation of 
regulated cargo is retained in the area of nascent granule formation.
To illustrate an example, consider the sorting of POMC. SgIII binds the cholesterol-rich 
membrane at the N-terminus, while either binding CgA or CPE via the C-terminus (100, 
346–348).  SgIII  and  CPE  are  both  closely  associated  in  cholesterol-rich  membrane 
domains, and can individually bind to POMC  (349, 350). As a nascent granule forms, 
CgA is carried to granules by SgIII, while POMC is carried by CPE (and also CgA), 
where they will encounter each other in the lipid raft-enriched membrane. SgIII is also 
required to properly sort CgA in AtT-20 cells (110), but can only bind to either CgA or 
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CPE at  one  time  (349).  Therefore,  at  the  nascent  granule  membrane,  POMC can be 
handed off to CgA which has a high binding capacity due to aggregation, while SgIII 
laterally binds to either CgA (to retain POMC) or CPE (to facilitate a transfer to the 
SgIII-CgA complex)  (349,  350).  This  “hand  off”  mechanism  describes  two  actions 
happening in parallel, from the independent delivery of POMC via CPE and CgA/SgIII, 
to the transfer to CgA/SgIII complexes. This view is compatible with a condensing ISG 
actively retaining hormones in the maturing granule.
1.7 Rationale and Specific Aims
In the case of proglucagon, it is organized into several constituent hormone sequences. 
Each  of  these  sequences  contains  at  least  one  putative  sorting  signal,  in  addition  to 
several  dibasic  sites  that  flank  each  major  hormone  domain.  At  present,  neither  the 
existence  of  sorting  signals,  nor  the  existence  of  sorting  receptors  involved  in 
proglucagon trafficking, have been investigated. Based on the discussion of signals and 
receptors above, it is likely that such a mechanism should exists, especially considering 
the need for α- and L-cells to produce distinct subsets of proglucagon-derived hormones.
I  hypothesize  that specific sorting signals within the hormone domains of proglucagon 
determine  its  intracellular  trafficking  through  specific  interaction  of  a  receptor  to 
facilitate efficient storage within granules and processing to mature hormones.
Aim 1: To identify sorting receptors and sorting signals that mediate the sorting of 
proglucagon to secretory granules.
A) I will identify candidate sorting signals using the predicted 2D and 3D structure of 
proglucagon, and determine whether these structures are necessary for sorting by using 
site-directed mutagenesis to specifically disrupt each structure.
B) I will determine whether a known prohormone sorting receptor, carboxypeptidase E, is 
necessary for sorting proglucagon to granules by quantifying intracellular trafficking in 
the absence or presence of transfected CPE. The mechanism will be confirmed by using 
siRNA-mediated depletion of CPE from an α and L cell line, and measuring the degree of 
regulated secretion by RIA.
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Aim 2: To characterize the molecular properties of sorting signals within the peptide 
domains of  proglucagon.
A) I  will  determine  which  hormone  domains  contain  sorting  information  by  making 
specific genetic constructs and following intracellular trafficking and measuring regulated 
secretion.
B) To  determine  the  biochemical  nature  of  the  sorting  signal  using  site-directed 
mutagenesis.
C) I will determine the temporal sequence of proglucagon processing and sorting.
Aim 3: To develop and validate a quantitative co-localization algorithm to determine 
in which sub-cellular compartment a protein of interest is targeted.
I  will  validate  the  utility  of  several  common  quantitative  immunofluorescence  co-
localization techniques by conducting computer simulation experiments. I will create a 
work-flow  for  conducting  quantitative  co-localization  analyses  for  future 
immunofluorescence  studies,  then  compare  this  method  with  more  complex  co-
localization analytic methods.
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Chapter 2
The  sorting  of  proglucagon  to  secretory  granules  is 
mediated  by  carboxypeptidase  E  and  intrinsic  sorting 
signals
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2.1 Introduction
Ingested nutrients  stimulate  the secretion  of  glucoregulatory hormones from both the 
pancreas  and  the  gut  to  exert  control  over  glucose  homeostasis.  Proglucagon  is  a 
polypeptide prohormone expressed in pancreatic  α cells, intestinal L cells, and a select 
subset of neurons in the brainstem. It is processed in a tissue-specific manner to produce 
distinct sets of constituent hormones. Expression of prohormone convertase (PC)-2 in α 
cells  produces  glucagon,  the  major  pancreatic  hormone  product  (1,  2).  Glucagon  is 
secreted in response to hypoglycemia and is the major counter-regulatory hormone to 
insulin, activating hepatic glycogenolysis and gluconeogenesis to maintain euglycemia 
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(3). In contrast, PC1/3 in intestinal L cells and neurons produces oxyntomodulin, GLP-1 
and GLP-2 (4–7). These nutrients are secreted in response to nutrient ingestion, and each 
has a distinct effect to control glucose homeostasis within a nominal range (8). GLP-1 is 
enhances post-prandial insulin secretion, whereas GLP-2 is an intestinotropic hormone 
that increases intestinal blood flow and nutrient assimilation  (9). Oxyntomodulin is an 
anorectic hormone, decreasing food intake and increasing satiety and energy expenditure 
(10). Therefore, nutrient status potently stimulates secretion of the proglucagon-derived 
peptides  so  they  may  exert  tight  control  over  glucose  metabolism  and  nutrient 
homeostasis.
In  order  for  endocrine  and neuroendocrine  tissues  to  robustly  respond to  changes  in 
nutrient status, neuropeptides and hormones are directed along the regulated secretory 
pathway. This biosynthetic pathway is distinct from unregulated, constitutive secretion, 
and maintains specialized storage organelles called secretory granules. Two hypotheses 
have  been  proposed  for  the  targeting  of  hormones  to  granules.  In  the  “sorting-by-
retention” model, hormones condense into large aggregates in the  trans-Golgi network 
(TGN)  that  are  retained  in  nascent  secretory  granules,  while  the  maturing  granule 
selectively removes other proteins. Alternatively, prohormones in the “sorting-for-entry” 
model specifically bind to either membrane-bound sorting receptors or membrane lipids, 
by  a  structural  sorting  signal.  Once  prohormones  enter  immature  granules,  they  will 
undergo endoproteolysis  to  yield  bioactive  hormones,  which  are  then  condensed and 
stored in the granules as an electron-dense core,  characteristic of their  appearance by 
electron microscopy. Secretion can then be stimulated in a Ca2+-dependent manner by an 
appropriate  secretagogue  (e.g.,  nutrient  ingestion).  Based  on  the  “sorting-for-entry” 
model,  we  can  begin  to  explore  the  molecular  mechanism of  the  sorting  signals  of 
proglucagon.
The known sorting signals of prohormones range in their molecular complexity. These 
include  1)  dibasic  amino  acid  sequences,  found  in  pro-neuropeptide  Y  (11);  2) 
amphipathic α-helices (12) such as those in pro-somatostatin (13), pro-CART (14), VGF 
(non-acronymic) (15), pro-renin (16), pro-gastrin (17), and pro-neurotensin (18); and 3) 
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acidic residues found on disulphide loops found within POMC (19) and proinsulin (20). 
An α-helix predominates the structures of glucagon (21) and GLP-1 (22) based on their 
known  X-ray  crystal  structures,  and  GLP-2  (23) by  the  NMR  solution  structure, 
suggesting  that  proglucagon  contains  significant  helical  content  within  its  hormone-
encoding domains.  Proglucagon also  contains  five  proteolytic  dibasic  sites  located  at 
hormone domain junctions (Figure 1). The α-helix of glucagon contains an embedded 
dibasic site, a motif that targets VGF to granules (15). Lastly, different sorting motifs may 
synergistically  enhance granule targeting  (24).  Therefore  proglucagon trafficking may 
rely on information encoded in several putative sorting signals, located in the α-helices of 
mature glucagon and glucagon-like peptide domains, and multiple dibasic cleavage sites.
Figure  1. Post-translational  processing  of  proglucagon  to  its  derived  peptides. A 
schematic representation of proglucagon in which each domain has been colour-coded, 
and the amino acid positions of key processing events have been identified. The amino 
acid numbering is relative to the first N-terminal amino acid of proglucagon (lacking the 
signal peptide). The major hormone products produced from tissue-specific processing by 
their respective prohormone convertase (PC) are shown at bottom. In pancreatic islet  α 
cells,  the  major  products  are  glucagon and major  proglucagon  fragment  (MPGF).  In 
enteroendocrine L cells and in the brain, the major products are GLP-1 (1-37), GLP-1 (7-
37), GLP-2, oxyntomodulin and glicentin.
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In order for hormones to be targeted to granules, a sorting receptor must recognize and 
bind  the  sorting  motif.  Carboxypeptidase  E  (CPE)  is  a  granule-resident  enzyme that 
cleaves C-terminal basic amino acids. It is known to be a sorting receptor for both pro-
opiomelanocortin (POMC) and pro-insulin by interaction of two acidic residues of the 
sorting signal, with complementary basic residues on the receptor surface  (19, 20, 25). 
Individually, PC1/3, PC2 and CPE are co-targeted to granules with hormones. PC1/3 co-
targets pro-renin to granules in order to produce renin in AtT-20 cells  (26). Deletion of 
the C-terminal tail of PC1/3 that tethers to lipid rafts of granule membrane mis-routes 
pro-renin for constitutive secretion (27, 28). However, no such evidence exists to suggest 
that PC2 directly impairs granule targeting, though this hypothesis was not specifically 
investigated. Even in α cells isolated from PC2 null islets (2) and a derivative α cell line 
(29) show no defect of regulated secretion (aside from the obvious defect in processing). 
A strain  of  mice called  CPEfat/fat,  harbors  a  mutant  S202P-CPE,  that  is  enzymatically 
inactive (30). CPEfat/fat mice constitutively secrete POMC (25) and proinsulin, becoming 
diabetic, and the granules of beta cells lack the characteristic electron-dense cores (30). 
Similar results for pro-insulin were observed in CPE knock-out mice (31). Because these 
enzymes are co-targeted to granules with their substrate hormones, and CPE has been 
shown to specifically interact with the POMC sorting motif,  the possibility exists that  
CPE, PC1/3 and PC2 are candidate receptors for proglucagon sorting.
In the present study, we investigated the requirement of CPE as a sorting receptor for 
proglucagon.  We hypothesized that in  the absence of CPE, sorting of proglucagon to 
granules would be greatly diminished. Furthermore, we also investigated whether PC1/3 
or PC2 co-expression would have an effect on sorting of proglucagon. We found that 
CPE alone  plays  a  role  in  trafficking  proglucagon  to  granules  and  that  this  may  be 
specific to α cells. We also investigated the hypothesis that proglucagon contains sorting 
signals by focusing on the glucagon α-helix and its embedded dibasic site. By finding that 
granule targeting was impaired by specific mutation of these two structures, we provide 
the  first  characterization  of  sorting  signals  contained  within  the  glucagon  α-helix  of 
proglucagon.
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2.2 Methods
2.2.1 Cell Culture, plasmids and transfection
Wild-type Neuro 2a (N2a wt) cells and Neuro 2a cells stably transfected with mouse CPE 
(N2a-CPE, clone 17) were obtained from Dr. Y. P. Loh (Bethesda, MD, USA). Cells were 
maintained in DMEM containing 10% FBS and stable transfectants were maintained in 
media containing 400 µg/ml G418. N2a wt cells were also stably transfected with the 
enzymatically  inactive  form  of  CPE,  E300Q  (32) using  Lipofectamine  2000  (Life 
Technologies).  Stable  transfectants  were  selected  in  800  µg/ml  G418,  pooled  and 
maintained in 400 µg/ml G418. To examine the role of CPE in sorting proglucagon, N2a 
wt, N2a-CPE and N2a-E300Q cells were transfected with hamster pre-proglucagon (in 
pcDNA 3.1; a kind gift from Dr. D. F. Steiner, Chicago, IL, USA). To examine the roles 
of  other  prohormone  convertases,  both  N2a  wt  and  N2a-CPE  cells  were  transiently 
transfected with plasmids encoding mouse PC1/3 and PC2 (kind gifts from Dr. N. G. 
Seidah,  Montréal,  QC,  Canada).  To  determine  whether  proglucagon  co-localizes  to 
granules of N2a-wt cells, we constructed a proglucagon-EGFP plasmid. Pre-proglucagon 
cDNA was PCR amplified to add the KpnI (proG-EGFP forward primer, 5’-GGT ACC 
ATG AAG AAC ATT TAC ATT GTG G-3') and BamHI (proG-EGFP reverse primer, 5'-
GGA TCC GCT TTC TTG TCA GTG ATT TTG GT-3') restriction sites (underlined) in 
frame with EGFP (bolded nucleotides). Using PCR amplification and restriction digest, 
pre-proglucagon was cloned into the pEGFP-N1 backbone (Clontech Labs, Takara Bio) 
to add a C-terminal EGFP tag. To determine possible sorting signals, the sequence of 
proglucagon was mutated independently at three sites: at the processing site, R70K71; at 
the dibasic site within glucagon, R17R18; and at two leucines that were postulated to 
flank the  helix  structure  within  glucagon,  L14  and L26.  The  processing  site  mutant, 
K71Q, was a kind gift  from Dr. D. F. Steiner (Chicago, IL, USA). We generated the 
mutation at the dibasic site, R18Q (forward primer sequence 5'-AAA TAC CTG GAC 
TCC CGC  CAA GCC CAA GAT-3'),  and the double leucine-to-proline mutation was 
done in two steps; L14P was made using forward primer 1,  5'-TAC AGC AAA TAC 
CCG GAC  TCC  CGC  CGA GCC-3';  and  L26P  was  subsequently  generated  using 
forward primer 2, 5'-CAA GAT TTT GTG CAG TGG  CCG ATG AAC ACC-3'. Bold 
sequences in primers indicate site of mutation.  All site-directed mutagenesis reactions 
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were  carried  out  using  the  QuikChange™  II  Site-Directed  Mutagenesis  Kit  (Agilent 
Technologies, Santa Clara, CA, USA) and results were confirmed by sequencing at the 
London Regional Genomics Facility, University of Western Ontario.
2.2.2 Depletion of Carboxypeptidase E by siRNA Knockdown
Specific knock-down of  CPE in either alphaTC1-6 or GLUTag cells was achieved by 
synthesizing siRNA using the Silencer siRNA Construction Kit™ (Life Technologies, 
Carlsbad,  CA, USA).  The kit  included a  negative control,  Ambion Silencer  Negative 
Control #1, a sequence with no known targets in the mouse genome. Initial targets were 
selected from the mouse CPE mRNA sequence (GenBank™ accession #NM_013128.1) 
as generated by Ambion's online algorithm, and subsequently screened using a BLAST 
search  to  identify  seven  candidate  sequences  with  no  homology  to  known  mouse 
mRNAs. All seven candidate siRNA sequences were synthesized, screened in both cell 
lines and validated for the extent of CPE depletion by western blot using the CPE 4-5 
antibody that detects the N-terminal domain of CPE (a gift from Dr. Y. P. Loh, Bethesda, 
MD, USA) (Figure 7A). A single target was chosen, CPE73, spanning nucleotides 1408-
1428 (sense strand: 5'-C CCT GCT GTT GGG GTG GAC TT), for its significant and 
reproducible ability to decrease CPE levels in both cell lines (Figure 7A). CPE73 was 
used  in  subsequent  depletion  experiments,  in  which  200 nM concentrated  CPE73 or 
control  siRNA  were  transfected  using  Oligofectamine  (Life  Technologies)  as  per 
manufacturers  instructions  for  72  h  prior  to  secretion  experiments  or  fixation  for 
immunofluorescence microscopy.
2.2.3 Western Blot
For  western  blot  analysis,  all  cells  were  grown in  six-well  plates,  lysed  and  protein 
extracted.  Protein  concentration  was  quantified  by  densitometry  and  20  µg  of  total 
protein was separated on 12% SDS-PAGE gels as previously described  (33). Proteins 
were  transferred  onto  nitrocellulose  membranes  and  probed  using  specific  antisera 
against  CPE (CPE 4-5),  or against  PC1/3 or PC2 (kind gifts  from Dr. N. G. Seidah, 
Montréal,  QC,  Canada).  Bands  were  visualized  using  Super  Signal  West  Pico 
chemiluminescent substrate (Thermo-Fisher Scientific, Toronto, ON, Canada) and bands 
were quantified by densitometry as described (33). Secreted CPE was detected by media 
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collection and lyophilized. The concentrated residue was resuspended in sample buffer 
and loaded entirely into one well. As a result of concentration, these samples migrated 
more slowly through the gel and had a greater apparent molecular weight (Mr) of 60 kDa.
2.2.4 Secretion Experiments
AlphaTC1–6 cells (a kind gift from Dr. C. B. Verchere, Vancouver, BC, Canada) were 
maintained in DMEM containing 15% horse serum and 2.5% FBS. GLUTag cells (a kind 
gift from Dr. D. J. Drucker, Toronto, ON, Canada) were grown in low-glucose DMEM 
containing 10% FBS. For stimulated secretion experiments, αTC1–6 cells were seeded in 
24-well  plates  in  replicates  of  six  and pre-incubated  in  Hank's  buffered  salt  solution 
(HBSS; 138 mM NaCl, 5.33 KCl, 4.00 NaHCO3, 1.26 CaCl2, 0.50 MgCl2, 0.44 KH2PO4, 
0.41  MgSO4,  0.30  Na2HPO4)  containing  25  mM  glucose  for  1  h.  Cells  were  then 
incubated  in  HBSS  containing  1  mM  glucose  and  10  µm each  of  forskolin  and  3-
isobutyl-1-methylxanthine (IBMX) for 1 h. GLUTag cells were incubated in low-glucose 
(5.5  mM)  DMEM  +0.5% FBS  without  (basal)  or  with  (stimulated)  10  µm  each  of 
forskolin and IBMX for 2 h. After all secretion experiments, media were collected and 
trifluoroacetic acid (TFA) was added to 0.1%. Cells  were rinsed twice in HBSS, and 
scraped in 1 mL homogenisation buffer (1 M HCl, 1 M formic acid, 1% (v/v) TFA, 1% 
(w/v) NaCl). The cells were sonicated in one 12 s burst, centrifuged and the supernatant 
was collected,  and both media and cell  extracts  were passed through a Sep-Pak C18 
reverse-phase cartridge to elute proglucagon-derived peptides as previously described (4, 
5). Glucagon and GLP-1 content were assessed by RIA using the glucagon and GLP-1 
RIA kits  (Linco/EMD Millipore,  Bedford,  MA,  USA).  The antibody provided  in  the 
glucagon RIA kit specifically detects the C-terminal end of glucagon and does not cross-
react with any other proglucagon-derived peptides.
2.2.5 Immunofluorescence and image acquisition
For immunofluorescence, cells were grown on glass coverslips, as described  (33). The 
primary  antibodies  used  were  directed  against  glucagon  (rabbit;  1:1000; 
Bachem/Peninsula Laboratories, Torrance, CA, USA), and either the Golgi marker p115 
(mouse; 1:50; Transduction Laboratories, San Jose, CA, USA), or the secretory granule 
marker  chromogranin A (rabbit;  CgA; 1:50; Abcam).  Additionally, primary antibodies 
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against  insulin  (guinea  pig;  1:1000),  GFP  (rabbit;  1:250;  A.  v.  peptide,  Clontech 
Laboratories,  Takara  Bio,  Mountain  View, CA,  USA),  or  transcription  factor  PDX-1 
(rabbit; 1:50) were used in the validation of the Pearson's correlation coefficient image 
analysis (described below). Coverslips were blocked in 10% goat serum and 1% bovine 
serum albumin in PBS. The anti-glucagon antibody was raised against the entire sequence 
of glucagon, and thus recognises unprocessed proglucagon, glicentin, oxyntomodulin and 
glucagon. To examine CPE immunoreactivity, slides were incubated with the CPE 7–6 
antibody (raised in rabbit;  kind gift  from Dr. Y. P. Loh, Bethesda, MD, USA), which 
recognises the C-terminus of CPE. Alexa 488-IgG (Invitrogen) was used to visualise the 
glucagon or CPE antibody, and Alexa 594-IgG for the p115 or CgA antibody.
Cells were visualized using an Olympus IX81 widefield fluorescence microscope and 
images were acquired using In Vivo software. Ten optical sections were acquired at 0.2 
µm steps to cover the z-axis field of the cells, using a 60x oil immersion objective lens. 
Image stacks were then processed by the blind (3D) deconvolution algorithm provided in 
Image-Pro Plus software (Media Cybernetics Inc., Rockville, MD, USA).
2.2.6 Image analysis using Pearson's Correlation Coefficient
Image analyses were conducted using FIJI (FIJI  is  just  ImageJ) (version 1.46h)  (34), a 
distribution  of  ImageJ  (NIH,  Bethesda,  MD,  USA).  Co-localization  analyses  were 
conducted  using  the  Co-localization  2  plugin  in  FIJI.  During  the  course  of  image 
analysis, it became apparent that there were bugs in the quantification of co-localization. 
I fixed the bugs and contributed the code to the FIJI/ImageJ project. Details of the bug 
fixes can be found in  Appendix 1.  Regions of interest were drawn around single- or 
multi-cell bodies from pseudo-coloured red and green fluorescent images to exclude as 
much background as possible. The segmented region was defined by a binary mask and 
applied to both image sets. Using raw, unprocessed images presents the possibility that 
any identified co-localizaion could instead be a false-positive. To ensure false-positives 
were not included in subsequent analyses, each red/green image pair was first screened 
using the Coste's significance threshold test (35). Costes' algorithm scrambled one image 
to test for spurious co-localization and simultaneously determines a threshold intensity 
for each colour, above which pixels are considered to be statistically correlated. Paired 
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red  and  green  pixels  were  then  used  to  quantify  co-localization  using  the  Pearson's 
correlation coefficient (PCC) (r), according to:
Here, the i-th and j-th pixels represent the respective regions of interest,  Sc1 and Sc2, of 
co-localized pixel intensities in each colour channel, and all signal intensities, regardless 
of co-localization, are denoted by S1 and S2 or their averages, S1av and S2av. Importantly, 
the numerator is dependent on an unbiased estimation of co-localized pixels as chosen by 
the Costes' algorithm, while the denominator uses all pixels within respective regions of 
interest to establish a signal-to-background ratio. This measurement also has the desirable 
properties of being invariant to the region of interest shape, and each pair of images is 
normalized to their own mean fluorescence intensities. Calculated correlation coefficients 
were treated as a single experimental dataset and differences were tested using a one-
factor  ANOVA omnibus  test,  and  Tukey's  HSD  post-hoc test  using  a  significance 
threshold of α = 0.05. Group sample sizes (n) varied between 10-25, with adequate power 
to detect the effect sizes shown here. The Pearson's correlation coefficient method was 
validated in INS-1 832/13 cells using markers known for a low degree of co-localization 
(insulin and PDX-1) and a high degree of co-localization (insulin and CgA).
2.2.7 De novo Protein Modeling
At present no crystal or solution structure of the full proglucagon molecule exists. To 
determine  whether  such  a  model  may  provide  mechanistic  insight  to  the  sorting  of 
proglucagon,  the  full-length  proglucagon  polypeptide  sequence  was  submitted  to  the 
Robetta  3D modelling  web  server  for  de  novo 3D protein  structure  prediction  (36). 
Robetta  uses  the  Ginzu  model  (37)  to  find  match  sub-domains  against  known 
homologous  structures  that  have  been  deposited  in  the  Protein  Data  Bank 
(http://www.rcsb.org/pdb/). Proglucagon was parsed into two sub-domains, each modeled 
using the incretin hormone,  glucose-dependent  insulinotropic  peptide (GIP; PDB:2B4N 
and  PDB:2OBU).  The  N-terminal  domain  (proglucagon  1-77;  PDB:2B4N)  had  a 
position-specific iterative BLAST (PSI-BLAST)  (38) confidence score of 5.40; the C-
terminal domain (proglucagon 78-158) (PDB:2OBU) had a HH-Search  (39) confidence 
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of 2.33.  The Robetta server assembled both sub-domain models for final folding and 
side-chain packing, to produce five full-chain 3D structures.
2.3 Results
2.3.1 Pearson's correlation coefficient accurately reflects degree 
of co-localization
If proglucagon sorting to granules is sensitive to changes in CPE expression, we should 
be able to detect a change in sub-cellular distribution at steady state using quantitative co-
localization. We used Pearson's correlation coefficient (PCC) to quantify the degree of 
co-localization.  The  degree  of  co-localization  correlates  with  sorting  efficiency  to 
granules,  and therefore we used co-localization as  a  measure of  sorting efficiency of 
proglucagon.  The  PCC  measurement  has  previously  been  used  to  describe  the  co-
localization of the neuropeptide secretogranin II to granules in both PC12 and chromaffin 
cells  (40).  Further,  the  PCC is  thought  to  be  an  accurate  method  of  co-localization 
because it correlates normalized fluorescence intensities on a pixel-by-pixel basis  (41). 
(A more detailed discussion on the quantitative techniques used in co-localization and 
common misunderstandings of PCC are addressed in Chapter 4.) Here we describe the 
qualitative degree of co-localization alongside quantitative measurements of Pearson's 
correlation coefficient.  Because the explanation of qualitative images  is  subjective by 
nature,  Zinchuk  and  colleagues  have  proposed  a  method  to  translate  qualitative 
descriptions  to  quantitative  ranges1 of  co-localization  parameters  (42).  Using  these 
mappings adds consistent  quantitative meanings  to  these subjective qualifiers.  Before 
using the PCC to measure proglucagon sorting efficiency, we first validated the method 
by measuring two proteins that are known to have either a low or high degree of co-
localization with each other.
To verify the degree of co-localization between two sets of proteins in their native cells, 
we used the insulin-producing rat INS-1 832/13 beta cell line. These cells efficiently store 
a large amount of insulin in secretory granules, which is co-stored with a granule matrix 
1 As described by Zinchuk, the “fuzzy” ranges for Pearson's correlation coefficient (auto-thrshold) map 
as follows. Very weak: -1.0 ~ -0.27; Weak: -0.26 ~ 0.09; Moderate: 0.10 ~ 0.48; Strong: 0.49 ~ 0.84 
and Very strong: 0.85 ~ 1.0.
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protein, chromogranin A (CgA). Therefore we expect a high degree of steady-state co-
localization between insulin and CgA in the Golgi and granules. Both insulin and CgA 
immunoreactivity were detected in a para-nuclear structure, consistent with the Golgi, 
and in punctate structures along the cell  processes,  consistent with secretory granules 
(Figure 2A). PCC analysis on these images showed a very strong co-localization (Figure 
2B), as expected. In contrast, the beta-cell specific pdx-1 transcription factor is active in 
the  nucleus,  and should  have  a  low degree  of  co-localization  with  insulin.  The  sub-
cellular distribution of insulin immunoreactivity was the same, while nearly all pdx-1 was 
localized  to  the  nucleus  (Figure  2A).  As  expected,  insulin  and  pdx-1  were  not  co-
localized  with  each  other,  but  the  PCC  analysis  showed  that  it  was  just  barely 
“moderately” co-localized by using the numeric mappings (PCC = 0.49, on the border 
between weak and moderate co-localization) (Figure 2A). Correspondingly, there is very 
low  overlap  after  inspection  of  the  pdx-1  immunofluorescence  signal  (Figure  2B). 
Insulin was very significantly co-localized to granules (p<0.001) than it was with pdx-1 
in the nucleus. This high degree of insulin and CgA co-localization by Pearson's has also 
recently been demonstrated in rat insulinoma INS-1 cells (43). Therefore we confirm the 
specificity of Pearson's correlation coefficient to measure co-localization.
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Figure 2. Validation of Pearson's correlation coefficient. (A) INS-1 832/13 cells were 
immunodetected  using  antibodies  against  insulin  (green)  and  pdx-1  (red)  or 
chromogranin  A (CgA, red).  Insulin  and CgA are located  in  the  Golgi  and secretory 
granules (punctate signal located in cell  processes),  while pdx-1 was localized to the 
nucleus. Representative images are shown. (B) Mean PCC of pdx-1 and insulin (light  
grey bar) and CgA and insulin (dark grey bar). As expected, there is weak correlation 
between insulin and pdx-1, and very strong co-localization between CgA and insulin. * 
p<0.01. Values are mean ± SEM (n=10).
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2.3.2 Proglucagon is sorted to granules in the presence of 
Carboxypeptidase E
We next  investigated the role  of CPE on the sorting efficiency of  proglucagon.  CPE 
immunoreactivity was not detected by western blot in wild-type N2a cells (N2a-wt), and 
could only be detected after stable transfection of CPE (N2a-CPE) (Figure 3A). In the 
absence of CPE (N2a-wt cells), proglucagon immunoreactivity was mostly localized to 
the cis/medial-Golgi, as indicated by p115 co-immunostaining (Figure 3B),  and there 
was a strong co-localization between proglucagon and p115 by PCC analysis (Figure 
3C).  In  contrast,  in  N2a-CPE  cells  which  over-express  CPE,  proglucagon 
immunostaining shifted toward being stored in punctate structures in the cell processes at 
steady  state,  consistent  with  storage  in  granules  (Figure  3B).  PCC analysis  showed 
moderate co-localization in the presence of CPE through a significant decrease in co-
localization (p<0.01) (Figure 3C). Therefore, the presence of CPE efficiently increased 
proglucagon sorting to granules, as reflected by a loss of co-localization with the early 
Golgi marker, p115, and punctate appearance of proglucagon in granules.
In order to validate that proglucagon is co-localized to granules, we transfected N2a-CPE 
with  proglucagon-EGFP  (enhanced  green  fluorescent  protein).  Cells  were  co-
immunostained for EGFP to detect proglucagon, and CgA to detect granules (as in INS-1 
cells) (Figure 4). As expected, proglucagon immunoreactivity very strongly co-localized 
(r = 0.84 ± 0.01) with CgA-positive punctate structures in the cell processes (Figure 4). 
Therefore, N2a-CPE cells efficiently sort proglucagon to granules.
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Figure 3. CPE plays a role in the sorting of proglucagon. (A) Western blot analysis of 
cell extracts from Neuro2A cells lacking CPE expression, and after transfection of wt or 
E300Q mutant  CPE. (B) Full-length proglucagon was transfected into N2a cells, either 
alone (– CPE), or co-transfected with CPE or E300Q mutant CPE. Cells were immuno-
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stained  using  antibodies  against  glucagon  (green)  and  the  Golgi  protein  p115  (red). 
Representative images are shown. Scale bar represents 10 µm. (C) FIJI/ImageJ software 
was used to determine the fluorescence intensity co-variance (PCC) of proglucagon and 
p115. Proglucagon showed a significant decrease in mean correlation with p115 when co-
expressed  with  CPE,  and  a  significant  increase  when  co-expressed  with  the  E300Q 
mutant CPE. Values are means ± S.E.M. (n=10–25). *p<0.01 vs – CPE; # p<0.01 vs both 
cells with and without CPE.
Figure 4. Proglucagon is sorted to secretory granules in N2a cells expressing CPE. N2a 
cells  were  transfected  with  CPE  and  proglucagon-EGFP, and  immunostained  using 
antibodies directed against EGFP (green) and CgA (red), a granule resident protein. Mean 
Pearson's  correlation coefficient  was significant  (PCC=0.84 ± 0.01,  n=6) and showed 
very strong co-localization.
2.3.3 Proglucagon sorting depends upon properly sorted CPE
In an effort to resolve whether the effect of CPE on proglucagon sorting was influenced 
by its enzymatic activity or its ability to sort to granules, we made stable transfectants of 
N2a-wt cells with the inactive Glu300Gln mutant of CPE (Figure 3A). If CPE acted as a 
sorting receptor for proglucagon, we hypothesized that proglucagon sorting efficiency 
should correlate with CPE trafficking. In E300Q CPE cells (N2a-E300Q), proglucagon 
immunoreactivity was localized to the Golgi, as in the cells lacking CPE (Figure 3B). 
Co-localization of proglucagon with p115 was very strong (Figure 3C), as reflected by a 
significantly  increased  PCC (p<0.01)  when compared to  that  of  N2a-wt,  indicating  a 
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greater abundance of proglucagon in the Golgi. Furthermore, co-localization analysis of 
proglucagon  with  p115  in  N2a-wt  cells  was  significantly  greater  than  in  N2a-CPE 
(p<0.01) (Figure 3C), suggesting that the presence of CPE significantly enhanced sorting 
efficiency of  proglucagon.  This  was  interesting  because  it  suggested  that  the  E300Q 
mutation impaired the post-Golgi sorting of proglucagon. In support of this hypothesis, 
E300Q-CPE was robustly detected in the Golgi (Figure 5A) and could not be detected in 
media (Figure 5B). On the other hand, CPE was detected along the tips of cell processes 
(Figure 5A) could be detected in media (Figure 5B), consistent with storage in granules. 
This suggests that E300Q CPE exit from the Golgi was also impaired, and is not properly 
sorted in N2a cells.
Figure 5. The E300Q mutant CPE is not sorted efficiently to secretory granules. (A) In 
cells  expressing wild-type CPE, punctate staining along the tips  of the cell  processes 
indicates  presence  in  secretory  granules.  In  cells  expressing  E300Q,  CPE 
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immunofluorescence largely coincides with that of p115. (B) Wild-type CPE is secreted 
from N2a cells where a portion is cleaved from the granule membrane resulting in a 
smaller, soluble form of secreted CPE. The E300Q mutant  CPE is not present in the 
media, further indicating that is it not transiting through the secretory pathway in N2a 
cells. The apparent increase in molecular weight of the secreted form is due increased salt 
content of the lyophilized sample resulting in slower migration through the gel, as stated 
in Methods.
2.3.4 The effect of PC1/3 and PC2 on proglucagon sorting
Since proglucagon is co-targeted to granules with either PC1/3 (in L cells) or PC2 (in α 
cells), we also tested the hypothesis that PC1/3 or PC2 were sufficient for proglucagon 
sorting. We were also interested in whether the co-expression of CPE with either PC1/3 
or  PC2  could  enhance  CPE-mediated  proglucagon  sorting.  N2a-wt  cells  were  a 
convenient system for this  experiment because they lack endogenous PC1/3 and PC2 
(Figure  6A).  We  transfected  N2a-wt  cells  with  either  PC1/3  or  PC2  alone,  or  in 
combination with wild-type CPE. When PC1/3 was transfected alone, it was detected as a 
single 84 kDa pro-form, while co-expression with CPE resulted in both an 84 kDa form 
and  an  active  66  kDa  form  (Figure  6A).  The  expression  pattern  of  PC2  remained 
unchanged  (Figure  6A).  Proglucagon  immunoreactivity  was  mostly  localized  to  the 
Golgi when expressed either with PC1/3 or PC2 alone (Figure 6B), and the Pearson's 
analysis showed that there were no significant differences from the N2a-wt cells lacking 
CPE (Figure 6C). The co-localization of proglucagon and p115 was unaffected by PC2, 
with or without CPE (Figure 6B,C). Proglucaogn was localized in the Golgi similarly to 
the  absence  of  CPE (Figure  6B),  and  Pearson's  analysis  showed  similarly  poor  co-
localization (Figure 6C). Addition of CPE mostly restored proglucagon sorting, as small 
amounts were seen in granules (Figure 6B) and Pearson's analysis showed improved co-
localization (p<0.05) compared to PC1/3 alone, though it was not restored to the same 
level as CPE alone. These results are consistent with CPE enhancing proglucagon sorting 
alone.
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Figure 6. The presence of PC1/3 or PC2 does not enhance sorting of proglucagon. (A) 
Western blot analysis of PC1/3 (upper panels) and PC2 (lower panels) expression after 
before  and  after  transfection  into  N2a  cells.  Wild-type  N2a  cells  have  no  detectable 
expression of either PC. In cells lacking CPE, PC1/3 immunoreactivity is present as a 
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single 84 kDa band, while in the presence of CPE, it is mostly present as a 66 kDa band. 
PC2  is  present  as  a  66  kDa  band  with  or  without  CPE.  (B)  Full-length  wild-type 
proglucagon  was  transfected  into  N2a  cells,  either  with  PC1/3  or  PC2  alone  or  in 
combination with CPE. Cells were processed using antibodies against glucagon (green) 
and the Golgi protein p115 (red). Representative images are shown. Scale bar represents 
10 µm. (C) Mean correlation of proglucagon and p115 fluorescence in cells expressing 
PC1/3 or PC2, alone or in combination with CPE, was not significantly different from 
cells not expressing CPE. Values are means ± S.E.M. (n=10–25). *p<0.01 compared with 
– CPE, # p<0.01 compared with + PC1/3 alone.
2.3.5 CPE affects proglucagon sorting in α cells, but not L cells
To determine  if  the  effect  of  CPE of  proglucagon sorting  is  relevant  to  α  or  L cell 
physiology, we conducted  knockdown studies  using  alphaTC1-6 cells,  an  α  cell  line 
derived from mouse glucagonoma, and GLUTag cells, a mouse L cell line derived from 
mouse enteroendocrine tumours. Out of a screen for CPE-specific siRNAs, we selected 
CPE73 for its reliable and reproducible ability to deplete CPE (see Methods; Figure 7A). 
To confirm whether CPE had a  physiologic effect,  we conducted secretion assays on 
alphaTC1-6 cells  for  glucagon,  and GLUTag cells  for  mature  GLP-1.  Using CPE-73 
siRNA, we significantly reduced CPE expression by 61±3% in alphaTC1-6 cells (n=3, 
p<0.05)  (Figure  7B)  and  by  74±7%  in  GLUTag  cells  (n=3,  p<0.05)  (Figure  8A). 
Knockdown of CPE in alphaTC1-6 significantly increased basal glucagon release (n=6, 
p<0.05) with a corresponding decrease in cell content of glucagon (n=6, p<0.05) (Figure 
7C,D).  The  transfection  efficiency  of  alphaTC1-6  cells,  as  assessed  by  EGFP 
transfection,  was  36.6  ±  3.7%  (calculated  from  10  images,  each  with  ~50  cells). 
However,  stimulated  secretion  by  forskolin/IBMX was  lost  with  reduced  CPE (n=6, 
p<0.01) (Figure 7C,D). In contrast, no differences in regulated secretion of GLP-1 were 
detected in GLUTag cells using forskolin/IBMX stimulation (n=6, p<0.001) (Figure 8B). 
CPE appears to specifically affect glucagon secretion from α cells, while L cells remain 
unaffected.
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Figure 7. CPE depletion affects regulated secretion of glucagon from alphaTC1–6 cells. 
(A) Screen of siRNA directed against CPE. Seven siRNA were synthesized against non-
homologous targets of mouse CPE, transfected into both cell lines, and screened for the 
extent of depletion by western blot using the N-terminally directed CPE4-5 antibody. A 
siRNA directed against GAPDH and a mock transfection without siRNA were used as 
controls.  Equal  protein lysates were separated on SDS-PAGE as determined by BCA 
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assay. The greatest degree of depletion was achieved using siRNA-73, and so this was 
used  for  subsequent  experiments.  (B)  Western  blot  analysis  shows  siRNA-mediated 
knockdown of CPE expression in alphaTC1–6 cells. (C and D) AlphaTC1–6 cells were 
treated with transfection agent alone (mock), or 200 nM of control siRNA or siRNA-73 
against CPE. (C) There was a significant increase in secretion in response to 10 mM 
forskolin/IBMX treatment in mock- and control-  transfected cells.  In cells transfected 
with siRNA CPE, basal secretion was significantly higher than in control cells, and there 
was no response to stimulation with forskolin/IBMX. * p<0.001 compared with control 
transfected basal secretion. Values are means ± S.E.M. (n=6). (D) Glucagon cell content 
decreased in cells transfected with siRNA-73 compared with control siRNA. * p<0.05, ** 
p<0.01  compared  with  control  siRNA  values.  Results  are  representative  of  four 
independent experiments.
Figure 8. CPE depletion has no effect on regulated secretion of GLP-1 from GLUTag 
cells. (A) Western blot analysis shows siRNA-mediated knockdown of CPE expression in 
GLUTag cells. (B) GLUTag cells were treated with transfection agent alone (mock) or 
200 nM of either control siRNA or siRNA-73 against CPE. There was robust stimulated 
secretion  in  response  to  10  mM forskolin/IBMX treatment  in  all  groups.  Values  are 
means  ±  S.E.M.  (n=6).  ***  p<0.001  compared  with  basal  secretion.  Results  are 
representative of four independent experiments.
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2.3.6 Proglucagon contains a sorting signal within the glucagon 
sequence
Sequence analysis of proglucagon revealed that glucagon contains a substantial α-helical 
structure, which contains two embedded basic arginines (R18R19). If these structures act 
as  sorting  signals,  then  sorting  should  be  impaired  by  their  specific  mutation.  We 
generated  independent  mutations  to  disrupt  either  the  dibasic  site  by  an  arginine  to 
glutamine mutation (R18Q), or the α-helix by dual leucine-to-proline kinks (L14P,L26P), 
and expressed these mutant proglucagons in the presence of CPE. Each mutant was more 
abundant  in  the  Golgi  (Figure  9A).  Compared  to  wild-type  proglucagon,  both  the 
L14P,L26P mutant (p<0.01) and R18Q dibasic mutant (p<0.05) were strongly and more 
significantly  co-localized  with p115,  and similar  to  each other  in  their  degree  of  co-
localization  (Figure  9B).  These  data  suggest  that  the  specific  α-helix  of  glucagon 
encodes the information for proper sorting of proglucagon.
2.3.7 Initial processing of proglucagon at K70R71 enhances 
sorting to granules
The precise order of when proglucagon undergoes cleavage at the K70R71 site and initial 
sorting to granules is not known. It is possible that this cleavage event makes the sorting 
signal accessible for more efficient sorting, or that sorting occurs first, and proglucagon is 
subsequently  processed.  While  PC1/3  and  PC2  are  the  physiologically  important 
convertases in the production of proglucagon-derived peptides, neither are expressed in 
Neuro2a cells and therefore would not cleave at  this site.  A related enzyme, furin,  is 
expressed in all cells  (44), and has been shown to process proglucagon at the K70R71 
inter-domain site (45). As furin is trafficked from the TGN to immature granules within 
the  secretory  pathway, cleavage of  proglucagon by furin  in  these  compartments  may 
facilitate  entry  to  granules.  To examine  this  hypothesis,  we  blocked  furin-mediated 
cleavage  by  mutation  of  the  K70R71  site  to  R71Q.  The  R71Q  mutant  was  mainly 
localized in the Golgi (Figure 9A), and Pearson's analysis showed that co-localization 
with  p115  (Figure  9B)  was  significantly  greater  (p<0.05)  than  that  of  wild-type 
proglucagon (Figure 9B). This suggests that processing of proglucagon at the K70R71 
enhances sorting efficiency, and supports the view that the initial processing event occurs 
before the sorting event.
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Figure 9. Identification of putative sorting signals in proglucagon. N2a cells expressing 
CPE were transfected with wt proglucagon, or the following mutants: K70R71Q, which 
disrupts a furin cleavage site; R18Q, which disrupts a dibasic site within glucagon; or 
L14P/L26P, which reduces the α-helical content of glucagon. (A) wild-type proglucagon 
shows strong immunoreactivity in the tips of the cell processes, and very weak signal in 
the Golgi. By contrast, there is strong Golgi signal that co-localized with p115 in cells 
expressing the K70R71Q mutant proglucagon, as well as signal in the cell  processes. 
Representative images are shown. Scale bar represents 10 µm. The R18Q and L14P/L26P 
mutants show some Golgi co-localization and post-Golgi signal. (B) Mean correlation of 
proglucagon and p115 fluorescence in cells expressing wt proglucagon (wt) or indicated 
mutants. All mutant constructs showed significantly higher mean correlation with p115 
compared  with  wt  proglucagon,  indicating  some  disruption  in  sorting.  *  p<0.05,  ** 
p<0.01 compared with wild-type.
2.3.8 Modelling the 3D structure of proglucagon
We sought to produce a 3D conformational structure of proglucagon in order to see if any 
new information could be provided regarding the mechanism of contained sorting signals. 
We submitted  the  full  proglucagon  sequence  for  de  novo structure  prediction  to  the 
Robetta  software  suite  (Seattle,  WA,  USA;  http://robetta.bakerlab.org/),  and  five 
structures  were  predicted.  The model  with  the  greatest  confidence  score  is  shown in 
Figure 10. Though the five structures contain very different spatial conformations, each 
predicted structure contains significant α-helical content, three of which are found within 
the sequences of glucagon (proglucagon 33-61), GLP-1 (proglucagon 72-108), and GLP-
2 (proglucagon 126-158), and the K70R71 inter-domain site are indicated in Figure 10. 
Since these helices appear to be randomly oriented within a disordered structure, joined 
by two flexible hinges of IP-1 and IP-2, this is consistent with a previous partial model of 
proglucagon (45). This model is unlike the previously reported structure  (45) in which 
glucagon,  GLP-1  and  GLP-2  are  depicted  as  rigid  α-helices  arranged  in  a  trimeric 
structure. Furthermore, our protein modelling data predict that the α-helices of GLP-1 
and GLP-2 may also serve as sorting signals. If CPE directly binds to proglucagon, our 
model the canonical “POMC signal” is formed from the flexibility of the molecule, or it 
may be that proglucagon contains a novel class of sorting signal that interacts with CPE.
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Figure  10. Structural  model  prediction  of  proglucagon.  The  Robetta  modelling  web 
server was used to generate a de novo 3D protein structure prediction for entire sequence 
of  proglucagon.  The results  are  presented  in  cartoon format,  with N- and C-terminal 
indicated, and the inter-domain cleavage site K70R71 labeled. The sequence of glucagon 
is  coloured  green,  GLP-1  (1–37)  yellow  and  GLP-2  red.  The  structure  is  largely 
disordered, with α-helices of glucagon, GLP-1 and GLP-2 oriented randomly within the 
structure.  The K70R71 cleavage site  appears to  be located in an unstructured region, 
which may provide flexibility and accessibility to furin.
2.4 Discussion
This is the first report to investigate the mechanisms of the sorting of proglucagon to the 
secretory granules of the regulated secretory pathway. Proglucagon processing largely 
occurs in granules, where, distinct sets of constituent hormones in both α and L cells are 
produced by tissue-specific  PC enzymes.  The mechanisms of  granule exocytosis  that 
result  in  the  nutrient-regulated  secretion  of  glucagon  and  GLP-1  have  also  been 
investigated.  The question  that  remains  is,  what  are  the  mechanisms underlying  how 
proglucagon is sorted to granules so that it may be processed and secreted. Proglucagon 
must  eventually  enter  granules,  where  the  mildly  acidic  and  millimolar  calcium 
environment  of  the  granule  lumen  are  required  for  optimally  active  prohormone 
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convertases to produce glucagon, GLP-1 and GLP-2. Furthermore, efficient storage in 
granules is necessary for α and L cells to remain sensitive to nutrient status and thus 
trigger  a  robust  secretory  response.  The initial  sequence  of  whether  sorting  precedes 
processing (or vice versa), are not known. As proglucagon is co-targeted to granules with 
its  processing  enzymes,  we  investigated  whether  these  enzymes  play  a  role  in  the 
underlying mechanism. Here we have identified sorting signals that directly affect the 
efficiency of sorting to granules. We have also identified a role for CPE as a sorting 
receptor to mediate proglucagon sorting to granules in an α cells and not L cells.
For this study, we chose the model Neuro-2a mouse neuroblastoma cell line because it 
correctly  targets  hormones  to  the  regulated  secretory  pathway  (46),  and  because  we 
obtained a clone that lacked endogenous CPE (47), that made for an excellent control to 
examine the role of CPE as a sorting receptor. Conveniently, the Neuro-2a wild-type cells 
also  lack  detectable  endogenous  PC1/3  and  PC2,  which  would  prevent  endogenous 
processing of proglucagon and allow their individual roles to be examined in the sorting 
of proglucagon.  In order to  quantify the degree of  sorting,  we chose to  examine co-
localization  by  calculating  Pearson's  correlation  coefficient.  The  use  of  Pearson's 
correlation coefficient (PCC) is readily applicable to this task (48) and is thought to be an 
accurate quantitative parameter for diffraction-limited microscopy (41). It has been used 
to characterize the sorting of neuropeptide SgII in PC12 cells (40). From its mathematical 
formulation,  Pearson's  is  robust  to  varying  protein  densities  and  uniform  noise.  A 
common alternative  parameter,  Mander's  coefficient,  was  created  in  order  to  solve  a 
perceived sensitivity problem  (41), and ironically, is far too sensitive in practice as to 
approach  near  perfect  co-localization  where  non-exists  (49).  Other  methods  of  co-
localization (e.g., overlap coefficient) discard meaningful fluorescence signal, or are not 
specific. A greater degree of correlation results in a more positive PCC value and two 
proteins are said to be co-localized. This should not be confused with measurements of 
the fraction of proteins which are co-localized, which is only accurately measured by sub-
diffraction  limiting  techniques  (e.g.,  super-resolution).  When  used  with  background 
subtraction,  and  compared  to  appropriate  biological  controls,  as  used  in  this  report, 
Pearson's  correlation  is  a  useful  quantitative  technique.  We measured  co-localization 
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between  proglucagon  and  p115,  a  marker  of  the  cis-  and  medial-Golgi,  by 
immunofluorescence microscopy. We used p115 instead of a granule marker, because in 
these  cells,  CgA gave  a  strong  Golgi  signal  which  masked  changes  to  proglucagon 
localization. The Pearson's method successfully discriminated between insulin and pdx-1, 
proteins known to be co-localized or segregated, and confirmed that proglucagon was co-
localized in CgA+ compartments in our Neuro-2a cells. Therefore,  our co-localization 
analyses  can  accurately  distinguish  co-localized  proteins  within  a  sub-cellular 
compartment. 
Since it has been shown that CPE acts as a specific sorting receptor for a wide range of 
hormones,  including  POMC  (25) and  proinsulin  (20),  this  was  the  most  promising 
candidate for a sorting receptor for proglucagon. When CPE was absent, the punctate 
granular immunofluorescence pattern was reduced, a pattern also seen with POMC in 
these N2a-wt cells  (47). Since α and L cells both express CPE, we sought to confirm 
these results in cells that normally synthesize proglucagon. When the siRNA knockdowns 
were conducted, two types of controls were included, a mock transfected control  without 
siRNA, and a scrambled siRNA non-specific to any known target in the mouse genome. 
It was felt that loading controls were not necessary because the mock and siRNA control 
transfections are internal controls. In the absence of CPE in alphaTC1-6 cells, regulated 
secretion of glucagon was lost. Consistent with our previous findings in which long-term 
culture  of  alphaTC1-6 cells  in  high  glucose (25 mM) upregulated  granule exocytotic 
machinery, these cells secrete glucagon in the presence of CPE  (33). Our results now 
suggest that CPE is needed for the sorting of glucagon to granules, and that CPE plays an 
α  cell  specific  role  for  sorting  proglucagon  to  granules,  as  GLP-1  secretion  was 
unaffected in the absence of CPE. There is relatively less CPE content in  α cells when 
compared to L cells  (50, 51), so it is theoretically possible that alphaTC1-6 cells were 
more  sensitive  to  knockdown  studies  than  were  GLUTag  cells  by  the  property  of 
containing  less  CPE.  Following  knockdown,  GLUTag  cells  could  have  retained  a 
minimum effective  threshold  of  CPE to still  allow for  the  sorting  of  proglucagon to 
granules  and  would  then  appear  unaffected  by  knockdown.  In  both  cell  types,  CPE 
removes the C-terminal basic residues from both proglucagon and its intermediates to 
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produce mature hormones. This may also suggest that α cells are more sensitive to the 
location of CPE activity on PGDPs compared to L cells, and there could exist a CPE-
independent mechanism in L cells.
In an effort to test if the enzymatic activity of CPE was required for sorting proglucagon, 
we used the E300Q-CPE mutant, which had been previously shown to have an intact C-
terminal sorting signal (47, 52) and target to granules of NIT3 cells derived from CPE fat/fat 
mouse beta cells  (32). However, the enzymatically inactive E300Q-CPE failed to sort 
proglucagon to granules. This was interesting because the immunofluorescence staining 
of  both  proglucagon  and  E300Q-CPE  localized  to  the  Golgi,  and  proglucagon  was 
strongly blocked from sorting to granules. In our hands, the E300Q-CPE was not secreted 
from Neuro-2a cells, while proglucagon strongly co-localized to the Golgi, contradicting 
this previous study (32). The strong immunofluorescence signal in the Golgi suggests that 
E300Q-CPE is  not  degraded.  Instead,  it  is  possible  that  the  impaired  trafficking  of 
E300Q-CPE is specific to N2a cells. Similar cell-specific findings were found with the 
S202P-CPE (fat) mutant, in which a significant fraction escapes proteosomal degradation 
and sorts to granules in NIT-3 cells  (53), yet appears completely degraded in pituitary 
cells  (30).  Nevertheless,  we  could  not  distinguish  whether  proglucagon  sorting  is 
independent  of  the  CPE enzymatic  activity. This  situation  is  similar  to  the  impaired 
sorting of PC1/3 that prevented pro-renin from entering granules (16).
CPE is activated in the acidic environment of the granules (pH ~5.5-6.0), and although 
the membrane bound form maintains some enzymatic activity, the soluble form of CPE is 
the major active form (54–56). Activation of CPE involves a conformational change of its 
enzymatic pocket, which can be specifically blocked by catalytic site-directed inhibitors 
(e.g.,  bromoacetyl-D-arginine)  (55).  The  conformational  state  of  CPE  is  already 
established to be a major determinant that determines whether the POMC sorting motif 
binds to complementary motifs on CPE-sorted prohormones (57, 58), independent on its 
enzymatic  activity  (55),  and consistent  with the characterization that  the E300Q-CPE 
maintained  sorting  function  (32).  Therefore,  our  results  suggest  the  possibility  that 
proglucagon is sorted by binding to a novel interaction surface of CPE distinct from that 
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used by POMC.
We generated several putative 3D structures of proglucagon in order to resolve whether it 
is compatible with the known sorting receptor motif of CPE. On the surface of CPE are 
two exposed basic residues, Arg255 and Lys260  (58), that can bind two acidic amino 
acids ~12-15 Å apart on POMC, proinsulin, pro-enkephalin and pro-BDNF (19, 20, 25, 
57,  58),  stabilized  by  two hydrophobic  residues  spaced ~5-7 Å apart.  Our  model  of 
proglucagon reveals that the mature hormone domains contain predominant α-helices, 
consistent  with  the  known  structures  of  purified  recombinant  hormones,  yet  the  3D 
organization of the molecule is largely disordered. Given the flexibility of the molecule, it 
is conceivable that a CPE binding motif could be in the disordered GRPP or IP-2, which 
contain several acidic amino acids. Alternatively, a coiled-coil conformation comprising 
glucagon and GLP-1, is another compatible CPE binding motif. Though hard to predict, 
the inherent flexibility of some intrinsically disordered proteins show binding diversity 
for multiple,  specific  ligands  (59).  Nevertheless,  the specific  nature of the interacting 
domains between proglucagon and CPE still need to be determined as it may represent 
novel sorting motif on the surface of CPE.
In addition to prohormone maturation, processing enzymes can influence trafficking of 
prohormones to granules. Both PC1/3 and PC2 are targeted to granules with proglucagon, 
and it is not yet known whether they are involved in the sorting of proglucagon. PC1/3 
has been implicated in sorting of pro-renin (16), so it may aid proglucagon sorting. One 
report of a human neuroendocrine cell line (BON-1) found that induction of PC1/3 up-
regulated expression of both CgA and SgII  (60), two granins that function together as 
sorting  machinery,  providing  evidence  of  co-operation  among  independent  sorting 
receptors.  Neither  the  pro-form  of  PC1/3  or  the  active  form  had  any  effect  on 
proglucagon sorting efficiency beyond the effect seen with CPE. In contrast, there is no 
evidence  that  PC2 plays  a  role  in  hormone  sorting  or  secretion,  but  we  decided  to 
investigate  it  given  that  it  producing glucagon  within  granules.  In  the  extreme,  PC2 
knockout mice are expectedly deficient in glucagon  (2, 61). These α cell granules had 
abnormal morphology, yet they appear to maintain regulated secretion of proglucagon 
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and processing intermediates (2), indicating that sorting of proglucagon was unaffected in 
the absence of PC2. Consistent with this report, we found that PC2 had no effect on the 
sorting of proglucagon, so it would seem that PC2 has no bearing on proglucagon sorting. 
Our data shows that CPE plays a role in sorting proglucagon in Neuro-2a and α cells,  
while L cells may possess an alternate sorting mechanism.
Adding  to  this  complexity  is  the  fact  that  proglucagon  undergoes  several  steps  of 
processing to yield mature hormones. It is thought that the first step of processing occurs 
at the inter-domain Lys70Arg71 cleavage site to yield glicentin and MPGF. These two 
peptides are consistently detected when proglucagon is transfected into a non-endocrine 
cell line, leading to the hypothesis that this cleavage occurs in the TGN. This processing 
event in non-endocrine cells that lack a regulated secretory pathway would be mediated 
by  furin,  since  it  is  expressed  in  all  cell  types  (4,  45).  By  pulse-chase  studies, 
proglucagon is first processed into glicentin and MPGF in α cells and many endocrine 
cell lines by ~30 minutes of chase  (1, 45, 62). However, this technique lacks sufficient 
resolution to identify the compartment in which proglucagon is processed, and therefore 
this initial cleavage could occur in the TGN or within immature secretory granules. Both 
glicentin and MPGF must then sort into secretory granules, where PC1/3 and PC2 will  
produce mature hormone. Therefore, the R71Q mutant used in our study represents an 
important block early in the sequence of post-translational processing, which we found 
significantly  reduced  sorting  efficiency.  This  is  interesting  because  it  suggests  that 
processing at this site increases sorting efficiency, and should happen prior to the sorting 
event. Another way to address the temporal order of the initial sorting and processing 
events  would  be  to  identify whether  glicentin and MPGF enter  the  same,  or  distinct 
granule  populations.  Due  to  a  lack  of  specific  antibodies  to  monitor  every  single 
proglucagon-derived peptide, and adequate systems to monitor proglucagon processing 
and trafficking  in  vivo,  it  is  unclear  which  granule  populations  contain  glicentin  and 
MPGF. As a result, this alternative approach cannot distinguish whether initial processing 
precedes  sorting,  and  if  so,  is  this  initial  processing  is  required  to  enhance  sorting 
efficiency. While there are several examples whereby different hormones enter the same 
granule population,  whether this is the dominant sorting mode for proglucagon is not 
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known. In the case of pro-TRH, processing intermediates are known to enter distinct sub-
populations of granules  (63). Our results raise the possibility that glicentin and MPGF 
contain independent sorting signals since glucagon and GLP-1 are liberated from these 
distinct intermediates.
An important finding of this paper is the first documentation of sorting signals contained 
within proglucagon. On the basis of sorting signals identified in other prohormones (64), 
we focused on two likely signals within proglucagon, 1) the glucagon α-helix, and 2) the 
dibasic site within the glucagon α-helix (Arg17Arg18). Since mutations to either structure 
similarly  reduced  the  sorting  efficiency  of  proglucagon,  it  is  likely  that  sorting 
information is uniquely encoded by the entire glucagon α-helix. That the two homologous 
α-helices  in  GLP-1  and  GLP-2  apparently  cannot,  or  do  not,  compensate  for  this 
mutation, may be a result of lacking an embedded dibasic site. Note that the information 
encoded in the α-helices of GLP-1 and GLP-2 is investigated in greater detail in Chapter 
3 (65). Efficient sorting to granules is important to guarantee both proper processing to 
mature hormones, and that α and L cells have sufficient stores of active hormones to 
remain  responsive  to  changes  in  nutrient  status.  Such a  robust  response is  needed if 
glycemic control by glucagon and GLP-1 are to be tightly controlled. The nature of the 
glucagon sorting signal, and whether GLP-1 and GLP-2 encode similar information is 
examined in Chapter 3.
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3.1 Introduction
Proglucagon is an endocrine prohormone that is expressed in pancreatic α cells, intestinal 
L cells, and select neurons of the hypothalamus and brainstem. It is the precursor for the 
peptide hormones glucagon, glucagon-like peptide (GLP)-1 and GLP-2. Glucagon is the 
main  glucose  counter-regulatory  hormone,  principally  stimulating  hepatic 
gluconeogenesis and glycogenolysis to maintain euglycemia (1). Conversely, GLP-1 and 
GLP-2  are  secreted  from intestinal  L  cells  in  response  to  nutrient  ingestion;  GLP-1 
stimulates  insulin  secretion  in  a  glucose-dependent  manner,  and  GLP-2  increases 
intestinal  blood flow and nutrient  absorption  (2).  Oxyntomodulin,  which contains the 
sequence  of  glucagon  plus  a  6  amino  acid  C  terminal  extension  (Figure  1)  is  also 
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postprandially  secreted  from  L  cells  and  acts  as  a  potent  appetite  suppressant  (3). 
Therefore,  all  three  hormones  exert  distinct  metabolic  actions  to  maintain  nutrient 
homeostasis.
Figure  1. Post-translational  processing  of  proglucagon  to  its  derived  peptides. A 
schematic representation of proglucagon in which each domain has been colour-coded, 
and the amino acid positions of key processing events have been identified. The amino 
acid numbering is relative to the first N-terminal amino acid of proglucagon (lacking the 
signal peptide). The major hormone products produced from tissue-specific processing by 
their respective prohormone convertase (PC) are shown at bottom. In pancreatic islet  α 
cells,  the  major  products  are  glucagon and major  proglucagon  fragment  (MPGF).  In 
enteroendocrine L cells and in the brain, the major products are GLP-1 (1-37), GLP-1 (7-
37), GLP-2, oxyntomodulin and glicentin.
The  post-translational  processing  of  proglucagon  by  prohormone  convertases  (PCs) 
follows a strict temporal sequence, in which an initial cleavage at K70R71 yields two 
fragments, glicentin and major proglucagon fragment (MPGF) in both α cells and L cells 
(Figure 1)  (4, 5). Pancreatic α cells produce glucagon through cleavage of glicentin by 
PC2 (4, 6), and PC1/3-mediated processing yields glicentin, oxyntomodulin, GLP-1 and 
GLP-2 within L cells and neurons (7–9). There is evidence that proglucagon processing 
in  α cells is altered under conditions of beta cell injury such that bioactive GLP-1 is 
produced  (10). Each of these peptide hormones must be stored in dense-core secretory 
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granules,  a  compartment  unique  to  endocrine  and  neuroendocrine  cells,  for  nutrient-
regulated  secretion.  It  is  well  documented  by  pulse-chase  and  immunoelectron 
microscopy studies that the final stages of processing occur in the secretory granules (5, 
11, 12), and therefore, the sorting of proglucagon to secretory granules is essential for the 
production of  its  bioactive peptide hormones.  However, it  is  not  known if  the initial 
cleavage  of  proglucagon  to  glicentin  and  MPGF  occurs  before  or  after  sorting  to 
granules. One component of a sorting mechanism that appears to be common to a number 
of prohormones is a sorting signal that is contained within the prohormone sequence. If 
the initial processing of proglucagon precedes sorting to granules, then a sorting signal 
must be present in each of glicentin and MPGF,  leading to the intriguing possibility that 
proglucagon contains at least two sorting signals that are spatially segregated.
Several types of prohormone sorting signals have been described that mediate specific 
interactions  with  membrane-bound  sorting  receptors  or  co-target  with  processing 
enzymes. Proinsulin (13, 14) undergoes aggregation mediated by hydrophobic residues. A 
disulfide-bonded loop exposes two acidic amino acid residues comprise a sorting signal 
within pro-opiomelanocortin (POMC) (15, 16), proinsulin  (14), proenkephalin  (17) and 
pro-brain-derived neurotrophic factor  (pro-BDNF)  (18),  and interacts  with the sorting 
receptor carboxypeptidase E (CPE). Paired basic amino acids that are cleavage sites for 
PCs  serve  as  sorting  signals  in  pro-neuropeptide  Y (pro-NPY)  (19),  pro-renin  (20), 
progastrin (21), proneurotensin (22) and pro-VGF (non-acronymic) (23), suggesting that 
these prohormones are co-targeted with their processing enzymes. Finally, amphipathic α-
helix  regions/domains  are  required  for  the  sorting  of  prosomatostatin  (24) and  pro-
cocaine  and  amphetamine  regulated  transcript  (pro-CART)  (25).  Any  or  all  of  these 
sorting  signals  may exist  within  a  single  prohormone and may synergize  to  increase 
sorting efficiency (23, 26, 27).
Of  these  various  known  sorting  signals,  proglucagon  contains  two  predicted  types: 
significant α-helical content within glucagon, GLP-1 and GLP-2, as documented by their 
known crystal or NMR structures (28–30), and a dibasic amino acid sequence within the 
α-helix  of  glucagon  (R17R18;  proglucagon  49-50).  Interestingly,  unlike  other 
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prohormones, the α-helices lie within ordered hormone-encoding regions, and not in a 
prodomain  (31).  Additionally,  these  hormone  domains  are  evolutionarily  conserved, 
particularly regarding their biophysical characteristics (32). We have previously identified 
R17R18 and the α-helix within glucagon as putative sorting signals, and our results also 
suggested that processing of proglucagon to glicentin and MPGF precedes sorting (33). 
Therefore, in the present study, we investigated the possibility that proglucagon contains 
multiple  sorting  signals  in  the  different  hormone  domains.  To  this  end,  we  have 
extensively characterized the role of each predicted α-helix within proglucagon in sorting 
to the regulated secretory pathway in the well characterized neuroendocrine PC12 cell 
line. Our study reveals that two non-amphipathic  α-helix domains within the sequences 
of glucagon and GLP-1 are necessary and sufficient to target proglucagon to granules. We 
also combine these results to a model of proglucagon processing and sorting in α- and L-
cells.
3.2 Methods
Plasmid construction and reagents 
Fusion proteins were constructed using proglucagon-derived peptide sequences attached 
to the 3’ end of the cDNA encoding the CH2/CH3 domains of mouse IgG-2b (termed Fc), 
preceded by the pro-renin signal peptide, as previously described (Figure 2) (24), (a kind 
gift  from  Dr.  T.  Reudelhuber,  Montreal,  QC,  Canada).  Proglucagon-derived  DNA 
sequences were amplified from Syrian hamster pre-proglucagon cDNA (a kind gift from 
Dr. D. Steiner, Chicago, IL, USA; GenBankTM accession J00059.1). All  primers were 
purchased from Sigma Aldrich (Oakville, Ontario, Canada), and the specific primers used 
in this study for PCR amplification or site-directed mutagenesis can be found in Table 1. 
All  fusion  constructs  were  constructed  in  pcDNA3.1  (Life  Technologies,  Burlington, 
Ontario, Canada).
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Table 1. Primer pairs used for cloning and mutagenesis
Fusion Construct Oligonucleotide Sequence Pair (5' → 3')
Fc (for construction of Fc 
alone and Fc-Glucagon)
Forward: 5'-AAGCTTGGCATGGATCAATTC
Reverse: 5'-GGATCCAGGCCTACCCGCAGA
Fc stop mutation Forward: 5'-GACCATCTCCCGGTCTCCGGGTTAGCCTGGATCC
Reverse: 5'-GGACTAGTGGATCCAGGCTAACCCGGAGACCGGGAG
Fc-Glucagon frame shift Forward: 5'-CCTGGATCCACTCAGTCCAGTGTGGTGG
Reverse: 5'-CCACCACACTGGACTGAGTGGATCCAGG
Glucagon * Forward: 5'-GAATTCCATTCACAGGGAACA
Reverse: 5'-GCGGCCGC  CTAGGTGTTCATCAG
Leu26Pro-Glucagon 
amplification
Forward: 5'-GAATTCCATTCACAGGGAACA
Reverse: 5'-GCGGCCGC  CTAGGTGTTCATCGG
Arg18Gln-Glucagon 
mutagenesis
Forward: 5'-AAATACCTGGACTCCCGCCAAGCCCAAGATTTTG
Reverse: 5'-CAAAATCTTGGGCTTGGCGGGAGTCCAGGTATTT
Leu14Pro-Glucagon 
mutagenesis
Forward: 5'-TACAGCAAATACCCGGGACTCCCGCCGAGCC
Reverse: 5'-GGCTCGGCGGGAGTCCGGGTATTTGCTGTA
Fc (for construction with 
GLP-1, GLP-2, Glicentin, 
MPGF)
Forward: 5'-GCTAGCATGGATCAATTCCGATGG
Reverse: 5'-AAGCTTACCCGGAGACCGGGAGATGG
GLP-1 (1-37) § Forward: 5'-GGATCCCACGATGAGTTTGAGAGG
Reverse: 5'-GAATTCTCCTCTGCCTTTCACC
GLP-1 (7-37) § Forward: 5'-GGATCCCACGCTGAAGGGACC
Reverse: 5'-GAATTCTCCTCTGCCTTTCACC
GLP1 E27 mutagenesis Forward: 5'-GGCCAGGCTGCAAAGGAGTTCATTGCTTGG
Reverse: 5'-CCAAGCAATGAACTCCTTTGCAGCCTGGCC
GLP-1 Stop codon 
mutagenesis
Forward: 5'-GGTGAAAGGCAGAGGATGA  GAATTCTGCAGATATCCTTAAG
Reverse: 5'-AAGGATATCTGCAGAATTC  TCATCCTCTGCCTTTCACCAGC
GLP-2 § Forward: 5'-GGATCCCATGCGGACGGCTCCTTC
Reverse: 5'-GAATTCGTCAGTGATTTTGGTTTG
GLP-2 Stop codon 
mutagenesis
Forward: 5'-CAAACCAAAATCACTGACTAG  GAATTCTGCAGATATCCTTAAGT
Reverse: 5'-AGGATATCTGCAGAATTC  CTAGTCAGTGATTTTGGTTTGAATC
Asp3Gln-GLP-2 mutagenesis Forward: 5'-GGATCCCATGCGCAGGGCTCCTTCTCC
Reverse: 5'-GGAGAAGGAGCCCTGCGCATGGGATCC
Asp8Lys,Glu9Lys,Asn11Lys, 
Asp15Lys-GLP-2 
mutagenesis
Forward: 5'-GCTCCTTCTCCAAGAAGATGAAGACGATTCTCAAGAGTCTTGCC
Reverse: 5'-GGCAAGACTCTTGAGAATCGTCTTCATCTTCTTGGAGAAGGAGC
Glicentin § Forward: 5'-GGATCCCATTCCCTTCAGGACACGGAGG
Reverse: 5'-GAATTC  CTAGCGTTTGGCAATGTTGTTCCTGTTC
MPGF § Forward: 5'-GGATCCCACGATGAGTTTGAGAGGCACGC
Reverse: 5'-GAATTC  CTATTTCTTGTCAGTGATTTTGGTTTGAATCA
Oxyntomodulin§ Forward: 5'-CTCGGATCCCATTCACAGGGAACATTCACCAGTGACTACAG
Reverse: 5'-GTGAATGGGATCCGAGCTCGGTACCAAGCTTACCCG
Note: Underlined sequence indicates the restriction sites used for cloning. Bolded sequences indicate site-
directed  mutations.  A conservative  mutation  was  made  within  GLP-1  to  remove  an  internal  EcoRI 
restriction site.  Bolded and underlined text indicates a stop codon. Constructs used a flexible linker of 
either eight amino acids (denoted by §; sequence: KLGTELGS) or a ten amino acid linker (denoted by *; 
sequence: GSTQSSVVEF).
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The cDNA sequence of Fc was selectively amplified using the Fc primers (Table 1) and 
ligated  to  the  pcDNA3.1  backbone,  between  HindIII  and  BamHI restriction  sites.  To 
construct an Fc expression plasmid, an in-frame stop codon was mutated between the 
coding  region  and  the  HindIII  restriction  site,  using  the  Fc  stop  primers  (Table  1). 
Mutagenesis  reactions  were  performed  using  the  QuickChange  II  Site-Directed 
Mutagenesis kit (Agilent Technologies, Mississauga, Ontario, Canada) according to the 
manufacturer’s protocol.
The Fc-wild-type glucagon fusion construct was generated ('Fc-WT Glucagon';  Figure 
2), in which glucagon cDNA was amplified using specific primers for glucagon (Table 
1), and ligated between the EcoRI and NotI restriction sites, joined by a 10 amino acid 
linker (Table 1). To determine possible sorting signals, the sequence of glucagon was 
mutated in two ways (Figure 2): two leucines, L14 and L26, which are postulated to 
stabilize  the  α-helix,  were  mutated  to  L14P,L26P  ('Fc-LP  glucagon')  by  specific 
amplification and mutation using the respective L14P and L26P glucagon primers (Table 
1); and the dibasic sequence R18R19 was changed to R18R19Q ('Fc-RQ glucagon') using 
the R18Q mutagenesis primers (Table 1).
Subsequent proglucagon-derived peptide constructs used a similar Fc expression system, 
in which Fc was ligated into the NheI and HindIII restriction sites. Expression constructs 
were  generated  for  the  following  peptides:  GLP-1  (1-37),  GLP-1  (7-37),  GLP-2, 
oxyntomodulin, glicentin and MPGF (referred to as Fc-GLP-1 (1-37), Fc-GLP-1 (7-37), 
Fc-GLP-2,  Fc-OXM,  Fc-Glicentin  and  Fc-MPGF, respectively;  Figure  1  &  2),  and 
ligated into the BamHI and EcoRI restriction sites. An internal EcoRI cut site was silently 
mutated using the GLP-1 E27 primers (Table 1). From Fc-GLP-2, we generated site-
directed point mutations, specifically changing five acidic amino acids to either neutral, 
D3Q, or basic, D8K, E9K, N11K, D15K (referred to as Fc-Dipolar GLP-2; Figure 1 & 2, 
Table  1).  These  mutations  were  chosen  in  order  to  mimic  the  dipolar  nature  of  the 
glucagon α-helix,  which share less than 40% homology, and also to keep the α-helix 
intact. Lastly,  each  of  these  constructs  was  terminated  by  an  in-frame  stop  codon, 
introduced either  by site-directed mutagenesis  or PCR amplification.  All  results  were 
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3.2.1 Cell Culture and transient transfections
Wild-type PC12 cells (a kind gift from from Dr. W. J. Rushlow, University of Western 
Ontario, London, Ontario, Canada), were maintained in high-glucose (25 mM) DMEM 
(Life Technologies), supplemented with 15% horse serum (Life Technologies) and 2.5% 
FBS  (Life  Technologies).  AlphaTC1-6  cells  (a  kind  gift  from  Dr.  C.  B.  Verchere, 
University of British Columbia, Vancouver, British Columbia, Canada) were cultured as 
previously  described  (34).  Cells  were  transfected  using  Lipofectamine  2000  (Life 
Technologies). To prepare cells for microscopy, cells were grown on glass cover-slips 
coated with rat-tail type I collagen (100 μg/mL; Sigma) at a density of 4∙105 cells/cm2 the 
day prior to transfection. For secretion assays, cells were grown in poly-D-lysine coated 
6-well tissue culture dishes (Corning, Mississauga, Ontario, Canada). Cells were allowed 
to grow for 48 h following transfection.
3.2.2 Secretion experiments
On  the  day  of  the  experiment,  media  were  changed  to  high-glucose  DMEM 
supplemented with 1% dialyzed FBS. After preincubation, cells were incubated for 3 h in 
the same medium (“3 h basal”) followed by 15 min incubations without (“-K”) and with 
(“+K”) 55 mM KCl to stimulate granule exocytosis  (35). Cells were quickly rinsed in 
Hanks' buffered salt solution (HBSS) between incubations. All media (1 mL per sample) 
were  collected  on  ice,  with  fresh  protease  inhibitor  cocktail  (Roche,  Mississauga, 
Ontario,  Canada),  2  μg/mL  aprotinin,  55  mM  Tris,  1  mM  EDTA,  pH  7.4  for 
immunoprecipitation,  and  cell  lysates  were  collected  and  protein  concentration  was 
quantified as previously described (34).
3.2.3 Immunoprecipitation, Western blot and secretion index
The media and cell lysates were applied to 50 μL of Protein A-Sepharose (GE Health 
Care,  Uppsala,  Sweden),  incubated at  4°C overnight  with rotation,  after  which beads 
were  recovered,  and  protein  was  eluted  by  heating  to  70°C  for  10  min.  The 
immunoprecipitated  proteins  were  separated  on  10%  NuPAGE  pre-cast  gels  (Life 
Technologies)  or  SDS-PAGE  and  transferred  to  nitrocellulose  membranes.  Fc-
immunoreactive bands were visualized by incubating membranes with goat anti-mouse 
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IgG HRP-conjugated antibody (1:5000 concentration;  Life  Technologies)  followed by 
SuperSignal  Chemiluminescent  substrate  (Thermo-Fisher  Scientific,  Toronto,  Ontario, 
Canada). Bands were quantified by densitometry as described previously (26). Secretion 
indexes were expressed as a ratio of stimulated to basal secretion, normalized to total 
protein (22), and  were used for statistical analysis.
3.2.4 Co-immunprecipitation of Chromogranin A complexes
To perform co-immunoprecipitation experiments, the Fc-construct transfected PC12 cells 
were lysed in either a neutral or pH 5.5 buffer (20 mM sodium acetate, 0.1 M KCl, 1% 
Triton X-100), cell debris was cleared by centrifugation (22,000x g for 10 min at 4°C), 
and  supernatant  was  taken  for  protein  quantification.  Protein  concentration  was 
quantified using a colorimetric BCA assay (Thermo-Fisher), and results read out on a 
multi-well plate reader (Bio-Rad). Immunoprecipitations were done for the Fc epitope 
using Sepharose A beads (as described), using a total of 100 ug whole cell lysate, diluted 
to a final volume of 1 mL (plus a  protease inhibitor  cocktail)  to  facilitate  over-night 
incubation (16 h, 4°C) on a tube rotator. The following morning, Sepharose beads were 
pelleted  (5,000x  g,  30  sec),  washed  in  the  same  ice-cold  buffer  used  for 
immunoprecipitation. The protein complexes were eluted by heating (70°C, 10 min) and 
immediately  chilled  on  ice.  Samples  were  then  immuno-blotted  for  CgA  to  detect 
possible co-immunoprecipated complexes.
3.2.5 Immunofluorescence
Cells were processed for immunofluorescence as previously described (26). Slides were 
incubated with antibodies against the secretory granule marker, chromogranin A (CgA) 
(1:100;  Abcam,  Cambridge,  MA,  USA),  or  the  synaptic-like  microvesicle  marker, 
synaptophysin  (1:250;  Abcam).  AlexaFluor488  IgG  (Life  Technologies)  was  used  to 
visualize the reporter, Fc, and AlexaFluor594 IgG for the CgA or synaptophysin antibody. 
Coverslips  were  mounted  using  a  ProLong  Gold  Anti-fade  mounting  medium  (Life 
Technologies).
3.2.6 Image Acquisition and Analysis
Immunofluorescence images were acquired using a Zeiss LSM 510 Duo Vario confocal 
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microscope  (Zeiss  Canada  Inc.,  Toronto,  Ontario,  Canada)  and  a  63x  1.4  NA Plan-
Apochromat  oil  differential  interference  contrast  objective  lens  using  the  Zen  2009 
software (Zeiss Canada Inc.). Three cover slips per transfection were imaged for analysis. 
Image analysis was conducted using FIJI version 1.46h  (36), a distribution of ImageJ 
(NIH, Bethesda, MD, USA), using the Co-localization 2 plug-in within FIJI. Regions of 
interest were manually drawn around distinct single- or multi-cell bodies, positive for Fc 
and either chromogranin A or synaptophysin. Co-localization of these pixels from each 
pseudo-coloured  image  were  used  to  calculate  Pearson’s  correlation  coefficient,  as 
previously described (33). To generate a 3D rendering of the spatial localization of Fc-
WT glucagon and Fc-Dipolar GLP-2, the Imaris software package (Bitplane AG, Zurich, 
Switzerland)  was  used.  The  3D voxel  information  was  used  to  assign  0.25-0.30  μm 
spheres to computed point sources of light in each channel. Only the co-localized spots 
are shown, as determined by spatial  overlap within a maximum distance of 0.30 μm. 
Correlation coefficients from each experiment were treated as one experimental data set 
(n=30-35).
3.2.7  Secondary  Structure  Predictions  and  Biophysical  Property 
Calculations
Secondary  structure  predictions  (see  Table  2)  were  carried  out  with  the  PSI-PRED 
algorithm (version 3.1) (37). Percent helical content was calculated as the ratio of total α-
helical  residues to the peptide length.  The corresponding pI was calculated using the 
ExPASy bioinformatics portal  (38) and the mean hydrophobic moment was calculated 
using the method of Eisenberg et al. (39). Hydrophobic cluster analysis was carried out 
by the method of Gaboriaud et al. (40).
3.2.8 Statistical Analyses
Differences were assessed using a one-way ANOVA with Tukey's  HSD post-hoc test. 
Statistical significance was accepted at the level of p<0.05, and the results are expressed 
as the mean ± standard error. Statistical analyses were performed using GraphPad Prism 
version 5.02 (GraphPad Software Inc, La Jolla, CA, USA).
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3.3 Results
3.3.1 Rationale for using PC12 as a model of hormone trafficking and 
secretion
While in our previous publication we observed abundant localization of proglucagon in 
secretory granules in Neuro2a cells (33), these cells did not respond to any secretagogue 
(K+,  Ba2+,  dbcAMP, IBMX  alone  or  in  combination)  in  our  hands.  Since  showing 
regulated secretion of our fusion constructs was a necessary part of our study, we sought 
another model of a cell type with a regulated secretory pathway. We avoided the use of α 
or L cell lines so as not to confound our results with endogenous proglucagon and derived 
peptides  due to  the multi-step nature of  proglucagon processing.  We chose the PC12 
neuroendocrine  cell  line,  because:   1)  they  have  a  very  well-characterized  regulated 
secretory pathway; 2) they express CPE, which we have shown to be a sorting receptor 
for proglucagon in α cells;  and 3) they lack significant PC1/3 and PC2 activity, thus 
allowing us to assay individual proglucagon-derived peptides for sorting independently of 
processing.  PC12  cells  were  used  to  characterize  the  sorting  of  multiple  classes  of 
neuropeptides  and  hormones  that  agree  with  the  mechanism  in  their  native  tissues, 
including:  proinsulin and pro-enkephalin (41), pro-BDNF (18, 42), pro-CART (25), pro-
neurotensin (43) POMC (17),  and pro-renin (44). In fact, the regulated secretory pathway 
in PC12 cells better characterized than in either of the accepted models of proglucagon 
processing, alphaTC1-6 and GLUTag cells, and they have many key proteins in common. 
PC12 and alphaTC1-6 cells express chromogranin A, human α cells additionally express 
chromogranin B, and secretogranins III  (34,  45,  46),  while  L cells  express CgB, and 
secretogranins II,  III  and V  (47),  thus showing similarities in sorting machinery. The 
exocytosis machinery is also similar, with both PC12 and alphaTC1-6 cells expressing 
the SNARE proteins syntaxin-1a, VAMP2, SNAP25 (34, 48) and the SNARE-associated 
proteins Munc13-1 and Munc18-1 (49, 50), while AP-1 and AP-3 are expressed by PC12 
and mouse α cells (51).  More recently, it has been shown that the GLUTag L cell model 
also  expresses  SNAP25,  VAMP-1,  -2  and  -3,  syntaxin-1a  and  Munc18-1  (52).  The 
literature therefore strongly supports the use of the PC12 cell line as a model for the 
sorting of proglucagon to the regulated secretory pathway in α and L cells.
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3.3.2 Glucagon contains an α-helix sorting signal
In order to identify sorting signals contained within glucagon, we transfected PC12 cells 
with either Fc alone or the Fc-WT Glucagon fusion constructs described in  Figure 2A. 
Expression of fusion constructs was confirmed by Western blot (Figure 2B). First, we 
determined the extent of regulated secretion of fusion proteins from PC12 cells using 55 
mM K+ as a secretagogue. The KCl secretagogue causes depolarization of the plasma 
membrane, triggering a rapid, calcium-dependent fusion of secretory granules with the 
plasma  membrane,  resulting  in  exocytosis  of  granule  cargo.  A lack  of  response  to 
secretagogue  stimulation  (i.e.,  secretion  index  equal  to  unity)  indicates  constitutive 
secretion,  whereas  a  significantly  elevated  secretion  index  indicates  the  ability  of 
glucagon to direct Fc into secretory granules of the regulated secretory pathway  (53). 
Second, we examined the extent to which the Fc fusion proteins were sorted to secretory 
granules by quantitative co-localization with the secretory granule marker, chromogranin 
A (CgA). Taken together, these experiments specifically determined the nature of sorting 
signals within glucagon that direct it to granules.
As  expected,  the  fragment  of  the  mouse  IgG  heavy  chain,  Fc,  was  secreted  in  a 
constitutive manner as shown by the lack of K+-stimulated release, and a secretion index 
of 1 (Figure 3A, B).  In contrast,  fusion of Fc to WT glucagon resulted in  regulated 
secretion, as indicated by a robust secretory response to 55 mM K+ (Figure 3A) and a 
secretion index that was significantly elevated (p<0.05) compared to Fc alone (Figure 
3B). Therefore, WT glucagon contains a signal that is sufficient to sort Fc to granules. We 
then investigated the structural nature of the sorting signal within glucagon by mutating 
the  α-helix  (Fc-LP Glucagon)  and  the  role  of  the  R17R18  motif  in  sorting  (Fc-RQ 
Glucagon). The secretion of Fc-LP glucagon secretion did not increase upon secretagogue 
stimulation (Figure 3B), and the secretion index was not significantly different from Fc 
alone (Figure 3B). In contrast, Fc-RQ glucagon showed similar regulated secretion to 
WT glucagon (Figure 3A), and significantly greater secretion index (p<0.05) compared 
to Fc alone (Figure 3B). These results suggest that the α-helix within glucagon, and not 
the dibasic site, may serve as a sorting signal to direct proglucagon into granules.
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To  identify  the  subcellular  distribution  of  the  fusion  proteins,  we  conducted 
immunofluorescence  confocal  microscopy  to  visualize  Fc  immunoreactivity  and  the 
extent of co-localization with the secretory granule marker, CgA. Co-localization was 
quantified  as  the  fluorescence  intensity  co-variance  between  Fc  and  CgA 
immunofluorescence, using Pearson’s correlation coefficient (PCC), described previously 
in  (33). Fc alone had a para-nuclear staining pattern characteristic of Golgi localization 
(arrowhead, Figure 3C). The corresponding measured fluorescence correlation of Fc and 
CgA (Figure 3D) appears high, but likely reflects the fact that both Fc and CgA are co-
trafficked through the Golgi under steady-state conditions, rather than localization of Fc 
in  granules.  In  contrast,  Fc-WT  glucagon  expression  was  localized  in  CgA-positive 
granules along the cell periphery and toward the tips of the cell processes (arrow, Figure 
3C), a pattern that indicates localization in secretory granules (33). Pearson’s correlation 
of Fc-WT glucagon with CgA was significantly greater than Fc alone (p<0.01;  Figure 
3D), thus demonstrating the sorting of Fc-WT glucagon to secretory granules. When the 
α-helix  of  glucagon  was  disrupted  in  Fc-LP  glucagon,  Fc  immunoreactivity  was 
predominantly localized to the Golgi, and the corresponding Pearson’s correlation was 
not  significantly  different  from  Fc  alone  (Figure  3D).  Lastly,  Fc-RQ  glucagon  was 
localized within CgA-positive secretory granules in a punctate pattern similar to that of 
Fc-WT glucagon (arrow, Figure 3C). Pearson’s correlation of Fc-RQ glucagon with CgA 
was  significantly  greater  than  Fc  alone  (p<0.001)  (Figure 3D)  and  not  significantly 
different  from Fc-WT glucagon.  Taken  together,  our  results  indicate  that  the  α-helix 
within glucagon is a necessary and sufficient sorting signal, while the dibasic R17R18 
motif is not required for sorting.
In order to show that the sorting of the Fc constructs is not an artifact of the cell type, we 
repeated  secretion  and  immunofluorescence  experiments  using  Fc-WT  glucagon  in 
alphaTC1-6 cells, a glucagon-secreting cell line (34). Fc-WT glucagon exhibited a similar 
degree of stimulated secretion with 15 mM arginine (SI = 2.3 ± 0.1 vs 1.1 ± 0.2 for Fc 
alone, p<0.01) to that seen in PC12 cells stimulated with 55 mM K+. Similar values were 
also observed in  alphaTC1-6 cells  with the localization of  Fc-WT glucagon in CgA-
positive granules (PCC =  0.80 ± 0.03 vs  0.51 ± 0.03 for Fc alone, p<0.001) as in PC12 
101
cells. As shown in Figure 2B, the level of expression of Fc-WT glucagon in alphaTC1-6 
cells was within the range observed for PC12 cells. These results validate the use of PC12 
cells and Fc-PGDP constructs to identify sorting signals in proglucagon.
3.3.3  GLP-1,  but  not  GLP-2,  efficiently  targets  Fc  to  secretory 
granules
Since our previous work indicated that the processing of proglucagon to glicentin and 
MPGF may precede entry into granules  (33), we tested the possibility that proglucagon 
may contain sorting signals within its other constituent peptides. Fc fusion proteins of the 
glucagon-like peptides, GLP-1 and GLP-2, were constructed and expressed in PC12 cells. 
Both GLP-1 (1-37) and GLP-1 (7-37) were included so as to test  the role of the N-
terminal 6 amino acids of full-length GLP-1. Both the Fc-GLP-1 (1-37) (p<0.001) and 
Fc-GLP-1 (7-37)  (p<0.001)  exhibited robust  K+-stimulated secretion compared to  the 
constitutively secreted Fc reporter (Figure 4A,B). Surprisingly, Fc-GLP-2 did not exhibit 
regulated secretion (Fig 4A,B). Immunofluorescence microscopy showed that both forms 
of Fc-GLP-1 directed Fc to granules, as evidenced by a punctate fluorescence pattern 
along the cell periphery and toward the tips of cell processes (arrow and inset,  Figure 
4C). There was significant correlation between CgA and Fc fluorescence for Fc-GLP-1 
(1-37)  (p<0.001)  and  Fc-GLP-1  (7-37)  (p<0.001)  (Figure  4D)  Fc-GLP-2  showed  a 
stronger para-nuclear localization, and interestingly, was also present in punctate vesicles 
which appeared to be distinct from those that were immuno-positive for CgA (arrowhead 
and inset,  Figure 4C). There was no significant difference in co-localization with CgA 
and Fc compared with Fc alone (Figure 4D), consistent with the lack of K+-stimulated 
secretion. Therefore, our data suggest that GLP-1 (7-37) contains sufficient information 
for granule sorting. However, GLP-2 is not sorted efficiently into dense-core secretory 
granules, and may instead be routed to another vesicle compartment in PC12 cells.
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3.3.4 A dipolar α-helix GLP-2 mutant sorts to secretory granules
Since  GLP-2  shares  only  38%  and  32%  homology  with  glucagon  and  GLP-1, 
respectively, it  possible that the sequence context contributes to the differences in the 
sorting of glucagon and GLP-1 compared with GLP-2. We therefore introduced point 
mutations in GLP-2 that  would mimic the charge distribution within the sequence of 
glucagon  by  changing  four  acidic  amino  acids  in  the  α-helix  to  basic  lysines  (see 
Methods, Table 1), termed “Fc-Dipolar GLP-2” (Table 2). In contrast to Fc-GLP-2, Fc-
Dipolar GLP-2 showed a robust response to 55 mM K+ (Figure 4A), and the secretion 
index was similar to that of Fc-WT glucagon and significantly greater  than Fc alone 
(p<0.05) and Fc-GLP-2 (p<0.05) (Figure 4B). Immunofluorescence microscopy showed 
that Fc-Dipolar GLP-2 was localized to CgA-positive granules (Figure 4C). The extent 
of co-localization between Fc-Dipolar GLP-2 and CgA was significantly greater than Fc 
alone (p<0.001) and WT GLP-2 (p<0.001) (Figure 4D). Therefore, altering the charge 
distribution of the a-helix of GLP-2 was sufficient to direct Fc to secretory granules.
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Table 2. Biophysical Properties of Major Proglucagon Derived Peptides.
Fusion 
Peptide
Peptide Sequence 1) Mutation
2) pI
3) Mean Hydropohic 
Moment
Helical 
Cluster 
Projection
Fc-WT 
Glucagon
HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
(72% α-helix content)
1) WT
2) 5.76
3) 0.55
Fc-LP 
Glucagon
HSQGTFTSDYSKYP  DSRRAQDFVQWPMNT
(45% α-helix content)
1) L14P, L26P
2) 6.39
3) 0.47
Fc-RQ 
Glucagon
HSQGTFTSDYSKYLDSR  Q  AQDFVQWLMNT
(72% α-helix content)
1) R18Q
2) 4.43
3) 0.58
Fc-GLP-1 
(7-37)
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
(68% α-helix content)
1) WT
2) 4.68
3) 0.69
Fc-GLP-2 HADGSFSDEMNTILDSLATRDFINWLIQTKITD
(67% α-helix content)
1) WT
2) 4.23
3) 0.66
106
Fc- 
Dipolar 
GLP-2 
HAQGSFS  KK  M  K  TIL  K  SLATRDFINWLIQTKITD
(67% α-helix content)
1) D3Q, D8K, E9K, 
N11K, D15K
2) 10.46
3) 0.64
Amino acid sequences of the peptides used in this study are shown, with the wild-type or mutant  
sequence  indicated.  Underlined  portions  of  sequence  correspond  to  α-helical  content  of  the 
peptides.  Stars indicate  proline  (hydrophobic),  diamonds indicate  glycine  (uncharged, 
hydrophobic),  open squares indicate threonine (uncharged, polar), and  dotted squares indicate 
serine (uncharged, polar). Enclosed amino acids represent hydrophobic patches.
3.3.5  Biophysical  Properties  of  Glucagon,  GLP-1  and  GLP-2  α-
helices determine sorting efficiency
Despite the fact that the amino acid sequences of glucagon, GLP-1(7-37) and GLP-2(1-
33) are all highly conserved and contain a predominantly α-helical structure, our results 
clearly show that the α-helix alone is not sufficient to target PGDPs to granules.  We 
determined the biophysical nature of the helices by calculating the hydrophobicity and 
charge  distribution  for  the  helical  portion  of  each  peptide.  The  hydrophobic  clusters 
within wild-type glucagon (Table 2 & Figure 3) were disrupted within Fc-LP glucagon 
and remained intact in Fc-RQ glucagon, indicating that the leucines are important in the 
formation  of  larger  hydrophobic  clusters.  Therefore,  the  signal  within  glucagon must 
consist of an intact α-helix. We then conducted hydrophobic cluster analysis of glucagon, 
GLP-1 and GLP-2,  and did not  observe  any differences  in  either  size or  location  of 
hydrophobic clusters (Table 2) between these highly-conserved sequences (54). These α-
helices are flanked by highly conserved N- and C-terminal tails, indicating that these α-
helices are in a similar peptide context. The mean hydrophobic moments for the α-helix 
regions  of  glucagon,  GLP-1  and  GLP-2  were  similar,  reflecting  the  degree  of 
amphiphilicity of these helices. However, there were significant differences in net charge 
of the α-helices. The calculated pIs for the glucagon and GLP-1 α-helices were greater 
than that of GLP-2 (Table 2), suggesting the net charge (electrical polarization), rather 
than hydrophobicity, is a more important determinant of proglucagon sorting (Table 2). 
Lastly, based on the charged amino acid distribution, glucagon and GLP-1 have a net 
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polarization along the length of their helices, while GLP-2 has a more uniform negative 
charge distribution. By introducing a dipolar mutation to GLP-2, the charge distribution 
resembled that of glucagon/GLP-1, thus reconstructing a net polarization within GLP-2. 
Our results demonstrate that efficient targeting of glucagon (Figure 3), GLP-1 (Figure 4) 
and the GLP-2 dipolar mutant (Figure 4) to granules is determined by dipolar α-helices, 
that contain distinct positive and negative patches to polarize the length of the helix are 
sufficient to target glucagon and GLP-1 to secretory granules.
3.3.6 MPGF, but not glicentin, sorts to secretory granules
It has been documented that initial processing of proglucagon occurs at K70R71 early in 
the secretory pathway (5), possibly in the Golgi, to yield glicentin and MPGF (Figure 1). 
In  this  scenario,  the  processing  of  proglucagon to  glicentin  and MPGF may precede 
sorting to granules. We therefore examined the sorting behavior of glicentin and MPGF, 
with the hypothesis that processing at K70R71 would occur prior to sorting. Surprizingly, 
however,  secretion of Fc-Glicentin was not stimulated by 55 mM K+ (Figure 5A) and its 
secretion index was similar to Fc alone (Figure 5B), indicating that glicentin was not 
sorted  to  the  regulated  secretory  pathway.  In  contrast,  secretion  of  Fc-MPGF  was 
significantly stimulated by 55 mM K+ (p<0.001)  (Figure 5A, B).  These results  were 
corroborated by analyses  of subcellular  localization.  In  contrast,  Fc-Glicentin showed 
very  little  co-localization  with  CgA (arrow and  inset, Figure 5C).  Quantification  of 
Pearson's correlation coefficients showed Fc-MPGF had a significantly higher value than 
Fc-Glicentin  (p<0.01)  and  Fc  alone  (p<0.01)  (Figure  5D).  Therefore,  our  data 
demonstrate  that  MPGF, but  not  glicentin,  is  sorted  to  granules,  thus  implying  that 
proglucagon must be sorted to granules prior to being cleaved to glicentin and MPGF. 
This is an intriguing finding because both glicentin and MPGF contain sorting signals 
(glucagon and GLP-1, respectively), yet they are sorted quite differently. These results 
suggest that 1) the sorting signal within the sequence of GLP-1 is sufficient to direct 
MPGF to secretory granules, and 2) the sorting signal within glucagon is masked by the 
N-terminal GRPP (Figure 1).
3.3.7 Oxyntomodulin sorts to secretory granules
In  order  to  determine  if  GRPP  is  masking  the  sorting  signal  within  glucagon,  we 
108
generated Fc-OXM (Figure 2). Secretion of Fc-OXM was significantly stimulated by 55 
mM  K+ (p<0.01)  (Figure  5A,  B),  in  contrast  to  Fc-Glicentin.  Immunofluorescence 
microscopy of Fc-OXM showed co-localization with CgA-positive granules (Figure 5C), 
and  quantification  of  Pearson's  correlation  coefficient  showed  that  Fc-OXM  had  a 
significantly greater value than Fc alone (p<0.01; Figure 5C, D). Therefore, the sorting 
signal within glucagon is sufficient to direct oxyntomodulin to granules. These results are 
consistent with the hypothesis that GRPP masks the glucagon sorting signal in the context 
of glicentin (Figure 1), thus providing a mechanism by which glicentin is not sorted to 
granules.
3.3.8 The Dipolar  α-helix can bind to chromogranin A in a pH- and 
calcium-dependent manner
Since CgA is the most abundant protein constituent of PC12 secretory granules, I tested 
whether CgA could specifically bind the dipolar α-helix. To test for a specific reaction in 
conditions that mimic the lumen of mature secretory granule, pH 5.5 and 10 mM calcium, 
two  sets  of  pull-downs  were  examined,  for  a  total  of  four  conditions.  PC12  cells 
transfected with a panel of Fc constructs were immunoprecipitated, using either a neutral 
or  pH  5.5  sodium acetate  buffer,  with  or  without  10  mM added  calcium.  The  only 
condition that could pull down CgA by immunoprecipitating for Fc, was the pH 5.5 and 
10 mM Ca2+ condition (Figure 6). CgA was not pulled down using untransfected PC12 
cell lysate, nor with Fc alone, or Fc-LP glucagon. In contrast, CgA bound most strongly 
to Fc-WT glucagon, Fc-GLP-1 (7-37) and Fc-MPGF, with minimal detected binding to 
Fc-WT GLP-2 and Fc-Glicentin.  These results  suggest  a  specific  interaction  between 
CgA and the dipolar α-helix sorting signal.
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Figure 6. Identification of CgA as a sorting receptor.  Immunoprecipitation for an Fc-
fusion  protein,  and  immunoblot  for  CgA.  Western  blot  image  is  from  co-
immunoprecipitation  in  a  pH  5.5  sodium  acetate  buffer  with  10  mM  Ca2+.  No  co-
immunoprecipitated complexes were detected under neutral pH, or without 10 mM Ca2+ 
(total  of  4  conditions  tested).  At  right  is  a  CgA immunoblot  from  10  µg  lysate  of 
untransfected PC12 cells. + symbol indicates relative quantity of immunoprecipitate.
3.4 Discussion
Highly efficient sorting of proglucagon is required for the maturation of the proglucagon-
derived peptides,  and subsequent  storage  within  secretory  granules.  Proglucagon is  a 
unique  prohormone  from  the  perspective  of  its  structural  organization.  Several 
prohormones,  such  as  pro-thyrotropin-releasing  hormone  (pro-TRH)  and  pro-
gonadotropin-releasing  hormone  (pro-GnRH),  have  structured  prodomains,  while  the 
active  hormone  domain(s)  are  completely  disordered (31).  In  contrast,  proglucagon 
exhibits  disordered prodomains (GRPP, IP-1 and IP-2),  with mostly ordered hormone 
domains, as our previous work has shown (33). Additionally, the sequences of glucagon, 
GLP-1 and GLP-2 are highly conserved with respect to their charge distribution  (32). 
With this information in hand, we wished to characterize how proglucagon is targeted for 
regulated secretion by identifying the relevant sorting signals encoded within the ordered 
hormone domains of proglucagon. We constructed fusion proteins linking each PGDP to 
a reporter, Fc. Our results demonstrate that both glucagon and GLP-1 contain dipolar α-
helices in which charged residues are distributed around hydrophobic patches, and that 
these helices direct sorting to granules. In contrast, GLP-2, which contains an α-helix that 
is not polarized, is very inefficiently sorted. Surprisingly, the sorting of glicentin, which 
contains  the  sequence  of  glucagon  and  therefore  the  identified  dipolar  α-helix,  was 
inefficient,  while  MPGF maintained its  sorting  efficiency. Oxyntomodulin  was sorted 
efficiently  to  secretory  granules,  thus  demonstrating  that  the  N-terminal  sequence  of 
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glicentin  masked  the  sorting  signal  contained  within  the  α-helix  of  glucagon.  We 
conclude that proglucagon contains two sufficient sorting signals contained within the 
sequences of glucagon and GLP-1, in the form of a dipolar α-helix, and that the α-helix of 
glucagon is masked after proglucagon is processed to glicentin.
In our  previous  studies  of  proglucagon trafficking using  Neuro2a cells,  our  index of 
sorting efficiency was the co-localization between proglucagon and the cis/medial-Golgi 
marker, p115 (33). The high correlation value of R18Q-proglucagon led us to conclude 
that the dibasic R17R18 sequence within glucagon could contribute to sorting. In the 
present study, we calculated co-localization of the Fc constructs with the granule-resident 
protein CgA. Here, a high correlation reflected more efficient co-localization in granules, 
indicating that the R17R18 sequence may not be a factor in the sorting of proglucagon to 
granules, or that it may be cell type-specific. However, it is important to note that the 
sorting of the α-helix mutant of glucagon was calculated to be inefficient in both systems, 
indicating that the α-helix within glucagon is a primary sorting signal for proglucagon 
regardless of the cell type.
Previously  identified  α-helical  sorting  signals  indicates  that  their  amphipathic  nature 
directs sorting of prohormones and their processing enzymes to the regulated secretory 
pathway.  Prohormones  containing  granule-targeting  amphipathic  helices  include  pro-
somatostatin (24) and pro-CART (25). The sorting signals of the prohormone processing 
enzymes PC1/3  (53, 55), PC2  (56), and CPE  (57) are also amphipathic  α-helices. Our 
previous  work  showed  that  reducing  the  α-helical  content  within  glucagon  reduced 
proglucagon sorting efficiency in Neuro2a cells (33). We now show that proglucagon 
contains  two sorting  signals  in  the  form of  non-amphipathic  α-helices  with  a  unique 
arrangement  of  hydrophobic patches  and charged residues.  Dikeakos  et  al. addressed 
sorting determinants  by using synthetic  α-helices,  finding that  the tested  amphipathic 
helices with a charged face, or a non-amphipathic helix with a substantial hydrophobic 
patch and segregated charged residues,  were efficiently  sorted to granules  (27).  They 
inferred two important features of helical sorting signals: segregation of charged residues 
from hydrophobic patches is essential; and the degree of hydrophobicity correlates well 
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with sorting efficiency. While synthetic α-helices were sorted with as few as 5 charged 
residues (27), our data showed that as few as three charged residues within the sequences 
of glucagon and GLP-1 can direct sorting. The pIs of the helices within glucagon and 
GLP-1 are more similar than GLP-2 to the granule lumen environment (pH 5.5), possibly 
aiding their targeting to granules. Our hydrophobic cluster analyses show a dipolar charge 
distribution segregated from hydrophobic patches within glucagon and GLP-1,  which 
were able to sort to granules. In contrast, the helix within GLP-2 has slightly different 
characteristics;  while  the  nature  of  the  hydrophobic  patches  are  identical  to  those  in 
glucagon and GLP-1, the charge distribution is not dipolar, consisting of only negatively 
charged  residues  along  the  helix.  This  difference  resulted  in  very  inefficient  sorting, 
suggesting that charge distribution is more important than hydrophobicity for the non-
amphipathic α-helices of proglucagon. We may now estimate the minimal hydrophobic 
domain required for sorting, in which a large, contiguous hydrophobic face (27), can be 
reduced to two dis-contiguous patches of 3 to 4 residues on opposing faces of the helix. 
This inference is  supported by the recent finding that the pro-CART helix contains a 
smaller  hydrophobic  face  relative  to  synthetic  helices  (25).  This  underscores  the 
importance of the α-helix as a platform for sorting signal construction in general, and in 
proglucagon, the sorting information is encoded by the dipolar distribution of electric 
charge in relation to hydrophobic patches along the helix surface.
The differences in  sorting efficiency between glicentin and MPGF suggest a context-
dependent regulation of sorting when considering that glicentin does not efficiently sort 
to granules, despite containing a sorting signal within the sequence of glucagon. After 
proglucagon is initially processed at the inter-domain cleavage site, K70R71, glucagon is 
flanked by the sequences of GRPP and IP-1 (Figure 1). We used the PSI-PRED server 
(37) to analyze the predicted secondary structure of glicentin, and it revealed that IP-1 is 
disordered when not joining glucagon to GLP-1, a characteristic of omega loops  (58). 
The N-terminal GRPP domain is also highly disordered, and enriched in acidic residues. 
Our previous model of proglucagon shows this disordered region masks the basic N-
terminal residues of the glucagon helix (33), and the present study confirms this masking 
by showing that removal  of the GRPP domain results in the targeting of Fc to granules.  
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Conformational masking has been demonstrated in moesin, in which an α-helical domain 
regulates the degree of unmasking between its N- and C-terminal ligand-binding domains 
(59); and in the prohormone protachykinin, in which the negatively charged pro-region 
masks the positively charged product, calcitonin gene related peptide (60). We now show 
that glicentin experiences a similar conformational masking by GRPP. On the other hand, 
MPGF experiences no such masking since IP-2, which links the helices of GLP-1 to 
GLP-2, appears to be partially helical  (5, 33), thus maintaining the availability of the 
GLP-1 helix for efficient targeting to granules.
Figure 7. Schematic representation of proglucagon sorting and processing in  α and L 
cells. Proglucagon (red bars) is synthesized in the ER and transported through the Golgi 
to the trans-Golgi network (TGN). Our data support the hypothesis that proglucagon is 
first sorted to immature secretory granules (ISGs) via dipolar a-helices within glucagon 
and GLP-1, and then cleaved to glicentin and MPGF (squares), possibly by furin. Within 
mature  secretory  granules  (SGs),  the  prohormone  processing  enzyme  PC2  processes 
glicentin  to  glucagon  in  α cells,  while  PC1/3  cleaves  glicentin  and  MPGF  to  yield 
oxyntomodulin, GLP-1 (7-37) and GLP-2 in L cells.
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This  asymmetry  between  glicentin  and  MPGF  trafficking  presents  interesting 
implications for the temporal relationship between proglucagon processing and sorting. It 
is well documented that proglucagon processing begins with the early cleavage event at 
the interdomain  site,  K70R71  (5,  9);  in  alphaTC1-6 cells,  glicentin and MPGF were 
detected at 30-45 min via a pulse-chase paradigm (4). Our previous work has shown that 
mutation of K70R71 reduced the efficiency of proglucagon sorting in Neuro2a cells (33), 
and this result led us to conclude that processing may occur before sorting. However, the 
present study does not support this conclusion. If proglucagon processing occurs prior to 
sorting,  our  present  model  would  predict  that  glicentin  would  be  sorted  inefficiently, 
which would impact the production of glucagon in α cells. Therefore, we now propose 
that the K70R71 site simply acts as another sorting signal, and together with the α-helices 
of glucagon and GLP-1, targets intact proglucagon to granules, whereupon processing to 
glicentin and MPGF occurs, as illustrated in Figure 7. Our model also suggests that the 
two  α-helical  sorting  signals  are  functionally  redundant,  perhaps  reflecting  an 
evolutionary  selection  towards  a  high  sorting  efficiency  for  proglucagon.  That  the 
sequences  of  glucagon  and  GLP-1  are  highly  conserved (32) lends  evidence  to  this 
reasoning. This is in contrast to pro-TRH, where PC1/3-mediated processing early in the 
secretory pathway is required for efficient sorting to distinct sub-populations of granules 
(61, 62).
Identification of sorting signals within proglucagon gives rise to the question of potential 
binding partners, or sorting receptors. While the results of Chapter 2 indicated a role for 
CPE in α cells, I also tested the possibility that CgA could act as a receptor because it is  
the most abundant soluble granule protein in both α and PC12 cells. CgA could only be 
co-immunoprecipitated  using  Fc-constructs  at  mildly  acidic  and  millimolar  calcium 
conditions that mimic the mature granule chemical environment, and that the interaction 
was specific to the dipolar  α-helix and the quantity of complex that was pulled down 
correlated well with co-localization analyses. Therefore it is promising that CgA may be a 
sorting receptor for glucagon in  α cells. The absence of the processing enzymes PC1/3 
and PC2 from PC12 cells supports our previous findings (33) that neither enzyme plays a 
role in the sorting of full-length proglucagon. The amphipathic α-helices identified within 
114
prohormone processing enzymes, PC1/3 (26, 63), PC2 (56), and CPE (16), are known to 
associate with the cholesterol-rich domains of granule membranes. However, we could 
not  demonstrate  binding of  purified proglucagon to liposomes (data  not  shown),  and 
therefore hypothesize that proglucagon may bind to granule proteins. It is possible that 
granins  bind  prohormones,  such  as  POMC  (64).  We  have  some  evidence  that 
proglucagon sorting involves interaction with CPE in α cells  (33). Studies investigating 
the roles of other granin proteins in sorting proglucagon are currently underway.
In conclusion, we have shown that proglucagon contains two dipolar non-amphipathic α-
helices with relatively small hydrophobic faces that act as sorting signals for entry into 
secretory  granules  of  endocrine  cells.  Our  data  support  a  mechanism  by  which 
proglucagon is sorted to granules prior to the initial cleavage event that results in the 
production of glicentin and MPGF (Figure 7). That these sorting domains lie within the 
ordered  domains  of  encoded  proglucagon-derived  peptides,  and  not  in  a  disordered 
prodomain  that  characterizes  many  other  prohormones,  highlights  the  unique  sorting 
“signature” of proglucagon, and further emphasizes the disparate nature of sorting signals 
that lie within prohormones and other proteins destined for the secretory granules of the 
regulated secretory pathway.
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Chapter 4
Practical  Co-localization  Analysis  for  Quantitative 
Fluorescence Microscopy
Statement of Author Contribution
This review is wholly the work of Mr. Guizzetti.
4.1 Introduction
In  the  previous  two  chapters,  I  have  used  quantitative  fluorescence  microscopy  to 
objectively examine the sub-cellular trafficking of proglucagon in situ. The conclusions 
of these chapters have heavily relied upon co-localization analyses of these images to 
draw conclusions  about  the  varying degrees  of  sorting efficiency along the secretory 
pathway.  Image  quantification  allows  the  researcher  to  extract  quantifiable  data, 
sometimes from biologically variable samples or using limited image data, that can be 
then  be  used  for  hypothesis  testing  to  reach  accurate  and  precise  conclusions. 
Increasingly more cell  biology studies  are using quantitative fluorescence microscopy 
techniques to examine the function and the associations between two labelled molecules 
within specific intracellular compartments, most often proteins. Co-localization analysis 
remains  the  most  common  image  analysis  tool  for  confocal  immunofluorescence 
microscopy in cell biology research. While super-resolution studies are still less common 
than those using the more accessible  confocal  microscope,  it  is  useful  to discuss  the 
practical  application  and  interpretation  of  co-localization  in  diffraction-limited  image 
sets. Despite the literature already devoted to the use of co-localization, there are still new 
studies published that claim to analyze co-localization, or fail to make any analysis and 
instead switch a qualitative descriptions, and in general, these studies are not rigorous in 
their analytic methodology. To complicate matters, researchers will sometimes alternate 
between their intended meaning of the word “co-localization.” The usage changes from 
qualitative descriptions of overlapping/coincident fluorescence signals, or if calculating a 
co-localization, still choose to use statistics that are less than ideal for the application, or 
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considered  for  the  structures  that  need  to  be  resolved  for  protein  localization  and 
intracellular trafficking.
In  order  to  convert  from analog  light  into  a  digital  image,  a  fundamental  hardware 
component is the photomultiplier, converting the incident photons into a digital signal. As 
an image is acquired, the laser beam is raster scanned or swept across the sample, and the 
emitted light is collected, amplified by the photomultiplier, converted to a digital signal 
and is  registered as a single pixel.  Therefore,  each complete  image is  formed by the 
sequential acquisition of each pixel. It is good practice while doing optical imaging to 
increase SNR by monitoring the live exposure histogram of an acquired image in real-
time. By adjusting emitted light intensity (e.g., by increasing laser power, electronic gain, 
pinhole aperture),  the PMT will  detect more incident photons, translating to a greater 
discrete pixel intensity and utilizing as much of the image dynamic range as possible. 
This permits more accurate and precise quantification because the collected image data 
will better represent the specimen. Care should be taken such that no pixels are over-
saturated  due  to  over-exposure,  as  this  will  lose  higher  intensity  pixel  information. 
Conversely, the minimum pixel intensity should be just above the adjusted black value of 
the PMT, to ensure the emitted photons are properly represented. The quality of down-
stream image processing is only as good as the final image produced by the entire digital 
microscope system, and digital images are more sensitive to imperfections than compared 
to what our eyes perceive.
Image  processing  are  “off-line”  techniques  used  to  correct  for  some  deficit  in  the 
collected images. These techniques may improve image SNR by removing background 
(segmentation),  filtering out noise, or using deconvolution. Some techniques can be to 
reduce size or dimensionality of the data, such as drawing regions-of-interest, or making 
3D projection images, while others can be to interpolate new information such as 3D 
volume rendering and reconstruction. This is not an exhaustive list, but gives the reader 
ideas of some image processing techniques. The researcher should be aware that raw 
images are data, and must be treated as such. When performing any image processing 
technique, it is essential that they be made on duplicates of the original images so that the 
raw data can always be accessed, and it necessitates the creation of a digital backup. Any 
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of the techniques performed must also be stated in the publication's methods section for 
transparency and reproducibility.
There  are  also  some  practical  tips  to  keep  in  mind  in  how computers  represent  the 
intensity of each pixel. A pixel is represented by a computer as a number of bits (usually 
8-,  12-  or  16-bits),  called  a  bit-depth.  The bit-depth  represents  the  range of  possible 
values that a pixel can have. For example, an 8-bit image can take 28 possible values (256 
shades of grey), and is the dynamic range of all pixel values in image. When working 
with  digital  images,  the  bit-depth  must  never  be  reduced  or  truncated.  Doing  so 
compresses the dynamic range of the image, and “clips”/truncates the high intensity pixel 
data.  This  high-intensity  detail  is  likely  to  contain  the  signal-of-interest,  and  would 
represent a degradation of image and data quality. As  a practical example, a 16-bit image 
(65,536 levels of grey) contains pixel intensities in the range of 10-40,000, and when 
converted to 8-bit, clips all pixels at or above 256 to the same intensity, resulting in a 
severe  loss  of  image  detail  and  apparent  over-saturation  of  the  clipped  8-bit  image. 
Similarly,  histogram compression  results  in  a  altered  image  contrast  between  pixels. 
Acquired images are often converted to tagged-image file format (TIFF) files for analysis 
because all pixel information is maintained in its raw state and does not allow for “lossy” 
compression schemes, unlike JPG and other formats, that discard information to produce 
a smaller image file. Image processing should be done on the raw image data so that the 
researcher is assured the results are representative of the image, and not an artifact of the 
image  file  format.  Several  commercial  and  free  software  packages  conduct  image 
conversion and analysis. The techniques that are applied to one image (of one image 
channel) must be applied to all image channels for consistency of data quality. This is 
important  for  conducting  co-localization  studies,  which  require  two (or  more)  image 
channels.
4.2  Quantitative  Multi-Channel  Image  Analysis  and  Co-
localization
For consistency, it will be useful to first define what is meant by co-localization, and 
what it can tell the user regarding their species of interest (usually proteins). Ideally, the 
researcher wants  an image analysis  tool  that  can determine whether  two proteins  are 
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physically interacting with each other, and would turn to co-localization as a quantitative 
measure of interaction. However, diffraction-limited microscopy does not offer sufficient 
resolution to quantify such a physical interaction due to the nature of image acquisition. 
Instead,  suitable  microscopy  techniques  to  validate  inter-molecular  interaction  must 
utilize the physical phenomenon of Förster resonance energy transfer (FRET) (detecting 
interaction  with  spatial  resolution  of  <10  nm),  or  bimolecular  fluorescence 
complementation  (BiFC)  (producing  an  active  fluorophore  upon  protein 
complementation) (for reviews see (1, 2)). Additionally, the increasing adoption of super-
resolution microscopy is better suited for the quantification of the percent of interacting 
proteins. The much greater spatial resolution affords the development of new algorithms 
and  more  sophisticated  tests  of  interaction,  such  as  object-based  or  proximity-based 
methods  (3–6),  or  adopting techniques  from statistical  physics  to  account  for  several 
proteins of interest, for example (7).
Co-localization  can report  on  the  degree  of  spatial  co-distribution.  Quantitative  co-
localization  accounts  for  two  components:  simple  overlap  (sometimes  called  co-
occurrence), and the tendency to co-distribute (or co-segregate). Therefore, fluorescence 
co-localization is best suited for determining the tendency to associate with the same 
cellular  or  molecular  structure,  as  opposed  to  measuring  the  association  of  freely 
diffusing and interacting molecules. Simple overlap alone is insufficient to determine co-
localization, and various overlap coefficients have been used as the basis for evaluating 
co-localization.  Worse yet, “judging by eye,” for the degree of yellow signal when red 
and green signals overlap, is highly subjective and offers meaningless interpretation. This 
can best be demonstrated by the optical illusion in which the perceived colour contrast of 
one colour varies within the context of its background, in other words, seeing colours that 
are really not there (e.g., Munker illusion1) (8). Incorporation of spatial association adds 
robustness  to  the  co-localization  methods,  in  that  two (or  more)  bodies  that  are  co-
localized should be observed in the same location and should have concordant spatial 
locations.  In  studies  of  intracellular  trafficking  of  cargo  proteins,  the  most  common 
approach is to fluorescently label one cellular compartment, such as the  cis- or  trans-
1 This optical illusion can be generated using FIJI by going to File > Open Samples > Spirals, and 
observing that the blue and green spirals are actually the same colour.
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Golgi (e.g., (9–11)), or specific vesicular compartments, such as secretory granules (e.g., 
(10,  12,  13)),  or lysosomal/endosomal compartment  (e.g.,  (14–16)).  In  the context  of 
examining  protein  intracellular  trafficking  through  the  secretory  pathway,  accurate 
quantification can be used to  examine steady-state  distribution of  protein localization 
when compared to  transient  co-localization  in  the  Golgi,  or  it  can  be used to  assess 
efficiency of storage within a terminal destination within secretory granules. Live cell 
imaging can also extend this analysis to reveal kinetics of movement through distinct 
sub-cellular compartments, a question that is increasingly more relevant with confocal 
microscopy  (17) and  super-resolution  imaging  (14).  Accurate  co-localization 
quantification  can  lead  to  new  insights  for  cell  biological  processes,  such  as  the 
preference  to  secrete  insulin  from  younger  granules  of  pancreatic  beta-cells  (17). 
However, it is not justified by co-localization alone that just because two proteins exist in 
the  same  compartment  that  they  should  necessarily  be  interacting,  just  as  it  is 
unreasonable to expect that co-localization can always quantify the stoichiometric ratios 
of interacting proteins. It is important to understand the capabilities and limitations of 
such quantification techniques.
Here I present a framework for conducting a quantitative co-localization study to measure 
protein co-localization and intracellular trafficking. To better inform the user on how to 
interpret  various  commonly  used  correlation  parameters,  I  have  generated  simulated 
image sets containing point source objects,  in order to provide a cell-free context for 
understanding parameter interpretation and evaluating their performance. The simulated 
image sets  are  also useful  to  control  the statistical  distribution of  pixel  intensity  and 
spatial location. I will make several assumptions about the reader in order facilitate the 
discussion. Firstly, the reader should be familiar with good confocal imaging practices (a 
good primer on common pitfalls in confocal microscopy is found at ((18))). Images are 
captured in which the “signal” is well above the “background” and “noise” due to cellular 
and substrate auto-fluorescence (e.g., ((19, 20))), controlling uneven illumination (e.g., 
(21)), and the fluorophores are sufficiently separated in their excitation/emission spectra 
to prevent fluorophore cross-talk and bleed-through. Furthermore, image sets must be 
acquired in uncompressed image formats. A good review on the digital aspects of image 
files and microscopy can be found by (22).
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Both commercial (e.g., Imaris, Image Pro, Axiovision, Colocalizer Pro) and free software 
packages  (e.g.,  FIJI/ImageJ)  that  measure  co-localization  include  several  different 
algorithms from which the user is expected to know the correct method to use. Especially 
in  earlier  co-localization  studies,  researchers  often  presented  several  computed 
measurements  alongside  their  immunofluorescence  images,  not  deciding  on  a  single 
“best” algorithm for their data. Ideally, the choice of co-localization parameter should be 
an objective measurement of true co-localization of 2 (or more) labelled molecules. The 
co-localization  statistics  should  be  1)  sensitive  to  the  effect  of  one  molecule  co-
distributing with the other; 2) insensitive to background noise; 3) insensitive to relative 
changes in fluorescence intensity channels (e.g., scale independent); and because no two 
cells  are  alike,  4)  the  statistics  should  be  insensitive  to  changes  in  overall  cell 
morphology, such that they are shape independent. I will discuss these four points to help 
interpret the multitude of co-localization measurements.
4.2.1 Mathematical parameters used for co-localization analyses
This  section  discusses  the  parameters  used  for  quantitative  co-localization  and  their 
mathematical  definitions.  The  most  commonly  used  parameters  for  these  studies  are 
Manders'  overlap  coefficient  and  Pearson's  correlation  coefficient,  and  some  less 
common correlation parameters  (listed  in  Table  1).  If  the reader  is  familiar  with the 
mathematical definitions of the parameters, they can skip ahead to the next section for a 
discussion of the merits of these parameters.
Table 1. Mathematical parameters used for quantitative co-localization analyses.
Coefficient Name Measured quantity Equation Ref.
Overlap Simple overlap 1 (23)
Manders' overlap (MOC) Intensity-weighted Overlap 2,3 (23, 24)
Pearson's correlation (PCC) Correlation between channel 
intensity
4,5 (25)
Spearman's rank-correlation 
(SRC)
Rank-ordered correlation 
between channel intensity
4 (26)
Kendall's tau Rank-ordered correlation 
between channel intensity
6,7 (27, 28)
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reports the degree of similarity between two images conditioned on the assumption that 
they are independent.  The possible  advantage to  using Kendall's  tau over  Spearman's 
rank-correlation coefficient is that Kendall's tau correlation can be assumed normal in 
real applications under the null hypothesis that all possible rank-ordered pairs occur with 
equal  likelihood  (27).  Since Kendall's  tau calculation  of  rank-pairs  is  exhaustive,  the 
complete  distribution  can  be  quickly  calculated  (27),  using  a  computer  to  verify  the 
Normality assumption,  allowing the computation of approximate confidence intervals. 
These  qualities  make  it  a  strong  candidate  to  consider  alongside  more  accepted 
parameters of co-localization for co-localization analysis, and should also be applicable 
in super-resolution image studies.
The original version of this test are based on interpretation of scatter plots in the intensity 
correlation  analysis  (ICA)  (30,  31).  The  ICA  method  is  based  on  the  underlying 
assumption that pixel intensity in one image is symmetrically distributed (not necessarily 
from  a  Normal  distribution),  such  that,  for  an  image  which  as  random  (or  mixed) 
staining, the sum of mean differences is zero ( ∑ Si−Sav≃ 0 ). By extension, the two 
channel  version  assumes  that  the  joint  probability  distribution  of  pixel  pairs  is  also 
symmetrically  distributed,  such  that  ∑ (S1, i−S1, av )⋅(S2, i−S2,av )≃0 .  When  individual 
pixel intensities are plotted against the product (S1, i−S1,av )⋅(S2, i−S2,av ) , a scatter plot is 
produced, that can be visually examined to judge correlation of immunostaining. A scatter 
plot that is biased to the right of vertical line at (S1, i−S1,av )⋅(S2, i−S2,av )=0 is interpreted 
as correlation, while a scatter plot mainly along this vertical line represents independent 
staining,  and  a  bias  to  the  left  represents  segregation.  However,  because  this 
interpretation is  subjective,  a  it  required  the  computation of  Li's  intensity  correlation 
quotient (ICQ), in order to allow for a hypothesis testing using the sign-test.
ICQ=
∑ [ (S1, i−S2,av )⋅(S2, i−S2, av ) ]>0
∑ (S1, i−S2, av )⋅(S2, i−S2,av )
−0 .5 ;ICQ∈[−0 .5,0.5 ]      (Equation 8)
The  ICQ  computes  the  sum  of  the  product  of  concordant pixels  (e.g.,  those  that 
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correlate), over the sum of all products of pixel pairs (e.g. those that correlation and those 
that don't).  In a sense, Li's ICQ is a binary correlation, and just as the other parameters 
presented here, does not measure co-localization. The subtraction of 0.5 is to centre the 
range about zero, with ICQ values less than zero representing segregation, and greater 
than zero representing correlation, and thus co-localization. At present, Li's ICQ is only 
implemented in FIJI.
4.3 Methods
Several  parameters  have  been  proposed  to  measure  co-localization,  the  two  most 
common of which are Pearson's correlation coefficient (Table 1, Eq. 4,5) and Manders' 
overlap  coefficient  (Table  1,  Eq.  2,3)  for  quantitative  fluorescence  microscopy,  as 
determined by PubMed searches reporting co-localization. For reasons detailed below, 
this review is focused on the PCC, and less common but potentially useful rank-based 
parameters – SRC, Kendall's tau and Li's ICQ. In the interest of practising quantitative 
co-localization, I recommend against using the overlap and Manders' coefficients (Table 
1,  Eq.  1-3).  The  overlap  coefficient  makes  no  attempt  to  normalize  the  channel 
intensities, and is simply too sensitive to variations in noise, relative channel fluorescence 
intensity, and channel mean to be of any practical use (32). Therefore it is equivalent to 
creating  a  simple  overlap,  and the  researcher  is  left  to  “measure  by  eye.”  Similarly, 
inspection of the Manders' overlap coefficient formulation, and experimental results from 
Adler  agree  that  it  is  best  "to  abandon the  MOC and  the  related  k1  and k2 pair  of 
coefficients"  (32) in favour of Pearson's correlation and rank/sign-based correlations or 
another of the parameters discussed herein. Their findings are also in agreement with the 
findings  of  others  (11,  33) and the authors'  experience,  with real  and simulated data 
showing poor performance with the MOC and complete insensitivity to the degree of 
correlation.  For these reasons, MOC will  not be considered further here, in favour of 
more  robust  parameters.  The  inclusion  of  Li's  ICQ  and  the  rank-based  correlation 
coefficients,  SRC  and  Kendall's  tau,  are  interesting  but  have  not  been  considered 
extensively in the literature.  Li's  ICQ (Eq. 8) was first  introduced a decade ago, and 
reduces the parameter to a binary comparison of pixel values. It has the potential to be as 
robust  as the PCC to noise,  background and differences  in  relative channel  intensity. 
Similarly, the SRC and Kendall's tau are rank-based, and those may also offer similar 
130
advantages. These three parameters, along with the classic PCC and Costes' automated 
threshold version of PCC (34) are compared in detail.
4.3.1 Image simulations and Co-localization Analysis
Simulated greyscale images were generated using a custom written script in the Python 
programming  language  (Python  Software  Foundation.  Python  Language  Reference, 
version 3.2. http://www.python.org) using the Python Image Library (Pillow, version 2.5; 
http://github.com/python-pillow/Pillow).  Each  image  set  contains  a  pair  of  pseudo-
coloured  images  to  represent  two  fluorescence  acquisition  channels.  All  simulations 
contained randomly located point objects,  which were subsequently convolved with a 
Gaussian  kernel,  to  simulate  the  effect  of  point-spread  function  blurring  of  confocal 
microscopy image formation. To control for the percent of object co-localization, both 
simulated image channels shared a subset of the randomly generated objects for partial 
co-localization, or the same set of objects for perfect co-localization. Objects with 0% co-
localization (segregated objects), had unique sets of random object locations. To simulate 
image noise,  randomly generated Gaussian values  were subsequently added to image 
sets. The ratio of mean object intensity to mean background noise was held constant to 
maintain signal-to-noise. For display purposes, the generated grey-scale images were then 
pseudo-coloured, for display purposes. Simulations were performed for 1,000 repetitions, 
and the calculated parameter values were averaged. Co-localization was measured using 
the Coloc 2 plugin of the FIJI/ImageJ software package (http://fiji.sc/) (35), and verified 
using a custom written Python script for selected co-localization statistics.  Calculated 
correlation  values  for  co-localization  were  averaged  over  all  simulations  and  are 
presented as the mean value, and analyzed using the R software package (version 3.1; 
http://www.r-project.org/).
4.3.2 Image Acquisition of Multifluorescent Beads and Chromatic 
Aberration Calibration
Multi-fluorescent beads (Thermo-Fisher) 5.0 µm in diameter were imaged using a Zeiss 
LSM  510  laser-scanning  confocal  microscopy  under  60x  objective  magnification. 
Microscopy was performed at the Biotron imaging facility at the University of Western 
Ontario. Images were imported into FIJI for measurement of each colour channel's x- and 
y-axial line profile. Overlay of red, green and blue line profiles show that the microscope 
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is calibrated for lateral chromatic alignment, and no chromatic defect is observed.
4.4 Results
4.4.1 Chromatic calibration of the microscope
Before collecting any images for co-localization analysis, the confocal microscope must 
be chromatically calibrated. Improper calibration leads to colour fringing artifacts and 
will already degrade the detection ability of co-localization from a systematic bias, most 
especially  pronounced  when  trying  to  analyze  punctate  structures  that  correspond  to 
secretory granules (as is commonly done). The easiest method is to use multi-fluorescent 
beads, which are both inexpensive and commercially available. (Core imaging facilities 
may even have these beads readily available for this purpose.) The fluorescent coatings of 
the  beads  are  chosen  to  be  compatible  with  the  most  common  filter  sets  used  in 
immunofluorescence  imaging,  typically  blue  (e.g.,  DAPI),  green  (e.g.,  FITC, 
AlexaFluor488), orange (e.g., Cy3, TRITC) and red (e.g., Cy5, AlexaFluor647). Using 
the same light path that will be used for capturing immunofluorescence images, acquire a 
few images  of  fluorescent  beads  in  each  channel  that  will  be  used  for  imaging.  By 
drawing  a  line  profile  through  the  beads  for  each  of  the  x-  and  y-axes,  and  then 
overlaying the profiles, any offset of the bead centre/edges can be measured, as in Figure 
1.  Ideally, this  pinhole  alignment  need  only  be  done  once  prior  to  beginning  image 
acquisition on sample specimens. If there is an offset (in any direction) and images have 
already  been  acquired  using  the  uncalibrated  microscope,  proper  alignment  can  be 
restored by digitally translating one channel with respect to another, restoring alignment 
post-acquisition. In reality, there will always be some residual optical aberration left in 
the  system,  but  chromatic  and  optical  alignment  is  necessary  to  properly  detect  co-
localization.
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channel  against  the  other  channel.  These  graphs  can  be  viewed  during  real-time 
acquisition in some commercial packages (e.g., those offered by Zeiss or Leica) or post-
acquisition in many software packages (e.g., FIJI). In this scatter plot, each data point is 
made up of spatially matched pixel intensity values, one from each image. Essentially, a 
cytofluorogram represents a 2D histogram of pixel matched values across the image set, 
with a variation of this to also show the intensity or height of each intensity pair as a heat 
map. If the researcher uses Pearson's correlation coefficient, it  is exactly equal to the 
slope of the regression line through the cytofluorogram. Assessment of image data in this 
graph is superior to examining a simple overlay, because the user can immediately see the 
quality of image data, how much of the signal is not correlated or contains noise, and an 
initial assessment of co-localization.
Let's consider three conditions of overlap in  Figure 2. First, a set of simulated objects 
that  (by  design)  perfectly  overlap  and  co-distribution  (Figure  2A).  Evaluating  this 
cytofluorogram of perfect co-localization (Figure 2A'), I expect every yellow pixel to 
coincide with a magenta pixel, and their pixel intensity changes concordant with each 
other. As expected, all calculated parameters of co-localization, shown in Table 2, agree 
with  the  theoretical  maximum value.  Partial  co-localization  of  simulated  objects  was 
achieved by translating the objects in one image by 1 pixel in both the x- and y-directions 
(Figure 2B). This results in a partial overlap of all objects, but should otherwise still be 
considered co-localized. It is instructive to notice that this scenario is also representative 
of  uncorrected  chromatic  aberration,  in  which  colour  fringing  effects  will  degrade 
correlation  values.  The  cytofluorogram (Figure  2B')  still  shows  positive  correlation, 
indicating co-localization,  albeit  with added noise contributed by the non-overlapping 
regions. The corresponding correlation parameters in  Table 2 all show good agreement 
with the perfect co-localization case, reflecting the notion of very good, but imperfect, 
co-localization.
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Table 2. Performance of selected co-localization parameters under differing conditions of 
true co-localization and segregation.
Condition PCC PCC (with 
threshold)
SRC Kendall's 
tau
Li's ICQ
Theoretical range [-1,+1] [-1,+1] [-1,+1] [-1,+1] [-0.5,+0.5]
Perfect co-
localization
1* 1* 1* 1* 0.5*
Partial co-
localization
(1 px shift)
0.88 0.85 0.93 0.88 0.46
Minor co-localization
(2 px shift)
0.61 0.52 0.85 0.76 0.42
Perfect segregation -5.0·10-2 -7.6·10-4 -0.23 -0.21 0.32
Note: These values correspond to images shown in Figure 2. Values are presented as the 
mean over n=1,000 simulations. * values are presented as exact, and conform with their 
respective theoretical maximum.
Lastly, I consider perfectly segregated objects (Figure 2C). The exact same distribution 
of point objects  have been horizontally translated so as to not overlap at  all,  and the 
cytofluorogram shows all magenta and yellow objects clustered along the axes (Figure 
2C'). The slope of the regression line is -0.05 (approximately equal to 0), indicating good 
agreement  with  object  segregation.  With  respect  to  the  PCC,  these  values  are 
approximately  equal  to  0,  though  in  both  conditions  of  partial  co-localization  and 
segregation, the un-thresholded Pearson's value over-estimates the degree of correlation. 
Also  some  authors  have  misinterpreted  the  Pearson's  formula  concerning  perfect 
segregation  as  yielding  a  value  of  -1.  However,  the  proper  interpretation  for  no 
association  (perfect  segregation)  would  be  a  value  of  0,  indicating  no  linear  co-
dependence, while a value of -1 represents perfectly negatively correlated data. It is very 
rare  for  immunofluorescence  images  to  contain  truly  negatively  correlated  labelled 
molecules, and therefore negative Pearson's correlation values much below 0 should be 
inspected more closely as it may be symptomatic of imaging artifacts (such as uneven 
illumination). In real immunofluorescence images, the “lobes” that extend along the axes 
of  the  cytofluorogram represent  uncorrelated background signal  (i.e.,  noise and auto-
fluorescence). Lastly, Li's intensity correlation quotient (ICQ) (Table 1, Eq. 8) performed 
136
the poorest of these parameters to distinguish co-localized from segregated objects, given 
its  theoretical  range  is  -0.5  to  0.5.  While  the  intuition  behind  the  ICQ  is  easy  to 
comprehend, using this parameter may result in inefficient detection of co-localization 
differences,  consistent  with  the  findings  of  (32,  36).  In  the  case  of  even  less  co-
localization (Table 1), but not complete segregation, the values continue to trend toward 
no association,  with  the  rank-based  methods  (Spearman's,  Kendall's  tau)  maintaining 
power to detect co-localization from small offsets. Overall, the correlation parameters of 
Pearson, Spearman and Kendall preserve much of their dynamic range for quantification 
of co-localization.
4.4.3 Li's ICQ is insensitive to known co-localization
Previous  attempts  to  estimate  sensitivity  of  a  co-localization  parameter  to  various 
“ground truth” degrees of co-localization fixed the percent of co-localized point objects 
(23, 31). However, the observed effects are exaggerated when these tests are arranged as 
a regular grid for MOC, SRC and PCC, because they are susceptible to slight changes on 
a change of a few co-localized objects.  To produce a more robust estimate when the set 
of co-localized objects is fixed (“ground truth”), point objects were randomly generated 
as in Figure 2, to remove any effect of objects arranged in a grid, while accounting for a 
small amount of random overlap, representing spurious co-localization. For this set of 
simulations, a fixed percentage of object co-localization was imposed, ranging from 0% 
to 100% (Figure 3). Li's ICQ displays the least sensitivity to co-localization, and at 0% 
object co-localization, yields a value slightly higher than reported in  Table 1 (0.37 vs 
0.32). This difference is not due to the number of objects (both have 200 random objects), 
but is instead showing that when a group of objects is random dispersed in the same 
image area (as in Figure 3), there may be minimal spurious overlapping, increasing the 
parameter value, but when objects are segregated in the image, the parameter is a little 
more sensitive to this separation.
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Figure  3. Effect  of  object  overlap  on  the  measured  correlation  coefficients  without 
background noise.  200 random point objects  were generated, and Gaussian blurred to 
simulate  optical  blurring  by  the  microscope's  point-spread  function.  A  predefined 
percentage of object overlap (from 0-100%) was imposed, such that "ground truth" object 
co-localization was fixed. For each level of object co-localization, 1,000 simulations were 
run, and the mean parameter values plotted. Connecting lines are shown as an aid for the 
eye.
4.4.4 Background and noise
Image background is from the specimen caused by several factors, the most common of 
which  is  auto-fluorescence  (from cells  or  substrate  coatings),  mounting  medium,  the 
choice of glass, and other sources that uniformly offset (or add to) pixel intensity. Prior to 
the imaging session,  the photomultiplier  amplifier  offset  should be adjusted to  a true 
black  value.  Diffuse  fluorescence  signal  arising  from  the  specimen  is  not  typically 
considered  valuable  for  co-localization,  and  should  be  accounted  for  in  analysis  by 
setting an appropriately high threshold value for co-localization. On the other hand, noise 
creates variance in the pixel intensity, and obscures the “real” value. Noise is caused by 
electronic sources in the detector electronics, as well as fluorophore cross-talk and bleed-
through.  Methods  that  specifically  reduce  Poisson  noise  (shot/detector  noise)  from 
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electronic  sources  in  confocal  imaging  were  developed  with  good performance  (37). 
Another common noise removal technique is median filtering (low-pass filtering)  (38), 
which is scalable to 2D and 3D, but the tradeoff is a loss of resolution and only reduction, 
not elimination, of noise. The concept of signal thresholds was quickly introduced with 
co-localization  measurements,  and  different  methods  exist.  Coste's  (34) proposed  a 
automated iterative method to select a threshold using orthogonal regression, iterating 
through progressively lower threshold values for each axes of the cytofluorogram until 
the  PCC  (below  threshold)  becomes  negative  (it  is  implemented  in  some  software 
packages,  such as FIJI's  Coloc 2 plugin).  In most  cases,  researchers are interested in 
positive correlations,  and this auto-threshold algorithm is  appropriate in that case.  An 
alternative approach (39) produces threshold by weighting the effect of each pixel to its 
contribution to both MOC and PCC, and is also applicable in the case when negative 
association is of interest. Thresholding methods are most effective for removing (constant 
intensity) background and only partially reduce the effect of noise.
4.4.5  Higher  order  image  structure  in  images  may  negatively 
skew co-localization
For an ideal co-localization parameter, it would be beneficial if the value were linearly 
proportional  to  the  degree  of  co-localization.  Over  the  entire  range  of  percent  co-
localization, the SRC, Kendall's tau, and PCC (without threshold) have an approximately 
linear response. The Pearson's using the Coste's auto-threshold shows some instability at 
<5% of co-localization, and this is because an acceptable threshold value could not be 
determined. This instability is possible (though not guaranteed) when the PCC has values 
very close to its extremes (-1 or 1)  (40).  However, the PCC (with auto-threshold) is 
stable and is the most sensitive across the majority of this range. Coincidentally, these 
three parameters also estimate the percent of overlap, though there is no mathematical 
basis  for  this  in  the  general  case  because  they  are  not  guaranteed  to  have  a  linear 
response, even in this ideal simulation. (Here, this approximation is because of a uniform 
background level and equal object intensity.) While simulation results of Figures 3 and 
Table 1 agree when there is partial or perfect co-localization, it reveals a negative bias in 
the SRC and Kendall's tau for images that have regular, or higher ordered structures of 
interest, resulting a lower reported parameter that the case where no co-localization is 
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expected  in  overlapping regions  of  interest.  In  these  cases,  cross-correlation  or  auto-
correlation methods (see Discussion) may offer an performance advantage. In biomedical 
application, randomly oriented and localized sub-cellular structures would be expected to 
have values closer to the 0% overlap values than the more negative extremes, arguing for 
the need to have an appropriate negative co-localization control to define the lower limit 
of the detection range for a particular biological system using a particular co-localization 
parameter.
4.4.6 Effects of gain and bias
The PCC, and its derivatives, SRC and Li's ICQ, are all robust (or insensitive) to effects 
of image gain and bias. This can be seen by substitution of the pixel value S1, i=a⋅S1, i in 
the case of gain, or S1, i=S1,i+a in the case of bias, into the formula for Pearson's and 
observing that the effect  cancels out.  Likewise,  these substitutions do not change the 
relative rank-order or sign-test, and therefore the SRC, Kendall's tau and Li's ICQ will 
not  be  affected.  This  finding  has  not  been  reported  with  respect  to  co-localization 
analysis. Therefore, the PCC, SRC Kendall's tau or ICQ are favourable to fluorescence 
microscopy in which digital offset is usually adjusted in each imaging session to set the 
black background level,  and gain may need to be adjusted slightly for differences in 
antibody staining between markers.
4.4.7 Effect of noise
An ideal co-localization should be robust to random background noise and still detect co-
localization by correlation. To determine how these parameters performed, I varying the 
type and amplitude of noise, and the signal-to-noise ratio when using point objects (as in 
Figure 4), calculated by ratio of the mean noise level to the mean object intensity. For 
confocal fluorescence images, having a minimum SNR of 20 is suggested for reliable 
object  detection  and quantification.  However, confocal  images  often  suffer  from less 
SNR due to limiting the collected light of the pinhole. A high SNR image is produced in 
direct relation to the effective resolution of objects within the image, as well as intensity 
measurements, for which these correlation parameters rely on. To evaluate performance 
using  low  SNR  conditions,  image  sets  were  generated  with  either  severe  (SNR=2) 
(Figure 4A) or moderate (SNR=5) (Figure 4B) degradation, in which it is either very 
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difficult or minimally sufficient to discern objects within the image  (41). Under three 
scenarios  of  known object  co-localization  (0%, 50% and 100%),  randomly generated 
noise was added to the images prior to computing each co-localization parameter, and the 
results are presented in  Table 2.  In the first,  low SNR scenario (Figure 4A), random 
Gaussian noise is added to represent noise, relative to the true mean signal (specified by 
the coefficient of variation). When objects are randomly dispersed, and no co-localization 
is expected, the PCC, SRC, Kendall's Tau and Li's ICQ correctly report no correlation. As 
the  degree  of  co-localization  is  increased  to  100%,  all  parameters  generally  report 
increased  correlation  or  association,  as  expected.  However,  the  dynamic  range  of 
correlation as reported by SRC, Kendall's tau and Li's ICQ, under all noise conditions, is 
far  too  small  to  accurately  reflect  any  co-localization,  and  therefore  all  three  are 
susceptible to extremes of noise. With respect to PCC, it is similar susceptible to high 
noise, yet detected co-localization given with less than 5% noise, though it under-reports 
the  degree  of  co-localization.  When  the  Costes'  auto-threshold  is  used  for  the  PCC, 
performance  at  low  noise  is  substantially  improved  over  non-thresholded  PCC,  but 
quickly destabilizes at greater levels of noise. The cause of this instability is a result of 
the  auto-threshold  algorithm over-fitting,  and  finding  an  unacceptably  high  threshold 
value, and therefore removing “true” data, as seen in the case of 15% noise. Therefore, 
these parameters all detect a lack of correlation/association even with unacceptably high 
noise,  yet  the SNR determines  overall  co-localization sensitivity, with the  PCC most 
robust to this noise at low noise levels.
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greatest response range, similar to that of the ideal case with no noise (Figure 3). The 
instability of Costes' auto-threshold is apparent at low SNR and high noise conditions 
(PCC (threshold) at  SNR = 2, 15% noise,  Figure 4A) compared to low SNR and low 
noise (SNR=2 and 5% noise,  Figure 4A), and is a result of over-fitting the orthogonal 
regression to find a threshold value due to the noise. Greater noise and lower SNR causes  
a general compression in the response range to different degrees of true co-localization. 
Conversely, greater overall SNR improves parameter sensitivity, and with respect to the 
PCC, is important for the stability of the auto-threshold stability. Overall, the PCC is the 
most  robust  to  noise  conditions,  and  with  high  SNR image  data,  offers  the  greatest 
response range to detect co-localization differences.
4.4.8 Effect of ROI selection
When co-localization  analyses  are  conducted,  it  is  considered  good practice  to  draw 
regions-of-interest  around  the  whole  cell  area  when  individual  cells  are  well-
distinguished,  if  for  nothing else but  to  remove excess  background and noisy pixels. 
Often  times  ROIs  are  drawn  around  sub-cellular  compartments  as  defined  by  a 
fluorescent marker. To determine the effect of ROI selection on the calculated statistics, I 
simulated  point  objects  that  were  generated  with  Gaussian  noise  (5% coefficient  of 
variation, mean of 100) in a situation where SNR was a not limiting factor, and with 
known degrees of object co-localization (from 0% to 100%) (Figure 5). Gaussian noise 
was chosen because of its symmetry, and would be expected to cancel out over a large 
number of pixels. Objects were randomly distributed in the centre of the image (original 
image dimensions were 512x512 pixel). When an ROI was selected around this centre 
region (225x225 pixel image dimension), the noise was removed from calculation, and 
the calculated statistics are consistent with the detection range reported in Figure 4 and 
Table 1. However, not using an ROI let a large area of uncorrelated noise on the image 
margins. The calculated parameters became inflated across all degrees of co-localization, 
compressing the response range, as a direct result of the extra noise heavily weighting the 
parameter calculations. Similar results were obtained with Poisson distributed noise to 
mimic detector “shot” noise (results not shown).
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Figure 5. Regions of interest improve parameter performance by reducing the weighting 
on  background  and  noise  pixels.  Images  were  generated  with  Gaussian  noise  with 
constant average background. Parameters were calculated for whole images (“no ROI” 
group) and using the  bounding area of point objects (“using ROI” group), with a fixed 
degree of known object co-localization. The response range of parameters is expanded 
when the ROI was used compared to not using an ROI.
4.4.9 Bench-marking common co-localization parameters using 
open data sets
In  order  to  evaluate  these  parameters  in  real  fluorescence  image  sets,  it  would  be 
instructive to see how they perform using cells that are labelled for two structures that do 
not  co-localize,  and  in  cells  that  display  a  wide  variation  in  morphology.  The 
morphological  variation is  an important  aspect  because they will  always be different, 
even in clonal cell lines, and the argument could be made that the relative areas of the 
two labels could have an influence on the calculated statistics. To this end, I used a freely  
available  image set  in  which  the  same cells,  under  experimental  conditions,  undergo 
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extreme variation in their morphology, while stained for truly segregated markers.  I used 
image set  BBBC020 from the Broad Bioimage Benchmark Collection  (42),  in  which 
murine bone-marrow derived macrophages were treated with a drug to investigate their 
ability to  spread. These cells were immunostained for CD11b/APC (a cell membrane 
protein)  and counter-stained with DAPI,  and there  is  no real  co-localization between 
these two structures. All computed parameters for this data set are shown in  Figure 6. 
Even though these images were taken with a wide-field fluorescence microscope, it is 
clear that the PCC and Li's ICQ parameters do not falsely identify co-localization. The 
SRC and Kendall's tau perform relatively worse, with a broader distribution of values, 
when when compared to simulated data, would suggest at least partial co-localization. 
Also  evident  is  that  the  Costes'  auto-threshold  appears  to  transform  the  Pearson 
distribution by creating a heavy left (lower) tail. Here, I suggest that for biological data, a  
negative value should be have the same interpretation as a zero value: the two labels are 
not co-localized – in this case, a cell surface marker is definitely not in the nucleus.
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Figure  6.  Performance  of  multiple  co-localization  parameters  on  open 
immunofluorescence image sets. An open image set of wide-field immunofluorescence 
images of bone marrow-derived macrophages (n=25), immunostained for cell membrane 
protein, CD31b/APC, and counter-stained with DAPI, serving as a control for non-co-
localizing  labels.  Images  were  collected  during  a  time-lapse  experiment  to  study 
macrophage spreading, and the heterogeneity of cell morphology serves as a good co-
localization false-positive benchmark. Details of the study can be found at (43) and image 
set “BBBC020” was obtained from (42).
4.5 Discussion
The term co-localization is used to mean many different things, including the degree of 
association between two proteins; a quantifiable measure of protein interaction; are two 
proteins in the same place; and the more rudimentary meaning of visual overlap between 
two fluorescent signals. I take co-localization to mean any two (or more) fluorescently 
labelled objects that are highly correlated and co-distribute within immunofluorescence 
images.  Ultimately, the  cell  biologist  wants  to  extract  quantitative  meaning  from the 
images they acquire. Even with perfect images, the biological question must be matched 
to  the  quantitative  techniques.  Co-localization  analysis  is  a  routine  method  for 
immunofluorescence microscopy, and cell biologists should strive to rigorously analyze 
their  images  beyond  the  “eyeball”  metrics.  However,  these  methods  all  have  their 
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limitations. They cannot answer the question of what percentage of one protein interacts 
with a second protein. Many examples of reliable proteins association can be found (e.g., 
secretory protein trafficking  (10, 44)), but potential limitations arise from transient co-
localization, or restricted localization within a sub-cellular compartment, or systematic 
errors to labelling strategy (e.g., (45)). These parameters are useful to answer questions of 
whether two (or more) fluorescence patterns are similar within the cell, as a measure of 
the degree of statistical association (but not chemical interaction).
An immediate quality check of immunofluorescence images can be observed from the 
cytofluorogram and PCC parameter. The section of the cytofluorogram that is correlated 
and contains co-localized pixels is usually described as the upper-right quadrant (those 
methods discussed here) or less commonly, by a radial arc centred along the diagonal of 
perfect co-localization (46). These areas are then quantified (e.g., by linear correlation) to 
determine the degree of co-localization and represents the biologically significant data. 
The cytofluorogram gives a good idea of how many uncorrelated pixels exist in each 
channel relative to what may contribute to correlated pixels. Since uncorrelated pixels 
and noise cannot be avoided in even the most perfect immunofluorescence images, it is 
critical to have a threshold value for each image channel. It is usually a good idea to 
restrict  the  ROI  for  analysis  to  entire  cell,  or  if  the  labelled  molecules  exist  in  one 
structure (e.g., the nucleus), then drawing the ROI around the nucleus will improve the 
quality of measurement. Of course, one must always compare to both a negative (known 
segregated) and positive (known highly co-localized) biological control, to establish the 
limits of detection within the particular biological and optical system.
There are several misconceptions regarding the use of correlation values as indications of 
co-localization that should be addressed. Regarding the PCC, some believe that it is not 
appropriate  for  immunofluorescence  co-localization  applications  because  the  acquired 
pixel data is rarely (if ever) normally distributed  (32). Pearson's correlation coefficient 
does not assume normality because it is defined based on the moments of the distribution, 
and therefore only requires finite variance and co-variance for the joint distribution. Both 
finite variance and finite co-variance are guaranteed since images are acquired with finite 
spatial  resolution  (determined  by  the  CCD  and  pixel  dimensions)  and  finite  pixel 
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dynamic range. In the condition where the joint probability distribution (of paired pixel 
intensities) is bi-variate Normal then the PCC is an exhaustive parameter to describes any 
linear dependence relationship. Second, the supposition that the PCC is not an acceptable 
parameter for hypothesis testing  (31) follows from the presumption that the normality 
condition is not met. However, the PCC has a long pedigree of being resilient to even 
severe  departures  from  normality  (47),  and  is  considered  a  reasonable  statistic  for 
hypothesis testing with specific application to co-localization analysis (33). While PCC is 
by is by no means perfect in every application (e.g., (48)), it offers many advantages over 
other  correlation  parameters  discussed  here  with  respect  to  less  complex  cases  of 
correlation. Li's ICQ was reported to be a better indication of co-localization (31), and it 
does make the implicit assumption that pixel intensities be symmetrically distributed. The 
parameter was chosen to simplify hypothesis testing by using the sign-test. However, this 
is  not  a  reasonable  assumption  especially  when  images  contain  noise.  Secondly,  the 
choice  of  the  underlying  distribution  of  the  sign-test  for  Li's  ICQ  is  the  Normal 
approximation  to  the  binomial  distribution,  but  in  all  fluorescence  microscopy 
applications,  pixels  do  not  satisfy  the  binomial  conditions  of  independence  (between 
pixels) and the probability of “success” (correlation), because pixels are more likely to be 
similar  to  their  immediate  neighbours due to  the blurring caused by the point-spread 
function of the imaging system. This is a property of both the point spread function in 
image  formation  (one  pixel  intensity  is  smoothed  out  over  many),  and  because  the 
cellular  location  of  a  labelled  molecule  may  be  restricted  to  protein  complexes, 
membranes or compartments. The SRC and even more, the Kendall's tau are promising 
statistics for co-localization analysis, and are currently implemented in FIJI.
4.5.1 Choice of appropriate controls
In terms of control experiments, it is first necessary to validate the probes that will be use 
for co-localization experiments, and then prepare to take good quality images. A set of 
slides should be sequentially imaged in all filter channels, where the slides are: 1) un-
labelled, to assess autofluorescence of the sample, 2) labelled with only one of the set of 
probes  (one  slide  per  probe)  to  determine  the  performance  of  each  probe,  and  3)  if 
necessary,  slides  in  which  primary  antibodies  are  omitted  to  test  specificity  of  the 
secondary antibody labelling. Once validated, the optical system should be checked for 
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proper  chromatic  calibration  (e.g.,  using  fluorescent  beads),  and  optical  alignment  to 
ensure the best quality image formation. If noise correction is anticipated, a replication 
based noise correction calculation  (37) is a method of reducing shot noise specifically 
from confocal images,  and requires a set  of four images and two sequential  scans to 
produce a  correction factor  for co-lcoalization analysis.  Other methods to consider  to 
reduce background and noise: software deconvolution, thresholding, sequential confocal 
image acquisition using line scanning or frame averaging.
The issue of biological controls is more flexible, and must be considered based on the 
particular system being examined. Negative controls should be collected in which two 
proteins are known to not interact or associate (except possibly by random diffusion). For 
example, if two proteins are expected to be restricted only to the nucleus, the choice 
could be as simple as a nuclear-localized GFP and DAPI, to characterize random intensity 
correlations within the ROI containing only the nucleus. On the other hand, if protein 
trafficking  is  being  monitored,  one  marker  should  be  a  stable  marker  of  the 
compartment(s) of interest (e.g., calnexin for the ER, or a  BGALT1 for the TGN); the 
second probe may be a protein that either does not traffic through the compartment but 
has  a  similar  sub-cellular  distribution  pattern  (e.g.,  endosomal  and  vesicular 
compartments), or does traffic through the compartment but does not interact within that 
compartment with a protein of interest. If using soluble dyes or GFP-derived proteins of 
acidic compartments, take precaution that they actually label the correct compartments 
(see for example, (45)). Positive controls are meant to mimic the correlation of interest, 
and serves as a maximum of the detectable co-localization. Such a control may be two 
proteins  that  are  known to  interact  within  the  compartment  of  interest,  they  may be 
artificial  interactions  in  the  same  compartment  (e.g.,  adding  high-affinity  tags  to 
recombinant proteins). A positive control can also be done by simultaneously labelling 
the same protein with limited amounts of two secondary antibodies, each labelled with a 
different  fluorophore.  The latter  method guarantees both correlated and co-distributed 
labelling of a protein of interest, but could suffer from the loss of sub-cellular context, 
and doesn't account for performance of a second labelled molecule. Having appropriate 
biological  controls  is  necessary  to  establish a  dynamic range of  independent  and co-
localized protein detection within the parameters of the imaging and biological systems, 
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and can then be used for statistical comparison. Lacking credible evaluation of known 
associated and independent proteins will be very difficult to interpret true from spurious 
co-localization.
4.5.2 Hypothesis testing of correlation parameters
Once all the images have been collected, an the quantification techniques complete, the 
cell biologist will next want to test their working hypothesis. Often the questions being 
asked are related to “does this mutant protein affect protein trafficking?” or “does a drug 
treatment alter protein localization?” or “does depletion or over-expression of one protein 
affect the distribution of two other proteins?” These are all very fine questions to ask, and 
with  co-localization,  they  will  be  answered  by hypothesis  testing,  usually  turning  to 
Student's t-test or an ANOVA. Under the  null hypothesis, none of these treatments will 
have any measurable effect,  and one must compute a test  statistic (e.g.,  t-statistic,  F-
statistic) that is  conditioned on the null distribution  to determine whether the observed 
value  is  more  extreme than  is  likely  to  have  occurred  by  random chance  within  an 
acceptable significance level (by convention, alpha is usually set to 5%).
The difficulty arises when considering what the joint probability distribution of two non-
co-localizing images looks like, and consequently, the shape of the test-statistic under the 
null hypothesis. This is not a trivial matter because if the null distribution deviates too far 
from normal, a standard t-test could have a much higher false-positive rate, and would 
lead  the  researcher  to  conclude  a  significant  finding  where  none  existed.  Having  a 
significant finding first assumes that the underlying null distribution is accurate (or close 
enough to accurate) and the finding was not likely to occur by chance. Conversely, failing 
to find a significant result could mean that the finding was likely to occur by chance 
given the null distribution, or that the null distribution is not accurate, and the conclusion 
is irrelevant because it was predicated on an invalid statistic. Most of the quantitative co-
localization studies neglect to address this specific point – what does a null distribution 
look like for any two non-correlation and non-co-localized image set? Presumably it will 
depend on a number of parameters, especially on the particular cell system, localization 
of the proteins, fluorophore labelling and the optical system used for imaging. It is also 
difficult, if not impossible, to predict this distribution in a general case a priori. How then 
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can I expect the statistical conclusions being drawn to be valid?
There is still no answer to the question of what a general null distribution looks like, but 
some researchers have made efforts in this way to find approximate distributions. Costes' 
significance test  proposes to work with two colour  channels  (34).  Briefly, one image 
channel is divided into discrete blocks, scrambling the image, and calculating the PCC 
with the other, original image, and repeated (usually 1,000 times). The expectation is that 
a  scrambled  PCC  will  be  less  correlated  that  the  original  image,  and  the  resulting 
scrambled  PCC  values  form  the  null  probability  distribution  due  only  to  random 
correlation, and the likelihood (p-value) can be computed. This scrambling technique, a 
form of bootstrapping, is not specific to PCC, and can be applied to any of the pixel- or 
voxel-based intensity correlation measures.  A drawback of both this  approach and its 
improvements  (49,  50) have  been compared  (33),  finding the  null  distribution  is  too 
broad  and  leading  to  false-positive  rates  greater  than  the  acceptable  significance 
threshold. A stronger implementation of this randomization technique not considered by 
McDonald was extended to multiple image labels, and is applicable to pixel-, voxel-, 
object- and intensity-based correlation techniques, but only considered the case of MCC 
(5). Through analysis of simulated and real image data (33), they find that the PCC is an 
acceptable parameter to use for hypothesis testing when using a one- or two-sample t-test, 
and expect similar performance for more complex experimental designs (e.,g requiring 
ANOVA or regression). Therefore, for most cell biological application of quantitative co-
localization, the standard statistical tests apply.
Another common pitfall is the issue of sample size, and often not reporting any power 
analysis calculation to determine the minimum sample size. The process of calculating a 
sample size is outside the scope of this paper (an excellent text on the subject can be 
found by (27, 28)), the maximum anticipated effect size should be carefully considered 
using a pilot experiment, and whether the researcher is interested in a one-tailed or two-
tailed hypothesis. For instance, many cell biological applications are interested in a one-
tailed hypothesis: the two labelled proteins are well segregated or they are co-localized 
(to some degree). A two-tailed hypothesis would be the anticipate greater or lesser co-
localization depending on the treatment. A well powered analysis requires consideration 
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of how the proteins of interest are localized in the cell. In the case of proteins that traffic  
together,  more  images  will  be  needed  for  a  well-powered  study  than  if  they  are 
segregated under some condition.
4.6  Conducting  Quantitative  Co-localization:  A 
suggested workflow
I suggest a workflow for co-localization analysis of immunofluorescence images start 
with  ensuring  that  the  microscope  be  optically  calibrated,  especially  for  chromatic 
alignment, and samples labelled with spectrally distinct fluorophores to minimize cross-
talk and bleed-through. While imaging, most software allow real-time monitoring of the 
histogram  which  should  be  checked  to  ensure  that  the  image  pixels  are  within  the 
dynamic range of the camera and that no pixels are saturated from over-exposure, and at 
a  sufficient  pixel  dwell  time  to  ensure  an  adequate  signal-to-noise  ratio.  Antibodies 
should  be  validated  such  that  the  labelling  is  specific  to  the  protein  of  interest  and 
localized  within  the known sub-cellular  compartment(s)  from literature.  Alternatively, 
recombinant  fluorescent  proteins  also  need  validation  for  immuno-detection  and 
biological validation demonstrating that the fluorescent protein tag does not interfere with 
its  usual  function  or  sub-cellular  trafficking.  Following  the  characterization  of  the 
imaging  system,  antibodies  and  fluorophores,  the  researcher  must  then  choose  of 
appropriate  biological  controls,  as  discussed  earlier.  For  3D imaging,  optical  z-stack 
images  should  be acquired  for  sufficient  axial  resolution of  the  sub-cellular  structure 
(e.g.,  0.2 µm step size), and for each imaging channel, the pinhole diameter must be 
matched for isometric resolution across each acquisition channel. Deconvolution for 3D 
confocal  image  stacks  is  recommended  for  imaging  intracellular  trafficking  in  fine-
structure organelles. Deconvolution requires a z-stack acquisition of the PSF by imaging 
single  fluorescent  beads  that  are  much  smaller  than  the  optical  resolution  of  the 
microscope using the identical light path settings of the microscope. This PSF should be 
used for deconvolution of microscope images. These steps are all important to ensure 
equal  resolution and good signal-to-noise ratios  in  collected images  to  produce  good 
quality image data. All image sets should also be saved in the microscope's native image 
format  to  preserve  the  experimental  meta-data  (containing  optical  path  information, 
microscope settings, etc.), and when exported for analysis, should be saved in their native 
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microscope  software  image  format  to  preserve  raw  images,  and  exported  to 
uncompressed tagged-image file format (TIFF) images for analysis.
Next, images for the negative and positive controls should be acquired. If possible, the 
live cytofluorogram at each stage of image acquisition should be viewed to monitor the 
relative amount of background in each channel, and can alert you to image quality issues 
during acquisition. Whether imaging individual or discrete clusters of cells, scan area 
should be increased to maximize pixel resolution and results in scanning the laser over a 
smaller sample area, reducing sample photobleaching and decreasing acquisition time. 
Once control images have been acquired, analysis can be done off-line. It is best to draw 
ROIs around single  or  distinct  clusters  of  few cells  for  analysis,  removing irrelevant 
background pixels. (Depending on the software package used, calculating co-localization 
coefficients can be performed using ROI selections, or these selections can be converted 
to a binary mask.)  To maximize efficiency several  co-localization coefficients can be 
calculated simultaneously, firstly the PCC with Costes' auto-threshold, and optionally the 
SRC and Kendall's  tau.  By examining the measured degrees of segregation (negative 
control) and association (positive control), the researcher now has a defined “dynamic 
range”  of  the  particular  experimental  system.  The Costes'  auto-threshold  can  also  be 
examined using the cytofluorogram to see if it is reasonable, in that a positive threshold 
value is reported, and it should be less than the mean signal intensity for each channel. If 
it is not reasonable, it may be symptomatic of poor image SNR, or not using an ROI and 
the background pixels prevent a reasonable threshold from being detected. If the control 
images look good and the co-localization parameters appear reasonable, images can be 
acquired  for  experimental  treatments  using  the  same  guidelines,  and  correlation 
parameters calculated. If the co-localization results by PCC are not clear, then consider 
the rank-correlation coefficients. If these results are still  not clear, then the researcher 
should explore using the more advanced cross-correlation functions (described below).
4.7  Advanced  methods  of  3D  co-localization  and 
extensions to super-resolution imaging
The co-localization methods described above work in simple cases, and in two colours 
only,  making  no  assumptions  about  the  underlying  biological  processes  involved  in 
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protein  co-localization.  Further  improvements  to  co-localization  analysis  have  been 
developed  by  including  more  information  or  using  more  sophisticated  analysis 
techniques.  Ideally, the quantitative co-localization method should be sensitive to co-
localization  of  one  channel  with  another  (and  extended  to  multiple  fluorophores), 
insensitive to noise and background, and be able to detect non-linear interaction patterns, 
such as protein complex assembly. Efforts made in this direction have been to propose 
new  co-localization  parameters,  and  increasingly,  moving  toward  super-resolution 
imaging.
With careful collection of z-stacks in microscopy, it is possible to achieve even greater 
resolution that the Rayleigh criteria by using optical deconvolution. Though more often 
used for wide-field fluorescence, 3D deconvolution can also be performed on confocal 
stacks, with the caveat that the volume be somewhat over-sampled (z-step of 0.2 µm) and 
voxel  sizes  matched  in  each  channel  to  achieve  equal  resolution  in  each  channel. 
Deconvolution is less often applied to confocal microscopy image sets, possibly because 
resolution  is  deemed  “good  enough”  for  the  proteins  or  structures  of  interest.  A 
comparison  was  performed  using  noise  filtering  and  3D  confocal  deconvolution 
techniques for multi-channel imaging (51) in which the both filtering and deconvolution 
improved co-localization parameter sensitivity. In their comparison, Pearson's correlation 
and Li's ICQ performed best. However, when resolution becomes a limiting factor (often 
by increased noise), noise removal techniques are necessary to simultaneously increase 
the  signal-to-noise  ratio  while  possibly  offering  improved  resolution,  with  resolution 
approaching  the  diffraction  limit  (41).  However,  when  noise  reduction  is  applied, 
confocal 3D deconvolution performs better than filtering methods in both simulated and 
real image sets (38, 52–54), and deconvolution should be performed on confocal stacks 
prior to co-localization analysis. Since 3D deconvolution is a computationally expensive 
task,  this  was an impediment,  especially  a decade ago when computational  power of 
desktop computers was more limited. However, a recent computational technique uses 
ImageJ  and  low-cost  computer  hardware  to  run  a  “blind”  (Lucy-Richardson) 
deconvolution  in  real-time,  removing  this  barrier  (55).  Such  “blind”  deconvolution 
methods  are  advantageous because  they  do not  require  any measurement  of  a  point-
spread function, but rather iteratively fit an ideal point-spread function to the images. To 
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provide better quality data for co-localization analysis deconvolution should be applied to 
improve image resolution and SNR.
Super-resolution  techniques  are  now  capable  of  dual-colour  nanoscopic  imaging 
technique.  Fluorescence  techniques  using  photoactivable  fluorescent  proteins 
(photoactivatable localization microscopy, PALM; and stochastic optical reconstruction 
microscopy,  STORM)  use  statistical  reconstruction  of  time-resolved  photoactivatable 
fluorophores to create super-resolution images. These images often create fusion proteins 
using photoactivatble or photoswitchable GFP (and derivatives thereof) to label specific 
intra-cellular structures or molecules. However, GFP-derived fluorophore brightness is 
known to  be  highly  pH-sensitive,  and a  common problem of  imaging within  mature 
granules (pH 5-5.5) is the partial or full quenching of fluorophore signal. Creating more 
stable PALM/STORM fluorophores in acidic conditions is an active area of development 
(56).  Presently there are  limited  numbers  of  fluorophores  with a  pKa compatible  for 
imaging within acidic compartments, though it has received little attention for granule 
imaging despite its apparent promise to imaging insulin secretory granules (57).
An alternative super-resolution approach called stimulated emission depletion (STED) 
uses  one  laser  to  excitation  a  diffraction-limited  spot,  while  simultaneously  using  a 
second laser to force stimulated emission of fluorophores within a sub-region, switching 
the fluorophores “off”, resulting in better lateral resolution  (58). STED achieves lateral 
resolution of about 15 nm in situ (59), and has the advantage of imaging live samples in 
real-time  with  approximately  50  nm  lateral  resolution  (60).  STED  systems  are  now 
compatible with multi-colour imaging (61, 62), and can be combined with TIRF or multi-
photon imaging. Recently, deconvolution techniques have also been considered for super-
resolution fluorescence imaging, as suggested by (60). Developing STED deconvolution 
algorithms is still actively being investigated (63), providing near-real time deconvolution 
speed  (on  the  order  of  1-10  seconds).  The  scaled-gradient-projection  deconvolution 
method is not just limited to STED, but any fluorescence microscopy method when the 
point-spread  function  is  supplied.  This  method  not  only  increases  STED  image 
resolution, but when applied to confocal images, brings the lateral resolution to ~90 nm, 
below the diffraction limit. Since the lasers used in confocal and STED microscopy are 
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fundamentally  diffraction-limited,  STED  imaging  can  still  suffer  from  poor  axial 
resolution.  Further  improvements  have  been  made  using  “compact”  STED  systems, 
increasing the axial resolution to ~100 nm (62, 64, 65), bringing STED into the realm of 
3D  nanoscopic  imaging.  STED  is  now  a  viable  nanoscopic  imaging  technique  for 
quantitative co-localization. For example, three-colour imaging can be used to determine 
object-based co-localization (61) or using conventional PCC analysis to determine biased 
interactions  between  hexokinase  and  distinct  isoforms  of  mitochondrial  voltage-
dependent  anion  channel  (66).  The  natural  increase  in  resolution  lends  itself  to 
developing more sophisticated object-based co-localization methods, especially for the 
application to monitoring protein trafficking along the secretory pathway (e.g.,  within 
secretory granules). These nanoscopic imaging techniques offer substantial increases in 
spatial  resolution,  and although they still  cannot directly  answer whether proteins are 
directly interacting, the increased resolution does offer greater insight to the dynamics of 
the secretory pathway and greater certainty to image within individual granules.
4.7.1 Novel and advanced co-localization parameters
A novel  rank-based  correlation  coefficient,  a  dual-channel  rank-weighted  correlation 
coefficient (RWC), has the clear advantage of being sensitive to both spatial correlation 
and intensity fluctuation (11). The intuition is similar to the PCC, in that a correlation is 
measured, but every pixel value is also weighted by rank. The biological benchmark for 
this  parameter  was  to  measure  intracellular  co-localization  of  the  temperate-sensitive 
VSV glycoprotein (tsO45-GFP), a model secretory cargo protein  (67, 68). By using a 
pulse-chase paradigm, a shift from the non-permissive incubation temperature 42°C to a 
permissive 32°C releases a wave of protein from the ER, and by fixing cells at intervals 
they measured co-localization from the ER to the trans-Golgi (11). Not only was this the 
first  quantitative  analysis  of  co-localization  for  this  cargo  protein,  their  findings  of 
intracellular trafficking kinetics agree with biochemical kinetic measurements, and show 
that the parameter performs well to detect small co-localization differences in a spatially 
compact structure of the Golgi.
Novel  co-localization  parameters  have  been  proposed  to  incorporate  structural 
information from 3D image stacks. Wang and colleagues  (69) reported two parameters 
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called the co-localization intensity and binary coefficients (CIC, CBC). This method has 
similar intuition to the correlation parameters discussed above, weighting similarities of 
pixel intensity from neighbouring focal planes to remove spurious cross-over that may 
otherwise  contribute  to  false  positive  co-localization.  This  method  is  more  robust  to 
spurious co-localization in noisy image sets, as tested using a model of nerve myelantion. 
An interesting aspect of their  technique is  that they specifically account for the axial 
signal overlap across neighbouring focal planes, and have tested the method within the 
limits of confocal axial resolution. It will be interesting to see how this method performs 
with  super-resolution  techniques  that  can  improve  axial  resolution  by  ~2-10-fold. 
Currently no commercial software packages perform this calculation.
A powerful technique for taking advantage of 3D information from confocal stacks is 
when sub-cellular compartments can be segmented and reconstructed into 3D volumes. 
At present, commercial (Image Pro, Imaris) packages and non-commerical packages both 
offer this ability. True “object-based” methods use these rendered volumes to detect co-
localization by several means. First, compartments such as vesicles can be reconstructed 
from image stacks based on an estimated size.  Typically, object-based co-localization 
occurs when the centroid of one object is near enough to another object's centroid, or it is 
within  the  reconstructed  volume  of  another  object  (see  for  example,  (5,  48)).  This 
advanced  method  builds  a  model  of  point-based  object  detection  for  investigating 
punctate objects (be it labelled proteins or vesicular compartments) with a bootstrapped 
statistical framework for making inferences, and is easily extended to 3D and time-lapse 
microscopy. This is still an area of active research to examine in such phenomena as virus 
entry into cells  (70), observing protein machinery maintaining cell polarity in  S. pombe 
using spherical  geometry  (71),  and dynamic  vesicle  identification  (3).  In  the  case  of 
intracellular protein trafficking, I have previously validated object-based co-localization 
of two secretory granule-targeted proteins, glucagon and a modified, dipolar GLP-2, to 
introduce a granule-targeting sorting signal (Figure 7). The co-localization of these two 
proteins were confirmed by PCC (72). The 3D renderings were reconstructed using each 
protein,  and  a  granule  resident  protein,  chromogranin  A,  and  the  percentage  of 
overlapping  objects  agrees  with  the  degree  of  co-localization  as  measured  by  PCC. 
Object-based  methods  have  the  advantage  of  being  able  to  exclude  objects  of 

158
colour image sets, and considers the effects of how the cross-correlation (both x- and y-
shifts of channel one with respect to channel two), and fitting a two-component Gaussian 
decay curve to the cross-correlation peak. When a fast-decaying component is present, 
this  differentiates  “true”  co-localization  from the  slow-decaying curve  that  represents 
auto-fluorescence. This technique also takes advantage of increased resolution of STED 
microscopy, explaining its  greater  sensitivity  to  detecting co-localization.  The idea of 
cross-correlation has been extended to dynamic single-particle tracking of confocal image 
stacks by comparing image cross-correlation with each particle's 3D trajectories to spatio-
temporally match fluorescent probes  (76). These cross-correlation and auto-correlation 
functions  are  particularly  suited  to  monitoring  dynamic  processes  over  time,  when 
intracellular trafficking or particle movement cannot be predicted a priori, but only after 
re-alignment.  They also  have the  advantage  of  being  sensitive to  repetitive  structural 
elements,  something that  may  be  useful  when monitoring  trafficking  through tubular 
structures or the Golgi cisternae.
Two novel  methods  take  advantage  of  nearest-neighbour  distance  metrics  and spatial 
inhomegeneity  to  detect  particle  clustering  as  a  marker  of  dynamic  protein-protein 
interactions. A recent approach (77, 78) whose method of co-localization is designed for 
super-resolution  images,  termed  spatial  association/apposition  analysis  (SAA).  Each 
particle object is segmented and evaluated for co-clustering probability with other nearby 
particles. First demonstrated to reveal receptor clustering on the cell surface (77), it has 
now  been  applied  to  monitor  inrtacellular  trafficking  by  vesicular  transport  and  is 
extended to multiple interacting particles. The spatial inhomogeneity assumption is that, 
if objects are not clustered, they should not exhibit a bias in nearest-neighbour distance or 
radial clustering to other objects. This technique has been validated for GSD microscopy, 
and should also be applicable to any single-particle super-resolution microscopy method. 
A mathematically related technique was reported to observe individual RNA polymerase 
II complexes, previously thought to exist as clusters of transcriptional factories within the 
nucleus  (79). The imaging technique is novel, adapting light-sheet and super-resolution 
microscopy to achieve much higher SNR images than conventional confocal microscopy, 
while  spatio-temporal  tracking  of  particles  is  used  to  detect  spatial  clustering  as  a 
measure of protein co-localization. This technique can also be be extended to measure 
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stoichiometric  interactions within particle  clusters.  The combination of  single particle 
tracking  methods  using  super  resolution  imaging  techniques  are  advantageous  for 
delineating stoichiometric ratios of protein clusters, and profiling the dynamic spatio-
temporal co-localization of proteins.
Lastly, a promising family of techniques that originate from the machine learning and 
image  segmentation  literature  are  Bayesian  approaches  to  co-localization.  The 
foundations of Bayesian analysis as applied to analysis of super-resolution images are 
best explored for image feature extraction (for review see (80)), though these methods are 
computationally  more  complex  than  many  of  the  alternative  method  described  here. 
Some progress in this direction have been to use Bayesian post-processing techniques of 
confocal and super-resolution images to localize proteins with similar precision to super-
resolution  imaging  alone  (81,82).  Recently  super-resolution  images  were  used  for 
Bayesian  localization  of  proteins,  to  detect  spatial  clusters  of  fluorescently  tagged 
receptors  in  the  cell  membrane  (83).  This  technique  is  promising  to  apply  when 
investigating multiple protein-protein interactions, such as the sorting events that occur in 
the regulated secretory pathway, as receptors are localized to newly forming granules 
with their cargo. As computational power increases, Bayesian analysis methods will be 
very interesting to follow for co-localization studies.
4.8 Conclusion
Extracting  quantitative  information  from  optical  microscopy  requires  care  in  the 
preparation  of  the  biological  specimen  but  also  knowledge  of  the  image  processing 
techniques  that  are  applied.  Diffraction  limited  microscopy in  particular  suffers  from 
blurring due to the point-spread function and variable image SNR. These aspects can be 
accounted for by appropriate image processing techniques, but it should be understood 
that these alter the “raw” image data. Trade-offs involved in image processing and image 
acquisition are illustrated by a discussion of quantitative immunofluoresence confocal 
microscopy for co-localization analyses, which represent the most common quantitative 
technique applied in confocal imaging. I suggest a workflow to acquiring 3D confocal 
image  stacks  for  co-localization  analysis  and  consider  the  most  commonly  used 
correlation parameters. As super-resolution and single particle imaging methods continue 
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to be adopted, extracting quantitative information will require the development of novel 
techniques. More sophisticated methods can also be applied to answer questions related 
to stoichiometry of the interaction between labelled molecules. As the resolution limits 
are  pushed  further  down,  the  sheer  amount  of  image  data  and  associated  analysis 
techniques will become the limiting factors for quantitative microscopy, and these data 
will continue to be mined to extract more quantitative spatial and temporal information.
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Chapter 5
5.1 Discussion and Future Directions
A central question in α- and L-cell biology is how proglucagon is sorted into granules in 
order to undergo processing to its constituent hormones and be effectively concentrated 
for later exocytosis. The  mechanisms of differential processing by PC1/3 and PC2 are 
well understood, but the specific location of where the convertase enzyme encounters its 
substrate, proglucagon, is not yet resolved. It is recognized that many (pro)hormones and 
neuropeptides contain sorting signals that are encountered and recognized by granule-
targeted  receptors  as  granules  are  formed.  Here  I  have  identified  that  proglucagon 
contains several sorting signals, and interestingly, two are contained within the mature 
hormone domains of glucagon and GLP-1 sequences. The molecular structure represents 
a novel class of α-helical sorting signals: an electrically polarized (dipolar) α-helix with 
discrete positively and negatively charged surfaces. This is distinct from the previously 
identified amphipathic  α-helices  which rely on a  large hydrophobic face.  I  have also 
characterized  some of  the  possible  molecular  interactions  in  both α-  and L-cells  that 
could serve as receptor-mediated binding of proglucagon. I have documented that sorting 
of proglucagon is cell-specific, requiring CPE, and is consistent with several reports that 
characterize CPE as a receptor for multiple hormones. I also have preliminary evidence 
for CgA serving a similar receptor role (in PC12 cells), binding to both the glucagon- and 
GLP-1 sorting  signals  in  a  pH-sensitive  manner. Therefore,  I  have  identified  distinct 
sorting signals within proglucagon and propose two receptors for interaction such that α-
cells can efficiently and adequately sort proglucagon to granules for processing to mature 
glucagon.
This  work  has  raised  new  and  unresolved  questions  concerning  the  biology  of 
proglucagon and the  field  of  hormone biology. Since  the  identification  of  dipolar  α-
helices as sorting signals, this molecular motif may be represented and unrecognized in 
other neuropeptides and hormones, proving that existing mechanisms for sorting are more 
adaptive  than  previously  thought,  or  supporting  the  existence  of  yet  unidentified 
receptors. On the basis of predicted protein secondary structure, dipolar helices may be 
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functional signals within pro-adrenomedullin (ADML),  pro-pituitary adenylate cyclase-
activating  polypeptide  (PACA),  glucose-dependent  insulinotropic  polypeptide  (GIP), 
pancreatic polypeptide (PAHO) and peptide-YY (PYY). Additionally, reinterpretation of 
the  amphipathic  α-helix  data  of  pro-cocaine  and  amphetamine-related  transcript 
(1) would  also  support  the  notion  of  a  dipolar  α-helix.  As  a  general  mechanism for 
dipolar α-helices, they are likely to undergo electrostatic association with charged granule 
targeted proteins (e.g., granin association is calcium- and pH-dependent) or charged lipid 
head groups of the granule membrane. A pH-dependent or cation-dependent interaction 
would support this view as suggested by initial experiments with glucagon and GLP-1. 
While no single universal mechanism for sorting prohormones exists, and there is a real 
possibility that new classes of signals have yet to be identified. An interesting possibility 
is that a β-sheet structure could be such a motif. The beta-sheet structure may form large-
scale aggregates, or target to granules by association with zwitterionic membrane lipids 
(e.g., phosphatidylcholine) or by association with cholesterol. One example is found in 
hepcidin, a key metabolic regulator of iron homeostasis. Both the pro-form and mature 
hepcidin are small  peptides (60 amino acids in the pro-form, and 20 or 25 in mature 
form), and the mature hepcidin structure has been resolved (see Table 1). Then there is 
the  curious  xenin-25,  a  regulated  secretory  protein  found  within  granules  of  many 
endocrine tissues. It is unique in that it is likely the shortest pro-peptide at 35 amino acids 
in  length,  and is  cleaved to mature xenin-25  (2).   Since it  constitutes the N-terminal 
domain of coatomer sub-unit A, a cytosolic coat protein, it is unknown how pro-xenin 
enters the regulated secretory pathway. Yet, xenin is still a secreted gut hormone (3) and 
the  beta  sheet  structure  may  constitute  a  novel  sorting  signal  (Table  1).  Further 
characterization of how neuropeptides and hormones will likely reveal new classes of 
motifs and interactions, and will contribute to the general understanding of sorting along 
the regulated secretory pathway.
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Table 1. Hypothetical novel classes of sorting signals.
Putative  sorting 
signal(s)
Example  Protein 
(Gene) name
3D Structure
Β-sheet or hairpin Hepcidin (HEPC)
Protein Data Bank ID: 1M4E
B-sheet Xenin-25 (COPA)
Results  were  generated  by  de  novo 
prediction.
Concerning new questions specifically related to the biology of proglucagon, there are 
some major  questions  to  resolve:  1)  what  is  the  location  where  proglucagon is  both 
initially sorted?; 2) where precisely is proglucagon initially cleaved into glicentin and 
MPGF?; 3) what is  the nature of the distribution of the processed PGDPs within the 
granule population?; and 4) what is the nature of interaction between proglucagon and 
CPE  and  CgA?  It  is  well  known  that  secretory  granules  are  functionally 
transported/diverted  to  distinct  pools  that  are  operationally  distinguished  based  on 
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whether  they  are  docked  at  the  plasma membrane or  nearby,  and whether  they  are 
immediately releasable or if there is a lag prior to exocytosis. This difference is largely 
explained  by the  type  of  effector  proteins  on  the  cytosolic  leaflet  of  the  granule  (in 
particular Rab3, Rab27 and SNARE proteins and SNARE accessory proteins) and the 
particular secretory state of the cell. For example, young granules spatially segregate near 
the membrane over older granules in bovine chromaffin cells, appearing docked at the 
membrane, while older granules are more mobile (4, 5). A related and under-considered 
question concerns the existence and identity of distinct sub-populations of newly formed 
secretory  granules.  In  other  words,  are  (neuro)endocrine  peptides  further  able  to 
differentially load cargo, thereby producing distinct subs-populations of granules? Many 
reports, principally by immuno-electron microscopy, report natural variation the spatial 
location and density of cargo proteins in the granule, distributed among the dense core 
and the translucent halo. However, whether this process is a by-product either of natural 
variations in granule biogenesis, or a result of divergent biogenesis mechanisms, remains 
a mostly unexplored question  (6). Immunoelectron studies of the distribution of GLP-1 
and GLP-2; glicentin and MPGF; and glucagon and MPGF; are all suggestive that the 
PGDPs are co-stored within the same granule,  and thus enter the same population of 
granules. However, this has not been definitively addressed, and the data at hand only 
suggest a correlation. Recent evidence has been identified in GLUTag cells whereby the 
classical techniques of labelling granules by means of GFP-tagged hormones (e.g., GH, 
BDNF and NPY), were each shown to co-distribute to varying degrees with GLP-1 (7). 
Though it was not the focus of that study, they found that GFP-tagged NPY and BDNF 
strongly localized to GLP-1-containing granules, while GFP-tagged GH was completely 
segregated from GLP-1. Super-resolution microscopy is an excellent method to examine 
the distribution of GLP-1 and GLP-2, or glucagon and MPGF, within granules.
Evidence in support of distinct sub-populations of granules have only been reported for 
pituitary-derived  neuroendocrine  cells.  In  AtT-20  cells  (corticotrophs),  exogenous 
expression  of  syncollin  enters  granules  containing  ATCH,  but  not  VAMP-2  (8),  the 
granule  membrane  v-SNARE required  for  exocytosis  and  in  agreement  with  similar 
findings of unequal cargo distributions in AtT-20 cells  (9). A parallel observation was 
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reported  in  multiple  beta  cell  lines,  in  which  the  loading  of  CgB  and  insulin  was 
heterogeneously distributed, some granules containing only insulin, a mix of insulin and 
CgB,  or  CgB  alone  (in  a  percent  ratio  of  66:27:7)  (10).  Though  they  demonstrated 
different  profiles  of  secretion  through  various  types  and  doses  of  secretagogue 
stimulation, the explanation could be due to truly distinct sub-populations of granules (as 
the authors suggested), or a coincidental result of a single population of granules that is 
being  dynamically  regulated  for  distinct  kinetics  of  exocytosis,  as  has  been  well-
documented from PC12 and chromaffin cells (11–13). This remains a possible additional 
layer of complexity to the granule biogenesis process and the functional significance of a 
diverse granule population.
To  understand  when  and  where  proglucagon  is  sorted  and  processed,  advanced 
visualization  techniques  and  proteomics  could  be  used  to  distinguish  the  sub-
compartments of the TGN from immature and mature SGs. This would necessarilyy add 
temporal  resolution  to  the  examination  of  the  dynamic  sorting  process.  While  the 
specificity of antibodies to detect all species of PGDPs without cross-reactivity is major 
challenge,  both  sensitive  and  specific  detection  methods  are  required  for  monitoring 
proglucagon undergoing processing. LC-MS-based proteomic detection (14, 15) certainly 
meets  these  requirements.  However,  proteomics  methods  destructively  sample  the 
contents of cells, requiring pooling and a loss of temporal and spatial resolution. The 
challenge is  to not only distinguish proglucagon from the PGDPs (i.e.,  glucagon and 
glicentin), but also to delineate the multiple compartments of the secretory pathway. The 
latter is somewhat easier to accomplish by immuno-staining proteins that either reside in 
ISGs but do not traffic to mature granules. Some examples include furin (16), mannose-6-
phosphate  receptor  (M6PR),  syntaxin  6,  clathrin  (17),  carboxypeptidase  D  (18), 
synaptotagmin  IV,  VAMP4  (19),  and  Golgi-associated,  γ-ear-containing,  ADP-
ribosylation  factor-binding  protein  (GGA)  (20),  adding  non-specific  compartment 
labelling. More specific labelling approaches have been proposed on the basis of using 
fluorescent proteins as molecular timers.
A molecular timer is any molecule that can develop or change its fluorescence properties 
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over time. Early uses of a fluorescent timer applied to intracellular trafficking used a pH-
sensitive GFP, pHluorin. As the pHluorin is exposed to increasingly acidic environments, 
the  GFP emission  profile  dims  from physiologic  pH  and  is  quenched  by  the  acidic 
environment  of  mature  granules  (21).  Applications  to  intracellular  trafficking  are 
particularly convincing when using fluorescence TIRF imaging to monitor live granule 
exocytosis, the fluorophore immediately recovering fluorescence as soon as the fusion 
pore forms to neutralize the acidic granular pH. The disadvantage of this technique is the 
progressive signal loss as granules mature, and no clear distinction of immature granules. 
A related idea takes advantage of the slowly-maturing RFP variant that changes emission 
from green to red, has been used to monitor chromaffin granule ageing and secretion 
(4) when fused to a granule-targeted protein. One such protein, syncollin, is targeted to 
granules of endocrine (22) and neuroendocrine cells (23), and unlike its natural inhibitory 
action of granule exocytosis, does not affect exocytosis kinetics as a fusion (24). A major 
draw back to this timer is that the transition time is ~ 16 h (4, 25), which would preclude 
the temporal resolution of nascent and maturing granules, but is ideal to monitor age-
coded mature granules. Therefore, a faster timer was engineered from th mKusabira-GO 
fluorophore,  undergoing  a  similar  green  to  orange  transition  (5),  which  has  a  linear 
transition over 1-10 hours, making it ideal for monitoring nascent and maturing granules. 
An interesting third approach to timing makes  use of a transgenic mouse expressing 
recombinant SNAP-tagged insulin for monitoring young granules in beta cell  (26). The 
SNAP domain is  derived from the  human O6-methylguanine-DNA methyltransferase, 
and when exposed to a benzylguanine-containing substrates, catalyzes a reaction that is 
used to transfer a fluorescent dye (e.g., TMR-Star, BG-505) to the SNAP tag  (27). As 
used in the SOFIA mouse  (26), the SNAP-tag approach offers the temporal resolution, 
and  was  used  in  a  pulse-chase  paradigm  to  preferentially  label  older  and  younger 
granules with different fluorescent dyes. While they showed preferential exocytosis of 
“young” over “old” insulin granules, the technique is extensible to specific “gating” of 
granules with defined age, and can be applied to specifically monitor immature granules.
To directly  address  the  question  of  where  the  initial  cleavage  event  of  proglucagon 
occurs,  fluorescent  tagging  strategies  could  be  leveraged  to  enrich  a  population  of 
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immature  granules  combined  with  downstream analysis  by  proteomics  techniques.  A 
challenge to investigate proglucagon has always been the availability and performance of 
antibodies  against  the  multitude  of  PGDPs.  To circumvent  this  issue,  proteomics  are 
ideally suited for accurate quantitation and fingerprinting of proglucagon and PGDPs. 
The approach described by (26) could be modified to only label the immature granules 
(granules only 15-30 minutes old) by first “blocking” a granule-targeted SNAP protein 
with the non-fluorescent BTP, followed by a short pulse of a rhodamine-derived TMR-
Star. Cell membranes can be gently lysed in hypotonic solution leaving in tact the granule 
population,  and  subjected  to  fluorescent-activated  organelle  sorting  (28).  Double-
labelling approaches to specifically label the immature SGs, either by a a fluorescent 
timer  or  specifically  tagged  ISG  protein  could  be  used  as  a  positive  control  or  for 
increased specificity by dual-fluorescence-activated sorting. By preserving the labelled 
immature granules, they can be enriched for LC-MS/MS proteomic analysis, or “printed” 
onto a thin layer of mica for imaging by atomic force microscopy, electron microscopy or 
optical imaging to ensure the quality and enrichment of immature granules. In this way, 
the contents of ISGs will reveal the relative abundance of proglucagon to the PGDPs. If  
this experiment is conducted in native cell lines, and compared with cells that either lack 
PC1/3 and PC2 (e..g, PC12), or in native cell lines in which PC1/3 and PC2 have been 
depleted or inhibited, this approach also answers whether initial cleavage occurs in the 
TGN or ISG. If the initial cleavage occurs in both compartments, this technique can also 
assign the degree of cleavage to each compartment. While more elaborate schemes can be 
imagined,  this  approach  is  advantageous  because  it  combines  the  sensitivity  of  MS 
analysis with the specificity of granules that have been defined by their age. One could 
also imagine a time course comparison to observe the changes in proteomic profile as 
granules age to confirm the conversion of proglucagon to its constituent hormones.
From Chapter 2, I concluded that the initial processing of proglucagon was necessary to 
enhance sorting, on the basis that a block in this event resulted less efficient sorting. I 
refined this model in  Chapter 3 by more closely examining the nature of the sorting 
signals within the proglucagon-derived peptides. Based on the data at hand, I concluded 
that the proglucagon cleavage event must occur after it is sorted to granules, on both the 
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nature  of  the  signals  and  the  marked  difference  in  trafficking  between  glicentin  and 
MPGF, where glicentin partially entered synaptic-like micro-vesicles. I developed and 
validated a  more rigorous approach to quantitative co-localization in  Chapter 3,  and 
discuss how it compares to other common methods in Chapter 4, as well as considering 
more innovative quantitative co-localization techniques. A more rigorous and quantifiable 
technique  to  directly  address  proglucagon  sorting  can  take  advantage  of  one  of  the 
advanced  co-localization  techniques  described  in  Chapter  4,  and  complementary 
proteomics-based approaches as previously described. Single-particle tracking analyses 
can be used to visualize the spatial distribution of glicentin and MPGF when combined 
with  high-temporal  resolution  labelling  techniques  (such  as  fluorescent  “timers”  and 
SNAP-tag  labelling),  bringing sufficient  resolution  to  monitor  sorting  and processing 
events in the secretory pathway.
5.2 References
1. Blanco, E. H., Lagos, C. F., Andrés, M. E., and Gysling, K. (2013) An amphipathic alpha-helix in the  
prodomain of cocaine and amphetamine regulated transcript Peptide precursor serves as its sorting 
signal to the regulated secretory pathway. PLoS One 8, e59695
2. Anlauf, M., Weihe, E., Hartschuh, W., Hamscher, G., and Feurle, G. E. (2000) Localization of xenin-
immunoreactive cells in the duodenal mucosa of  humans and various mammals.  J. Histochem.  
Cytochem. 48, 1617–26
3. Chowdhury, S., Reeds, D. N., Crimmins, D. L., Patterson, B. W., Laciny, E., Wang, S., Tran, H. D.,  
Griest, T. a, Rometo, D. a, Dunai, J., Wallendorf, M. J., Ladenson, J. H., Polonsky, K. S., and Wice,  
B. M. (2014) Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans 
with and without type 2 diabetes. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G301–9
4. Duncan, R. R., Greaves, J., Wiegand, U. K., Matskevich, I., Bodammer, G., Apps, D. K., Shipston, M. J., 
and Chow, R. H. (2003) Functional and spatial segregation of secretory vesicle pools according to  
vesicle age. Nature 422, 176–80
5.  Tsuboi,  T.,  Kitaguchi,  T.,  Karasawa,  S.,  Fukuda,  M.,  and  Miyawaki,  A.  (2010)  Age-dependent 
preferential  dense-core vesicle exocytosis in neuroendocrine cells revealed by newly developed 
monomeric fluorescent timer protein. Mol. Biol. Cell 21, 87–94
6.  Laslop,  A.,  Weiss,  C.,  Savaria,  D.,  Eiter,  C.,  Tooze,  S.  A.,  Seidah,  N.  G.,  and  Winkler,  H.  (1998)  
Proteolytic  processing  of  chromogranin  B and secretogranin II  by prohormone convertases.  J.  
Neurochem. 70, 374–83
7. Oya, M., Kitaguchi, T., Pais, R., Reimann, F., Gribble, F., and Tsuboi, T. (2013) The G protein-coupled  
receptor  family  C  group  6  subtype  A (GPRC6A)  receptor  is  involved  in  amino  acid-induced 
glucagon-like peptide-1 secretion from GLUTag cells. J. Biol. Chem. 288, 4513–21
8.  Wäsle,  B.,  Hays,  L.  B.,  Rhodes,  C.  J.,  and  Edwardson,  J.  M.  (2004)  Syncollin  inhibits  regulated 
corticotropin secretion from AtT-20 cells through a reduction in the secretory vesicle population. 
Biochem. J. 380, 897–905
9. Sobota, J. A., Ferraro, F., Bäck, N., Eipper, B. A., and Mains, R. E. (2006) Not all secretory granules are  
created equal: Partitioning of soluble content proteins. Mol. Biol. Cell 17, 5038–52
10. Giordano, T., Brigatti, C., Podini, P., Bonifacio, E., Meldolesi, J., and Malosio, M. L. (2008) Beta cell 
chromogranin B is partially segregated in distinct granules and can be released separately from 
172
insulin in response to stimulation. Diabetologia 51, 997–1007
11. Sombers, L. a, Maxson, M. M., and Ewing, a G. (2005) Loaded dopamine is preferentially stored in the 
halo portion of PC12 cell dense core vesicles. J. Neurochem. 93, 1122–31
12. Grabner, C. P., Price, S. D., Lysakowski, A., and Fox, A. P. (2005) Mouse chromaffin cells have two 
populations of dense core vesicles. J. Neurophysiol. 94, 2093–104
13.  Dong,  Y.,  Ning,  G.,  Ewing,  A.  G.,  and Heien,  M. L. (2014) Pituitary adenylate cyclase activating 
polypeptide modulates catecholamine storage and exocytosis in PC12 cells. PLoS One 9, e91132
14. Taylor, S. W., Nikoulina, S. E., Andon, N. L., and Lowe, C. (2013) Peptidomic profiling of secreted 
products from pancreatic islet culture results in a higher yield of full-length peptide hormones than 
found using cell lysis procedures. J. Proteome Res. 12, 3610–9
15. Lapko, V. N., Miller, P. S., Brown, G. P., Islam, R., Peters, S. K., Sukovaty, R. L., Ruhn, P. F., and 
Kafonek,  C.  J.  (2013)  Sensitive  glucagon  quantification  by  immunochemical  and  LC-MS/MS 
methods. Bioanalysis 5, 2957–72
16.  Dittié,  A.  S.,  Thomas,  L.,  Thomas,  G.,  and  Tooze,  S.  A.  (1997)  Interaction  of  furin  in  immature 
secretory  granules  from neuroendocrine  cells  with  the  AP-1  adaptor  complex  is  modulated  by 
casein kinase II phosphorylation. EMBO J. 16, 4859–70
17. Klumperman, J., Kuliawat, R., Griffith, J. M., Geuze, H. J., and Arvan, P. (1998) Mannose 6-phosphate 
receptors  are  sorted  from immature  secretory  granules  via  adaptor  protein  AP-1,  clathrin,  and 
syntaxin 6-positive vesicles. J. Cell Biol. 141, 359–71
18.  Varlamov,  O.,  Eng,  F.  J.,  Novikova,  E.  G.,  and  Fricker,  L.  D.  (1999)  Localization  of 
metallocarboxypeptidase D in AtT-20 cells. Potential role in prohormone processing. J. Biol. Chem. 
274, 14759–67
19. Eaton, B. a, Haugwitz, M., Lau, D., and Moore, H. P. (2000) Biogenesis of regulated exocytotic carriers  
in neuroendocrine cells. J. Neurosci. 20, 7334–44
20. Kakhlon, O., Sakya, P., Larijani, B., Watson, R., and Tooze, S. a (2006) GGA function is required for  
maturation of neuroendocrine secretory granules. EMBO J. 25, 1590–602
21. Miesenböck,  G.,  De Angelis,  D. A.,  and Rothman,  J.  E. (1998) Visualizing secretion and synaptic 
transmission with pH-sensitive green fluorescent proteins. Nature 394, 192–5
22. Ma, L., Bindokas, V. P., Kuznetsov, A., Rhodes, C., Hays, L., Edwardson, J. M., Ueda, K., Steiner, D.  
F., and Philipson, L. H. (2004) Direct imaging shows that insulin granule exocytosis occurs by 
complete vesicle fusion. Proc. Natl. Acad. Sci. U. S. A. 101, 9266–71
23. Hodel, A., and Edwardson, J. M. (2000) Targeting of the zymogen-granule protein syncollin in AR42J 
and AtT-20 cells. Biochem. J. 350 Pt 3, 637–43
24. Hays, L. B., Wicksteed, B., Wang, Y., McCuaig, J. F., Philipson, L. H., Edwardson, J. M., and Rhodes,  
C. J. (2005) Intragranular targeting of syncollin, but not a syncollinGFP chimera, inhibits regulated 
insulin exocytosis in pancreatic beta-cells. J. Endocrinol. 185, 57–67
25. Kebede, M. a, Oler, A. T., Gregg, T., Balloon, A. J., Johnson, A., Mitok, K., Rabaglia, M., Schueler, K., 
Stapleton, D., Thorstenson, C., Wrighton, L., Floyd, B. J., Richards, O., Raines, S., Eliceiri, K., 
Seidah, N. G., Rhodes, C., Keller, M. P., Coon, J. L., Audhya, A., and Attie, A. D. (2014) SORCS1 
is necessary for normal insulin secretory granule biogenesis in metabolically stressed β-cells.  J.  
Clin. Invest., 20–23
26. Ivanova, A., Kalaidzidis, Y., Dirkx, R., Sarov, M., Gerlach, M., Schroth-Diez, B., Müller, A., Liu, Y., 
Andree,  C., Mulligan, B., Münster, C., Kurth, T., Bickle,  M., Speier, S., Anastassiadis,  K., and  
Solimena, M. (2013) Age-dependent labeling and imaging of insulin secretory granules.  Diabetes 
62, 3687–96
27. Keppler, A., Pick, H., Arrivoli, C., Vogel, H., and Johnsson, K. (2004) Labeling of fusion proteins with 
synthetic fluorophores in live cells. Proc. Natl. Acad. Sci. U. S. A. 101, 9955–9
28. Gauthier, D. J., Sobota, J. a, Ferraro, F., Mains, R. E., and Lazure, C. (2008) Flow cytometry-assisted 
purification and proteomic analysis of the corticotropes dense-core secretory granules. Proteomics 
8, 3848–61
173
Appendix
Appendix 1. Code contributions to the FIJI/ImageJ project
In order  to  explore the computational  application  of  co-localization,  I  sought  a  software 
package  that  both  implemented  Pearson's  correlation  coefficient  and  was  intended  for 
scientific  applications.  Several  commercial  and  non-commercial  software  packages 
incorporate Pearson's correlation coefficient and multiple other co-localization algorithms. 
Among them, I chose to use FIJI/ImageJ, because of its popularity in biological sciences; it is 
free (in cost and license); open-source; has a responsive developer community; and runs on 
platforms. Within FIJI, the Colocalization analysis plug-in (called “Coloc 2”) measures co-
localization either on whole images, masked images or selected regions-of-interest (ROIs). I 
first tested the validity of the calculation by using “toy” image sets, such that the Pearson's 
correlation  coefficient  could  be  independently  verified  by manual  and Excel  spreadsheet 
calculations. From these tests, it became apparent that the Pearson's correlation coefficient 
calculations were numerically flawed, and resulted (at times) in substantially under- or over-
inflated  correlation  values  on  test  image  sets.  Obviously,  this  was  problematic,  and  in 
reaching out the core FIJI developers, I discovered that this bug had not yet been reported. 
Therefore, it is possible that had Coloc 2 been used for co-localization, incorrect correlation 
values may have been reported in scientific literature. At the same time as fixing this bug, I 
had also added another algorithm to compute Spearman's rank correlation coefficient. The 
Spearman's rank correlation might be useful for future co-localization studies using FIJI.
Bug fixes for the FIJI Colocalization analysis plug-in
The existing bugs inside of the Colocalization analysis plug-in could be divided into two 
categories: a numerical error, and a logical error. The latter, logical error, failed to properly 
handle ROI selections. In theory, any selected ROI would have its co-localization parameters 
calculated for only those pixels within the ROI. In this bug, a selected ROI correctly returned 
the pixels contained therein, yet the image statistics of each channel mean intensity and sum 
of  squared differences  were computed from the entire  image,  ignoring the selected ROI, 
causing  the  parameter  to  be  miscalculated.  Second,  the  numerical  error  was  the  use  of 
incorrect arithmetic in translating the mathematical equation for Pearson's correlation into 
computer arithmetic, resulting again in miscalculation. A by-product of this numerical error 
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was that there was a mismatch between the software calculation of an integer and a floating-
point value, that results in rounding error. This code was sent to the developer mailing list  
and was incorporated in the code base by the core developers (at approximately the same 
time as the Spearman rank correlation coefficient below).
Addition of the Spearman's Rank Correlation Coefficient Algorithm 
to FIJI
The Spearman's rank correlation coefficient is the rank-ordered equivalent of the Pearson's 
correlation  coefficient.  Specifically,  when  both  continuous  variables  used  for  Pearson's 
correlation are converted to their rank-order, the Pearson's ρ is equivalent to the Spearman's 
ρ. An additional component of this correlation value is that ties in rank must be resolved 
according to the average of their positions. For a sample of  i values (e.g., a pair of images 
each with i pixels), the Spearman's ρ is calculated as follows:
where  subscript  i is  the  rank  of  each pixel,  x and  y represent  each  image  channel,  and 
overbars represent mean pixel rank. Similar to Pearson's ρ, Spearman's ρ is also continuous 
on the domain [-1,1].
An attractive feature of using this technique is that Spearman's  ρ is more sensitive to non-
linear  statistical  co-relationships.  Despite  similar  advantages  to  Pearson's  correlation, 
Spearman's rank correlation has the potential to discriminate sub-cellular compartments by 
nature of its rank-ordered computation. However, this has not yet been critically applied to 
fluorescence microscopy for the purposes of protein co-localization in real image sets.
The revision history for the Spearman's rank correlation coefficient is publicly available from 
GitHub (commit# 5e134f48; found online at  
http://github.com/fiji/fiji/commit/5e134f487709fc37e5afd7e72b0f8d92605b4168). The 
substantive algorithm code has been re-produced below, from the 
SpearmanRankCorrelation.java source file:
public static <T extends RealType<T>> double 
calculateSpearmanRank(TwinCursor<T> cursor) {
    
    // Step 0: Count the pixels first.5
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    int n = 0;
    while (cursor.hasNext()) {
        n++;
        cursor.fwd();
    }
    cursor.reset();
    
    data = new double[n][2];
    ch1raw = new double[n];
    ch2raw = new double[n];
    ch1ranks = new double[n];
    ch2ranks = new double[n];
    
    for (int i = 0; i < n; i++) {
        cursor.fwd();
        T type1 = cursor.getChannel1();
        T type2 = cursor.getChannel2();
        data[i][0] = type1.getRealDouble();
        data[i][1] = type2.getRealDouble();
        ch1raw[i] = data[i][0];
        ch2raw[i] = data[i][1];
    }
    
    /**
     * Here's the concept. Rank-transform the data, then run 
     * the Pearson correlation on the transformed data.
     * 
     * 1) We will sort the dataset by one column, extract the 
     *    column values and rank them, and replace the data by 
     *    the ranks.
     * 2) Repeat the process now with the remaining column.
     * 3) Calculate the coefficient from the individual rank
     *    columns, the t-statistic and the df's of the test.
     */
    
    // Step 1: Sort the raw data, by column #2 (arbitrary choice).
    Arrays.sort(data, new Comparator<double[]>() {
    public int compare(double[] row1, double[] row2) {
        return Double.compare(row1[1], row2[1]);
        }
        });
    
    for (int i = 0; i < n; i++) {
        ch2raw[i] = data[i][1];
    }
    
    // Rank the data then replace them into the dataset.
    ch2ranks = rankValues(ch2raw);
    for (int i = 0; i < n; i++) {
        data[i][1] = ch2ranks[i];
    }
    
    // Step 2: Repeat step 1 with the other data column.
    Arrays.sort(data, new Comparator<double[]>() {
        public int compare(double[] row1, double[] row2) {
            return Double.compare(row1[0], row2[0]);
        }
        });
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    for (int i = 0; i < n; i++) {
        ch1raw[i] = data[i][0];
    }
    
    ch1ranks = rankValues(ch1raw);
    for (int i = 0; i < n; i++) {
        data[i][0] = ch1ranks[i];
        ch2ranks[i] = data[i][1];
    }
    
    // Step 3: Compute statistics.
    rhoValue = calculateRho(ch1ranks, ch2ranks);
    tStatisticSpearman = getTStatistic(rhoValue, n);
    dfSpearman = getSpearmanDF(n);
    
    return rhoValue;
}
   
public static double getTStatistic(double rho, int n) {
    double rho_squared = rhoValue * rhoValue;
    return ( rhoValue * Math.sqrt((n - 2) / (1 - rho_squared)) );
}    
public static double[] rankValues(double[] sortedVals) {
    
    int len = sortedVals.length;
    int start = 0;
    int end = 0;
    double[] newranks = new double[len];
    double avg = 0, ranksum = 0;
    boolean ties_found = false;
    
    // first assign ranks, ascending from 1
    for (int i=0; i<len; i++) {
        newranks[i] = i+1;
    }
    
    // check for tied values
    for (int i=0; i<len; i++) {
        start = i;
        end = i;
        
        // Advance values while you haven't exceeded the final value in the 
ranked data,
        // and until we break a tie in values.
        while ((++end < len) && (sortedVals[start] == sortedVals[end])) {
            ties_found = true;
        }
        
        // Check if we advanced our end position
        if ((end-start != 1) && (ties_found)) {
            // Compute arithmetic average of rank according to Spearman's 
method:
            // average = sum of ranks / number of ranks
            avg = 0;
            ranksum = 0;
            for (int j=start; j<end; j++) {
                ranksum += newranks[j];
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            }
            avg = ranksum / (end-start);
        
            // Assign averages to the tied ranks
            for (int x=start; x<end; x++) {
                newranks[x] = avg;
            }
            
            ties_found = false;         
        }
        
        //reset i
        i=end-1;
    }
    
    return newranks;
}
public static double calculateRho(double[] x, double[] y) {
    // Define some variables.
    double rho;
    int len = x.length; // the lengths should be the same for each array
    double mean_x = 0.0, mean_y = 0.0;
    double sum_x = 0.0, sum_y = 0.0;
    double sd_x = 0.0, sd_y = 0.0, sd_xy = 0.0;
    double ssd_x = 0.0, ssd_y = 0.0;
    double denominator = 0.0;
    int i = 0;
    
    // Calculate the mean of each rank set
    for (i = 0; i < len; i++) {
        sum_x += x[i];
        sum_y += y[i];
    }
    mean_x = sum_x / len;
    mean_y = sum_y / len;
    
    for (i = 0; i < len; i++) {
        // Calculate the Sum of Differences (numerator)
        sd_x = x[i] - mean_x;
        sd_y = y[i] - mean_y;
        sd_xy += sd_x * sd_y;
        
        // Calculate the Sum of Squared Difference
        ssd_x += (x[i] - mean_x) * (x[i] - mean_x);
        ssd_y += (y[i] - mean_y) * (y[i] - mean_y);
    }
    
    /** Calculate rho
     * We calculate it this way rather than the alternative in the case
     * (1 - [ (6 sum d^2) / (n(n^2 - 1)) ] which is a simplification when
     * there are no ties in rank transformed data.
     */
    denominator = Math.sqrt(ssd_x * ssd_y);
    rho = sd_xy / denominator;    
    return rho;
}
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